| Oct 10, 2025 | Action.Communication | - |
| Oct 9, 2025 | Receipt | - |
| Oct 9, 2025 | Proof Of Payment | - |
| Oct 9, 2025 | Other Document | - |
| Oct 9, 2025 | Fee | - |
| Oct 9, 2025 | Cover Sheet | - |
| Oct 9, 2025 | Application | - |
| Oct 7, 2025 | Order | - |
| Oct 7, 2025 | Action.Issueorder | - |
| Oct 6, 2025 | Action.Communication | - |
| Oct 5, 2025 | Receipt | - |
| Oct 5, 2025 | Cover Sheet | - |
| Oct 5, 2025 | Application | - |
| Oct 2, 2025 | Receipt | - |
| Oct 2, 2025 | Order | - |
| Oct 2, 2025 | Cover Sheet | - |
| Oct 2, 2025 | Application | - |
| Oct 2, 2025 | Action.Issueorder | - |
| Oct 1, 2025 | Statement Of Reply | - |
| Oct 1, 2025 | Receipt | - |
| Oct 1, 2025 | Exhibit | - |
| Oct 1, 2025 | Cover Sheet | - |
| Oct 1, 2025 | Application | - |
| Sep 26, 2025 | Action.Communication | - |
| Sep 25, 2025 | Receipt | - |
| Sep 25, 2025 | Other Document | - |
| Sep 25, 2025 | Exhibit | - |
| Sep 25, 2025 | Cover Sheet | - |
| Sep 25, 2025 | Action.Communication | - |
| Sep 24, 2025 | Order | - |
| Sep 24, 2025 | Action.Issueorder | - |
| Sep 18, 2025 | Request V.Def Pdf A Signed | - |
| Sep 18, 2025 | Receipt | - |
| Sep 18, 2025 | Pc154 Iqvia Agreement Gb | - |
| Sep 18, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 17, 2025 | Receipt | - |
| Sep 17, 2025 | Procedural Order | |
| Sep 17, 2025 | Outcome Of The Order | - |
| Sep 17, 2025 | Headnote And Keywords | - |
| Sep 16, 2025 | Request For Procedural Order | - |
| Sep 16, 2025 | Receipt | - |
| Sep 16, 2025 | Objection | - |
| Sep 15, 2025 | Pj087 Regulation N 469 Gb | - |
| Sep 15, 2025 | Pj086 Court Of Appeal 10X Genomics Harvard V Nanostring Upc Coa 3352023 Gb | - |
| Sep 15, 2025 | Pj085 Dmf Nl Court Of The Hague 1Ere Instance Nl | - |
| Sep 15, 2025 | Pj084 Dmf Be Cour Dappel De Bruxelles Appel Nl | - |
| Sep 15, 2025 | Pj083 Fingolimod De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj082 Phosphodiesterase Nl Appeal Court Of The Hague Appel Nl | - |
| Sep 15, 2025 | Pj081 Dmf De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj080 Munich Local Division 21 May Upccfi432023 De | - |
| Sep 15, 2025 | Pj079 Ca Paris 9 July N2407962 Fr | - |
| Sep 15, 2025 | Pj078 Case Law Of The Boards Of Appeal Id108 Gb | - |
| Sep 15, 2025 | Pj077 Bonnes Pratiques De Distribution Ansm Bulletin Officiel N20149Bis Fr | - |
| Sep 15, 2025 | Pj076 Upc Court Of Appeal 25 September Upccoa1822024 Gb | - |
| Sep 15, 2025 | Pj075 Guidelines For Examination In The European Patent Office Gvii4Gb | - |
| Sep 15, 2025 | Pj074 Decision De La Chambre De Recours De Loeb DU 4 October T 111003 Gb | - |
| Sep 15, 2025 | Pj073 Epo Boa 10 July Eisai V Stada Lenvatinib T 193423 Gb | - |
| Sep 15, 2025 | Pj072 Hamburg Local Division 3 June Upccfi1512024 Gb | - |
| Sep 15, 2025 | Pj071 Dusseldorf Local Division 30 April Upccfi4632023 Gb | - |
| Sep 15, 2025 | Pj070 Dusseldorf Local Division 9 April Upccfi4522023 De | - |
| Sep 15, 2025 | Pj069 Dusseldorf Local Division VALEO V Magna Upc Cfi 3682024 Gb | - |
| Sep 15, 2025 | Pj068 Court Of Appeal Biolitec V Light Guide Optics Sia Lightguide 24 February Upccoa5402024 Gb | - |
| Sep 15, 2025 | Pj067 Ld Munich 15 November Upc Cfi 152023 Gb | - |
| Sep 15, 2025 | Pj065 Cjeu 28 July Synthon C Mertz Memantine C19509 Gb | - |
| Sep 15, 2025 | Pj064 Cjeu 28 July Generics Uk C Synaptech Galantamine C42709 Gb | - |
| Sep 15, 2025 | Pj063 Cass Com 10 February N1320150 Fr | - |
| Sep 15, 2025 | Pj062 Directive 200448CE Gb | - |
| Sep 15, 2025 | Pj061 Neurim Mylan High Court Of Justice 3 June Ewhc 1362 Gb | - |
| Sep 15, 2025 | Pj060 Decision De La Chambre De Recours De Loeb 13 September T023916 Gb | - |
| Sep 15, 2025 | Pj059 Decision De La Chambre De Recours De Loeb 4 October T250612 Gb | - |
| Sep 15, 2025 | Pj058 Tj Paris Refere 17 June Rg 2153849 Cabazitaxel Sanofi C Ever Pharma Fr | - |
| Sep 15, 2025 | Pj057 Tj Paris 12 May Rg 2153136 Cabazitaxel Sanofi C Teva Fr | - |
| Sep 15, 2025 | Pj056 Santen C 673 18 Gb | - |
| Sep 15, 2025 | Pj055 Tgi Paris 22 September 1407707 Fr | - |
| Sep 15, 2025 | Pj054 Cour Dappel De Paris 14 February 1991 Newtec International C Sfeima Pibd N504 Iiii432 Fr | - |
| Sep 15, 2025 | Pj053 Cour De Cassation 20 November Pourvoi N 1118440 Fr | - |
| Sep 15, 2025 | Pj052 Tgi Paris 6 June Rg N1606916 Fr | - |
| Sep 15, 2025 | Pj051 Tgi Rennes 2 September Rg N9803029 Fr | - |
| Sep 15, 2025 | Pj050 Decision De La Chambre De Recours 3306 De Loeb 30 May T 16596 Fr | - |
| Sep 15, 2025 | Pj049 Decision De La Chambre De Recours 3502 De Loeb 29 October T 33515 Fr | - |
| Sep 15, 2025 | Pj048 Decision De La Chambre De Recours De Loeb 10 November 1988 T038187 Gb | - |
| Sep 15, 2025 | Pj047 Tj Paris 22 June Rg N2002792 Fr | - |
| Sep 15, 2025 | Pj046 Decision De La Chambre De Recours De Loeb 20 September T197909 Gb | - |
| Sep 15, 2025 | Pj045 Decision De La Chambre De Recours De Loeb 1Er April T 140906 Gb | - |
| Sep 15, 2025 | Pj044 Decision De La Chambre De Recours De Loeb DU 28 January T 023715 Gb | - |
| Sep 15, 2025 | Pj043 Basf C25899 Gb | - |
| Sep 15, 2025 | Pj042 Gsk C21013 14 Nov Gb | - |
| Sep 15, 2025 | Pj041 Ca Paris 14 February Rg 1903820 Sandoz C Msd Fr | - |
| Sep 15, 2025 | Pj040 Abraxis C 443 17 21 March Gb | - |
| Sep 15, 2025 | Pj039 Case Law Of The Boards Of Appeal Of The Epo I D74 Try And See Solution Gb | - |
| Sep 15, 2025 | Pj038 Tj Paris 20 January Rg N 1901997 Fr | - |
| Sep 15, 2025 | Pj037 Tj Paris 6 September Rg N2106416 Fr | - |
| Sep 15, 2025 | Pj036 Tj Paris 7 June Rg 2153474 Sanofi C Accord Cabazitaxel Fr | - |
| Sep 15, 2025 | Pj035 Ca Paris 29 October Etypharm C Merck Rg N1803876 Fr | - |
| Sep 15, 2025 | Pj034 Cour Dappel De Paris 18 December Rg N 1710112 Fr | - |
| Sep 15, 2025 | Pj033 Decision De La Chambre De Recours De Loeb 25 July T 025915 Gb | - |
| Sep 15, 2025 | Pj032 Decision De La Chambre De Recours De Loeb 29 May T 009198 Gb | - |
| Sep 15, 2025 | Pj031 Decision De La Chambre De Recours De Loeb 5 October T 33397 Gb | - |
| Sep 15, 2025 | Pj030 Decision De La Chambre De Recours De Loeb 6 October T 91801 Gb | - |
| Sep 15, 2025 | Pj029 Decision De La Chambre De Recours De Loeb 14 February 1989 T 24988 Gb | - |
| Sep 15, 2025 | Pj028 Case Law Of The Boards Of Appeal Of The Epo Id71 Reasonable Expectation Of Success Gb | - |
| Sep 15, 2025 | Pj027 Jurisprudences Francaises Essais De Routine Fr | - |
| Sep 15, 2025 | Pj026 Tgi Paris 7 May Hexal C Boehringer Rg 0812537 Fr | - |
| Sep 15, 2025 | Pj025 Jub Division Centrale De Munich 16 July Sanofi C Amgen Upccfi 12023 Gb | - |
| Sep 15, 2025 | Pj024 Jub Cour Dappel 26 February Nanostring C 10X Genomics Upccoa3352023 Gb | - |
| Sep 15, 2025 | Pj023 Decision De La Chambre De Recours 332 De L Oeb 26 February T 92600 Gb | - |
| Sep 15, 2025 | Pj022 Decision De La Chambre De Recours 332 De Loeb 2 June T 30899 Gb | - |
| Sep 15, 2025 | Pj021 Decision De La Chambre De Recours 352 De Loeb 22 October 1993 T 25392 Gb | - |
| Sep 15, 2025 | Pj020 Decision De La Chambre De Recours 332 De Loeb 13 July T 393 01 Gb | - |
| Sep 15, 2025 | Pj019 Ca Paris 19 January Rg 18 21115 Fr | - |
| Sep 15, 2025 | Pj018 Tj Paris 20 July Rg N 21 10327 Fr | - |
| Sep 15, 2025 | Pj017 Ca Paris 14 November Rg N 1502576 Fr | - |
| Sep 15, 2025 | Pj016 Tj Paris 28 March Rg 2208612 Fr | - |
| Sep 15, 2025 | Pj014 Upc Court Of Appeal 13 August Upccoa4462025 Gb | - |
| Sep 15, 2025 | Pj013 Tj Paris 18 June Rg N 23 02356 Fr | - |
| Sep 15, 2025 | Pj012 Munich Local Division 27 August Upccfi2012024 Gb | - |
| Sep 15, 2025 | Pj011 Tj Paris 27 July Rg N 22 54367 Fr | - |
| Sep 15, 2025 | Pj010 Guidelines For Examination Of The Epo Giv1 Gb | - |
| Sep 15, 2025 | Pj009 Ca Paris 25 May Rg 21 18398 Fr | - |
| Sep 15, 2025 | Pj008 Tj Paris 29 September Rg 21 55930 Fr | - |
| Sep 15, 2025 | Pj007 Tj Paris Ordonnance De Refere 6 October Rg 22 55799 Biogen C Viatris Dmf Fr | - |
| Sep 15, 2025 | Pj006 Cjeu 16 July Genmab V Hungarian Ip Office Spc C 181 24 Gb | - |
| Sep 15, 2025 | Pj005 Accord Cadre Leem Ceps 5 March Fr | - |
| Sep 15, 2025 | Pj004 Regulation No 1768 92 Gb | - |
| Sep 15, 2025 | Pj003 Tj Paris Ordonnance Viatris C Novartis 04 August Fingolimod Rg N 2254655 Fr | - |
| Sep 15, 2025 | Pj002 Ca Paris 14 February Rg 1906114 Fr | - |
| Sep 15, 2025 | Pj001 Decision Du Conseil Constitutionnel N 463 Dc DU 12 December Fr | - |
| Sep 15, 2025 | Pc152 Submissions In High Resolution Gb | - |
| Sep 15, 2025 | Pc151 Declaration Dawid Sierzant DU 15 September Et Annexes Gb | - |
| Sep 15, 2025 | Pc150 4 Aminopyridine C5H6N2 Cid 1727 Pubchem Gb | - |
| Sep 15, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 15, 2025 | Pc148 The Fixing Of The Price And Reimboursement Rate Sante Gouv Fr | - |
| Sep 15, 2025 | Pc146 Letter From Viatris To Mez DATED 2 July Gb | - |
| Sep 15, 2025 | Pc145 Letter From Viatris To Merz Of 10 July Fr | - |
| Sep 15, 2025 | Pc143 Chapter 33 Pymadin Paskov Et Al 1986 Gb | - |
| Sep 15, 2025 | Pc142 Kostadinova And Danchev Gb | - |
| Sep 15, 2025 | Pc141 Sartori Et Al 1994 Gb | - |
| Sep 15, 2025 | Pc140 Olg Munchen Acorda Therapeutics V Ratiopharm 6 October 6 U 3044 22 De | - |
| Sep 15, 2025 | Pc139 Upsto Trademark Status Document Retrieval Pymadin Sopharma Gb | - |
| Sep 15, 2025 | Pc138 Website Of The Faculty Of Medicine In Sofia Bg | - |
| Sep 15, 2025 | Pc137 They Are Looking For A Superpill For Alzheimers Technologies News Standard Bg | - |
| Sep 15, 2025 | Pc136 Russian State Archive Of Scientific And Technical Documentation Ru | - |
| Sep 15, 2025 | Pc135 Communication Between The Ceps And Viatris Fr | - |
| Sep 15, 2025 | Pc134 Patient Leaflet Pymadin Bg | - |
| Sep 15, 2025 | Pc133 Smpc Pymadin Bg | - |
| Sep 15, 2025 | Pc132 Free State Gazette Edition 33 Of 2Iv Unofficial Section Ru | - |
| Sep 15, 2025 | Pc131 Disaster Protection Plan Burgas Region Republic Of Bulgaria Bg | - |
| Sep 15, 2025 | Pc130 4 Aminopiridin Spinal Cord Injury Forum Ru Compressed | - |
| Sep 15, 2025 | Pc129 Iqvia About Us Gb | - |
| Sep 15, 2025 | Pc128 Adverse Exhibit No 503 Toumi Et Al External Reference Pricing Simulation Gb | - |
| Sep 15, 2025 | Pc122 Application For Provisional Measures Gb | - |
| Sep 15, 2025 | Pc121 Acorda V Alkem Trial Transcript Volume B Gb | - |
| Sep 15, 2025 | Pc120 Acorda V Alkem Trial Transcript Volume A Gb | - |
| Sep 15, 2025 | Pc119 Hamilton Et Al 1998 Olanzapine Versus Placebo And Haloperidol Quality Of Life And Efficacy Results On The North Am | - |
| Sep 15, 2025 | Pc118 Overall 1994 Journal Of Clinical Psychology VOL 50 Pages 95 102 Gb | - |
| Sep 15, 2025 | Pc117 Alhainen Et Al 1991 Discrimination Of Tetrahydroaminoacridine Responders By A Single Dose Pharmaco Eeg In Patients | - |
| Sep 15, 2025 | Pc116 Sas Library 1997 Repeated Measures Anova Using Sas Proc Glm Gb | - |
| Sep 15, 2025 | Pc115 Sheeber Et Al 1996 Data Analytic Techniques For Treatment Outcome Studies With Pretest Posttest Measurements An Ex | - |
| Sep 15, 2025 | Pc114 Cook Et Al 1983 Design And Analysis Methods For Longitudinal Research Ann Rev Public Health Gb | - |
| Sep 15, 2025 | Pc113 Vickers Hor Many Repeated Measures In Repeates Measures Designs Statistical Issues For Comparative Trials Bmc | - |
| Sep 15, 2025 | Pc112 Uryniak Et Al Responder Analyses A Phrma Position Paper Statistics In Biopharmaceutical Research VOL 3 N3 Gb | - |
| Sep 15, 2025 | Pc111 Schulz Et Al The Efficacy Of Quetiapine VS Haloperidol And Placebo A Meta Analytic Study Of Efficacy Schizopp | - |
| Sep 15, 2025 | Pc110 Temple 1994 Commun Stat Theory Meth VOL 23 Pages 449 521 Gb | - |
| Sep 15, 2025 | Pc109 Lewis Statistics In Medicine VOL 21 Pages 2931 2938 Gb | - |
| Sep 15, 2025 | Pc108 Weiner 1998 Can J Neurol Sci VOL 25 Pages 93101 Gb | - |
| Sep 15, 2025 | Pc107 Petkau 1998 Seminars In Neurology VOL 18 3 Gb | - |
| Sep 15, 2025 | Pc106 Leber Et DAVIS 1998 Threats To The Validity Of Clinical Trials Employing Enrichment Strategies For Sample Selectio | - |
| Sep 15, 2025 | Pc105 DTX 584 Gb | - |
| Sep 15, 2025 | Pc104 4 Aminopyridine Induces Functional Improvement In Multiple Sclerosis Patients A Neurophysiological Study Gb | - |
| Sep 15, 2025 | Pc103 Stefoski Et Al 1991 4 Aminopyridine In Multiple Sclerosis Prolonged Administration Neurology 1991 Gb | - |
| Sep 15, 2025 | Pc102 Clinical Studies In 20 Questions Atelier Presse Clinical Trials Leem 19 May Fr | - |
| Sep 15, 2025 | Pc101 Report By Dr Christian Wolf DATED 2 September Gb | - |
| Sep 15, 2025 | Pc100 EP1732548B9 Gb | - |
| Sep 15, 2025 | Pc099 Matusik Therapy Nutrients 14 4249 Gb | - |
| Sep 15, 2025 | Pc098 Le Progres Article Patients Deprived Of A Medication Due To A Change Of Packaging 26 June Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 2 2 Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 1 2 Fr | - |
| Sep 15, 2025 | Pc096 Kehl Responder Identification In Clinical Trials June Gb | - |
| Sep 15, 2025 | Pc095 CPMP Points To Consider Multiplicity Issues Clinical Trials Gb | - |
| Sep 15, 2025 | Pc094 Hayes Et Al Pharmacokinetic Studies Of Single And Multiple Oral Doses Of Fampridine VOL 26 N4 Pp 185 192 Gb | - |
| Sep 15, 2025 | Pc093 Hayes Et Al Pharmacokinetics Of An Immediate Release Oral Formulation Of Fampridine 4 Aminopyridine In Normal | - |
| Sep 15, 2025 | Pc092 July 1986 Comment Determiner La Posologie Optimale D Un Medicament Fr | - |
| Sep 15, 2025 | Pc091 Dose Ranging Study Wikipedia Gb | - |
| Sep 15, 2025 | Pc090 Rnb Ccp 033 Fr | - |
| Sep 15, 2025 | Pc089 Rnb EP536Fr | - |
| Sep 15, 2025 | Pc088 Chmp 1999 Clinical Investigation Of Medicinal Products In The Treatment Of Parkinson S Disease CPMP Note For Guida | - |
| Sep 15, 2025 | Pc087 Ccne Opinion 79 Transposition Into French Law Of The European Directive On Clinical Trials Of Medicinal Products F | - |
| Sep 15, 2025 | Pc086 Declaration Of Helsinki Ethical Principles For Medical Research Involving Human Subjects Gb | - |
| Sep 15, 2025 | Pc085 Nuremberg Code Gb | - |
| Sep 15, 2025 | Pc084 Afsep Press Release Of 28 May Fr | - |
| Sep 15, 2025 | Pc083 Barus Et Al Fr | - |
| Sep 15, 2025 | Pc082 Extrait De La Base De Donnees Publique Des Medicaments Fampridine Viatris 10 Mg Fr | - |
| Sep 15, 2025 | Pc081 Icht Topic 9 Guideline On Statistical Principles For Clinical Trials September 1998 Gb | - |
| Sep 15, 2025 | Pc080 Website Of The Foundation For Research Into Multiple Sclerosis Fr | - |
| Sep 15, 2025 | Pc079 Notice On The Prices Of Fampridine Pharmaceutical Specialities Fr | - |
| Sep 15, 2025 | Pc078 Info Sheet Fampyra 10Mg Sustained Release Tablet Fr | - |
| Sep 15, 2025 | Pc077 Accession Of Bulgaria Gb | - |
| Sep 15, 2025 | Pc076 Kehl Responder Identification In Clinical Trials With Censored Data Gb | - |
| Sep 15, 2025 | Pc075 Federal Court Of Canada 15 May Acorda V Pharmascience And Taro T 1416 18 And T 220 19 Gb | - |
| Sep 15, 2025 | Pc074 Usa Delaware District Court 25 April Acorda V Teva Roxane Mylan 14 882 Gb | - |
| Sep 15, 2025 | Pc073 Usa Delaware District Court 31 March Acorda V Roxane 14 882 Lps Gb | - |
| Sep 15, 2025 | Pc072 Germany Teva Revocation Of Patent EP548De | - |
| Sep 15, 2025 | Pc071 Germany Ratiopharm Revocation Of Patent EP536De | - |
| Sep 15, 2025 | Pc070 Germany Ratiopharm Admissibility Of The EP536Invalidity Claim De | - |
| Sep 15, 2025 | Pc069 Board Of Appeal Of The European Patent Office 4 September T 0799 16 Gb | - |
| Sep 15, 2025 | Pc068 Decision Of The Epo EP536Gb Compressed | - |
| Sep 15, 2025 | Pc067 Emea Points To Consider On The Choice Of Non Interiority Margin Gb | - |
| Sep 15, 2025 | Pc066 Emea 27 July Points To Consider On Switching Betweend Superiority And Non Inferiority Gb | - |
| Sep 15, 2025 | Pc064 Usa Court Of Appeal 10 September Acorda V Roxane Et Al Et 2134 Gb | - |
| Sep 15, 2025 | Pc063 Form 10 K Wikipedia Presentation Gb | - |
| Sep 15, 2025 | Pc062 Cohen Postgraduate Medicine September 1999 Gb | - |
| Sep 15, 2025 | Pc061 L Echelle Edss Expanded Disability Status Scale Fr | - |
| Sep 15, 2025 | Pc060 O Brien Journal Of Hypertension Gb | - |
| Sep 15, 2025 | Pc059 Ellen R Girden Anova Repeated Measures 1992 Gb | - |
| Sep 15, 2025 | Pc058 Federal Court Of Appeal Of Canada 8 August Acorda Therapeutics V Pharmascience Taro Pharmaceuticals A 145 20 | - |
| Sep 15, 2025 | Pc057 Fda Chapter I Food And Drug Administration Department Of Health And Human Services Subchapter D Drugs For Human Us | - |
| Sep 15, 2025 | Pc056 Polman Arch Neur VOL 51 November 1994 Gb | - |
| Sep 15, 2025 | Pc055 Sheiner Clin Pharmacol Ther Volume 46 Number 1 July 1989 Gb | - |
| Sep 15, 2025 | Pc054 Norleans Statistical Methods For Clinical Trials Gb Compressed | - |
| Sep 15, 2025 | Pc053 Excerpt From The Fda Website Drug Evaluation Process Gb | - |
| Sep 15, 2025 | Pc052 Schwid Et Al April Gb | - |
| Sep 15, 2025 | Pc051 Kaufman Al The Significant Change For The Timed 25 Foot Walk In The Multiple Sclerosis Functional Composite M | - |
| Sep 15, 2025 | Pc050 Extract From The National Institutes Of Health Website Fda Drug Review And Approval Gb | - |
| Sep 15, 2025 | Pc049 Ca 2 562 277 Gb | - |
| Sep 15, 2025 | Pc048 US8663685Gb | - |
| Sep 15, 2025 | Pc047 US8440703Gb | - |
| Sep 15, 2025 | Pc046 US8354437Gb | - |
| Sep 15, 2025 | Pc045 Declaration Of Dr Ron Cohen Gb | - |
| Sep 15, 2025 | Pc044 US8007826Gb | - |
| Sep 15, 2025 | Pc043 Goodman Diaporama Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc042 Medical Research Council Mrc Scale For Muscle Strength Gb | - |
| Sep 15, 2025 | Pc041 National Multiple Sclerosis Society Timed 25 Foot Walk T25 Fw Gb | - |
| Sep 15, 2025 | Pc040 Ninds Fatigue Severity Scale Fss Gb | - |
| Sep 15, 2025 | Pc039 Wikipedia Page Edss Gb | - |
| Sep 15, 2025 | Pc038 Goodman Poster Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc037 Supplemental Information Disclosure Statement Gb | - |
| Sep 15, 2025 | Pc036 Actrims Ectrims Final Program Gb Compressed | - |
| Sep 15, 2025 | Pc035 List Of References Ids Gb | - |
| Sep 15, 2025 | Pc034 List Of Documents Requested US11102559Gb | - |
| Sep 15, 2025 | Pc033 Acorda Therapeutics Form S1 Gb | - |
| Sep 15, 2025 | Pc032 Form S 1 Presentation Gb | - |
| Sep 15, 2025 | Pc031 Sec Overview Gb | - |
| Sep 15, 2025 | Pc030 Goodman Abstract Poster Gb | - |
| Sep 15, 2025 | Pc029 Shargel 1999 Applied Biopharmaceutics And Pharmacokinetics Chapter 7 Extraits Pages 169 178 179 Gb Compressed | - |
| Sep 15, 2025 | Pc028 VAN Diemen Et Al 1992 August Gb | - |
| Sep 15, 2025 | Pc027 EP0484186B1 Gb | - |
| Sep 15, 2025 | Pc026 Schwid Et Al 1997 The American Academy Of Neurology Volume 48 Pages 817 821 Gb | - |
| Sep 15, 2025 | Pc025 Bever 1994 The American Neurological Association 1994 Volume 23 Page 118 S121 Gb | - |
| Sep 15, 2025 | Pc024 Bever Et Al 1994 June Neurology 44 1054 1059 Gb | - |
| Sep 15, 2025 | Pc023 Davis Et Al 1990 The American Neurological Association 1990 Pages 186 192 Gb | - |
| Sep 15, 2025 | Pc022 Sherratt Et Al 1980 Nature Volume 283 5745 Pages 570 572 Gb | - |
| Sep 15, 2025 | Pc021 List Of Documents Cited In The Oppositions Gb | - |
| Sep 15, 2025 | Pc020 Merz Acquires Fampyra Gb | - |
| Sep 15, 2025 | Pc019 European Medicines Agency Guidelines Ich Topic E4 November 1994 Gb | - |
| Sep 15, 2025 | Pc018 EP536Oral Proceedings Gb | - |
| Sep 15, 2025 | Pc017 Verhagen Et Al Australian Journal Of Physiotherapy VOL 50 Gb | - |
| Sep 15, 2025 | Pc016 Piece Composite Synthese Wikipiedia Sur L Ecart Type Et La Valeur P Fr | - |
| Sep 15, 2025 | Pc015 Marien Et Beaud Guide Pratique Pour L Utilisation De La Statistique En Recherche Fr | - |
| Sep 15, 2025 | Pc014 Journal De La Societe Statistique De Paris 1956 Fr | - |
| Sep 15, 2025 | Pc013 Ting N Introduction And New Drug Development Process In Ting N Editor Dose Finding In Drug Development Springer Ne | - |
| Sep 15, 2025 | Pc012 Pirmohamed Et Al Bmj Volume 316 25 April 1998 Gb | - |
| Sep 15, 2025 | Pc011 Edwards And Aronson The Lancet VOL 356 October 7 Gb | - |
| Sep 15, 2025 | Pc010 Ich Topic E 8 General Considerations For Clinical Trials 17 July 1997 Gb | - |
| Sep 15, 2025 | Pc009 Griffin Et Al The Textbook Of Pharmaceutical Medicine 1993 Pages 221 222 Gb Compressed | - |
| Sep 15, 2025 | Pc008 Bopi 20 November N 1547 Pp 235 237 Et 258 Fr | - |
| Sep 15, 2025 | Pc007 Decision Et Requete De Delivrance Du Ccp N 13 C0033 Fr | - |
| Sep 15, 2025 | Pc006 Demande De Ccp Sur La Base Du Brevet EP2377536Fr | - |
| Sep 15, 2025 | Pc005 EP2377536B2 Gb | - |
| Sep 15, 2025 | Pc004 Fampyra Smpc Gb | - |
| Sep 15, 2025 | Pc003 Commission Implementing Decision Of 27 September C20246926 Gb | - |
| Sep 15, 2025 | Pc002 Rcp Fampridine Viatris Lp 10Mg Fr | - |
| Sep 15, 2025 | Pc001 Extrait Kbis Viatris Sante Fr | - |
| Sep 15, 2025 | Objection Viatris Sante App 339802025 Compressed Signed | - |
| Sep 11, 2025 | Summon Oral Hearing | - |
| Sep 11, 2025 | Order Summon The Oral Hearing | |
| Aug 18, 2025 | Procedural Order Timetable And Summon Oh | |
| Aug 18, 2025 | Hearing Dates | - |
| Aug 14, 2025 | Panel Appointment | - |
| Aug 7, 2025 | Acknowledgement Of Access To Case | - |
| Aug 6, 2025 | Notification Of Service | - |
| Aug 6, 2025 | Digital Tracking La Poste Service Receipt | - |
| Aug 5, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Notice To Accompany Service Of Order For Measures | - |
| Aug 1, 2025 | Letter For Service | - |
| Aug 1, 2025 | Formal Checks Notification Of Positive Outcome | - |
| Aug 1, 2025 | Exhibit No. 701 Application French Translation | - |
| Aug 1, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Aug 1, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Aug 1, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Aug 1, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Aug 1, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Aug 1, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Aug 1, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Aug 1, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Aug 1, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Aug 1, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Aug 1, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Aug 1, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Aug 1, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Aug 1, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Aug 1, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Aug 1, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Aug 1, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Aug 1, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Aug 1, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Aug 1, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Aug 1, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Aug 1, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Aug 1, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Aug 1, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Aug 1, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Aug 1, 2025 | Exhibit No. 401 Goodman Poster | - |
| Aug 1, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Aug 1, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Aug 1, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Aug 1, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Aug 1, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Aug 1, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Aug 1, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Aug 1, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 208 French Spc Register | - |
| Aug 1, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Aug 1, 2025 | Exhibit No. 206 French Patent Register | - |
| Aug 1, 2025 | Exhibit No. 205 EP536Patent | - |
| Aug 1, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Aug 1, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Aug 1, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Aug 1, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Aug 1, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Aug 1, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Aug 1, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Aug 1, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Aug 1, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Aug 1, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Aug 1, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Aug 1, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Aug 1, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Aug 1, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Aug 1, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Aug 1, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Aug 1, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Aug 1, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Aug 1, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Aug 1, 2025 | Exhibit No. 106 Larocca | - |
| Aug 1, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Aug 1, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Aug 1, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Aug 1, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Aug 1, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Aug 1, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Aug 1, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Aug 1, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Aug 1, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Aug 1, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Aug 1, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Aug 1, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Aug 1, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Aug 1, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Aug 1, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Aug 1, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Aug 1, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Aug 1, 2025 | Application For Provisional Measures | - |
| Aug 1, 2025 | Application For Measures Receipt | - |
| Aug 1, 2025 | Application For Measures Acknowledgement | - |
| Jul 31, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Jul 31, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Jul 31, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Jul 31, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Jul 31, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Jul 31, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Jul 31, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Jul 31, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Jul 31, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Jul 31, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Jul 31, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Jul 31, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Jul 31, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Jul 31, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Jul 31, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Jul 31, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Jul 31, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Jul 31, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Jul 31, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Jul 31, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Jul 31, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Jul 31, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Jul 31, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Jul 31, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Jul 31, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Jul 31, 2025 | Exhibit No. 401 Goodman Poster | - |
| Jul 31, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Jul 31, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Jul 31, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Jul 31, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Jul 31, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Jul 31, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Jul 31, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Jul 31, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 208 French Spc Register | - |
| Jul 31, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Jul 31, 2025 | Exhibit No. 206 French Patent Register | - |
| Jul 31, 2025 | Exhibit No. 205 EP536Patent | - |
| Jul 31, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Jul 31, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Jul 31, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Jul 31, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Jul 31, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Jul 31, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Jul 31, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Jul 31, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Jul 31, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Jul 31, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Jul 31, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Jul 31, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Jul 31, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Jul 31, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Jul 31, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Jul 31, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Jul 31, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Jul 31, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Jul 31, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Jul 31, 2025 | Exhibit No. 106 Larocca | - |
| Jul 31, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Jul 31, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Jul 31, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Jul 31, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Jul 31, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Jul 31, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Jul 31, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Jul 31, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Jul 31, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Jul 31, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Jul 31, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Jul 31, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Jul 31, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Jul 31, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Jul 31, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Jul 31, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Jul 31, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Jul 31, 2025 | Application For Provisional Measures | - |
| Oct 10, 2025 | Action.Communication | - |
| Oct 9, 2025 | Receipt | - |
| Oct 9, 2025 | Proof Of Payment | - |
| Oct 9, 2025 | Other Document | - |
| Oct 9, 2025 | Fee | - |
| Oct 9, 2025 | Cover Sheet | - |
| Oct 9, 2025 | Application | - |
| Oct 7, 2025 | Order | - |
| Oct 7, 2025 | Action.Issueorder | - |
| Oct 6, 2025 | Action.Communication | - |
| Oct 5, 2025 | Receipt | - |
| Oct 5, 2025 | Cover Sheet | - |
| Oct 5, 2025 | Application | - |
| Oct 2, 2025 | Receipt | - |
| Oct 2, 2025 | Order | - |
| Oct 2, 2025 | Cover Sheet | - |
| Oct 2, 2025 | Application | - |
| Oct 2, 2025 | Action.Issueorder | - |
| Oct 1, 2025 | Statement Of Reply | - |
| Oct 1, 2025 | Receipt | - |
| Oct 1, 2025 | Exhibit | - |
| Oct 1, 2025 | Cover Sheet | - |
| Oct 1, 2025 | Application | - |
| Sep 26, 2025 | Action.Communication | - |
| Sep 25, 2025 | Receipt | - |
| Sep 25, 2025 | Other Document | - |
| Sep 25, 2025 | Exhibit | - |
| Sep 25, 2025 | Cover Sheet | - |
| Sep 25, 2025 | Action.Communication | - |
| Sep 24, 2025 | Order | - |
| Sep 24, 2025 | Action.Issueorder | - |
| Sep 18, 2025 | Request V.Def Pdf A Signed | - |
| Sep 18, 2025 | Receipt | - |
| Sep 18, 2025 | Pc154 Iqvia Agreement Gb | - |
| Sep 18, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 17, 2025 | Receipt | - |
| Sep 17, 2025 | Procedural Order | |
| Sep 17, 2025 | Outcome Of The Order | - |
| Sep 17, 2025 | Headnote And Keywords | - |
| Sep 16, 2025 | Request For Procedural Order | - |
| Sep 16, 2025 | Receipt | - |
| Sep 16, 2025 | Objection | - |
| Sep 15, 2025 | Pj087 Regulation N 469 Gb | - |
| Sep 15, 2025 | Pj086 Court Of Appeal 10X Genomics Harvard V Nanostring Upc Coa 3352023 Gb | - |
| Sep 15, 2025 | Pj085 Dmf Nl Court Of The Hague 1Ere Instance Nl | - |
| Sep 15, 2025 | Pj084 Dmf Be Cour Dappel De Bruxelles Appel Nl | - |
| Sep 15, 2025 | Pj083 Fingolimod De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj082 Phosphodiesterase Nl Appeal Court Of The Hague Appel Nl | - |
| Sep 15, 2025 | Pj081 Dmf De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj080 Munich Local Division 21 May Upccfi432023 De | - |
| Sep 15, 2025 | Pj079 Ca Paris 9 July N2407962 Fr | - |
| Sep 15, 2025 | Pj078 Case Law Of The Boards Of Appeal Id108 Gb | - |
| Sep 15, 2025 | Pj077 Bonnes Pratiques De Distribution Ansm Bulletin Officiel N20149Bis Fr | - |
| Sep 15, 2025 | Pj076 Upc Court Of Appeal 25 September Upccoa1822024 Gb | - |
| Sep 15, 2025 | Pj075 Guidelines For Examination In The European Patent Office Gvii4Gb | - |
| Sep 15, 2025 | Pj074 Decision De La Chambre De Recours De Loeb DU 4 October T 111003 Gb | - |
| Sep 15, 2025 | Pj073 Epo Boa 10 July Eisai V Stada Lenvatinib T 193423 Gb | - |
| Sep 15, 2025 | Pj072 Hamburg Local Division 3 June Upccfi1512024 Gb | - |
| Sep 15, 2025 | Pj071 Dusseldorf Local Division 30 April Upccfi4632023 Gb | - |
| Sep 15, 2025 | Pj070 Dusseldorf Local Division 9 April Upccfi4522023 De | - |
| Sep 15, 2025 | Pj069 Dusseldorf Local Division VALEO V Magna Upc Cfi 3682024 Gb | - |
| Sep 15, 2025 | Pj068 Court Of Appeal Biolitec V Light Guide Optics Sia Lightguide 24 February Upccoa5402024 Gb | - |
| Sep 15, 2025 | Pj067 Ld Munich 15 November Upc Cfi 152023 Gb | - |
| Sep 15, 2025 | Pj065 Cjeu 28 July Synthon C Mertz Memantine C19509 Gb | - |
| Sep 15, 2025 | Pj064 Cjeu 28 July Generics Uk C Synaptech Galantamine C42709 Gb | - |
| Sep 15, 2025 | Pj063 Cass Com 10 February N1320150 Fr | - |
| Sep 15, 2025 | Pj062 Directive 200448CE Gb | - |
| Sep 15, 2025 | Pj061 Neurim Mylan High Court Of Justice 3 June Ewhc 1362 Gb | - |
| Sep 15, 2025 | Pj060 Decision De La Chambre De Recours De Loeb 13 September T023916 Gb | - |
| Sep 15, 2025 | Pj059 Decision De La Chambre De Recours De Loeb 4 October T250612 Gb | - |
| Sep 15, 2025 | Pj058 Tj Paris Refere 17 June Rg 2153849 Cabazitaxel Sanofi C Ever Pharma Fr | - |
| Sep 15, 2025 | Pj057 Tj Paris 12 May Rg 2153136 Cabazitaxel Sanofi C Teva Fr | - |
| Sep 15, 2025 | Pj056 Santen C 673 18 Gb | - |
| Sep 15, 2025 | Pj055 Tgi Paris 22 September 1407707 Fr | - |
| Sep 15, 2025 | Pj054 Cour Dappel De Paris 14 February 1991 Newtec International C Sfeima Pibd N504 Iiii432 Fr | - |
| Sep 15, 2025 | Pj053 Cour De Cassation 20 November Pourvoi N 1118440 Fr | - |
| Sep 15, 2025 | Pj052 Tgi Paris 6 June Rg N1606916 Fr | - |
| Sep 15, 2025 | Pj051 Tgi Rennes 2 September Rg N9803029 Fr | - |
| Sep 15, 2025 | Pj050 Decision De La Chambre De Recours 3306 De Loeb 30 May T 16596 Fr | - |
| Sep 15, 2025 | Pj049 Decision De La Chambre De Recours 3502 De Loeb 29 October T 33515 Fr | - |
| Sep 15, 2025 | Pj048 Decision De La Chambre De Recours De Loeb 10 November 1988 T038187 Gb | - |
| Sep 15, 2025 | Pj047 Tj Paris 22 June Rg N2002792 Fr | - |
| Sep 15, 2025 | Pj046 Decision De La Chambre De Recours De Loeb 20 September T197909 Gb | - |
| Sep 15, 2025 | Pj045 Decision De La Chambre De Recours De Loeb 1Er April T 140906 Gb | - |
| Sep 15, 2025 | Pj044 Decision De La Chambre De Recours De Loeb DU 28 January T 023715 Gb | - |
| Sep 15, 2025 | Pj043 Basf C25899 Gb | - |
| Sep 15, 2025 | Pj042 Gsk C21013 14 Nov Gb | - |
| Sep 15, 2025 | Pj041 Ca Paris 14 February Rg 1903820 Sandoz C Msd Fr | - |
| Sep 15, 2025 | Pj040 Abraxis C 443 17 21 March Gb | - |
| Sep 15, 2025 | Pj039 Case Law Of The Boards Of Appeal Of The Epo I D74 Try And See Solution Gb | - |
| Sep 15, 2025 | Pj038 Tj Paris 20 January Rg N 1901997 Fr | - |
| Sep 15, 2025 | Pj037 Tj Paris 6 September Rg N2106416 Fr | - |
| Sep 15, 2025 | Pj036 Tj Paris 7 June Rg 2153474 Sanofi C Accord Cabazitaxel Fr | - |
| Sep 15, 2025 | Pj035 Ca Paris 29 October Etypharm C Merck Rg N1803876 Fr | - |
| Sep 15, 2025 | Pj034 Cour Dappel De Paris 18 December Rg N 1710112 Fr | - |
| Sep 15, 2025 | Pj033 Decision De La Chambre De Recours De Loeb 25 July T 025915 Gb | - |
| Sep 15, 2025 | Pj032 Decision De La Chambre De Recours De Loeb 29 May T 009198 Gb | - |
| Sep 15, 2025 | Pj031 Decision De La Chambre De Recours De Loeb 5 October T 33397 Gb | - |
| Sep 15, 2025 | Pj030 Decision De La Chambre De Recours De Loeb 6 October T 91801 Gb | - |
| Sep 15, 2025 | Pj029 Decision De La Chambre De Recours De Loeb 14 February 1989 T 24988 Gb | - |
| Sep 15, 2025 | Pj028 Case Law Of The Boards Of Appeal Of The Epo Id71 Reasonable Expectation Of Success Gb | - |
| Sep 15, 2025 | Pj027 Jurisprudences Francaises Essais De Routine Fr | - |
| Sep 15, 2025 | Pj026 Tgi Paris 7 May Hexal C Boehringer Rg 0812537 Fr | - |
| Sep 15, 2025 | Pj025 Jub Division Centrale De Munich 16 July Sanofi C Amgen Upccfi 12023 Gb | - |
| Sep 15, 2025 | Pj024 Jub Cour Dappel 26 February Nanostring C 10X Genomics Upccoa3352023 Gb | - |
| Sep 15, 2025 | Pj023 Decision De La Chambre De Recours 332 De L Oeb 26 February T 92600 Gb | - |
| Sep 15, 2025 | Pj022 Decision De La Chambre De Recours 332 De Loeb 2 June T 30899 Gb | - |
| Sep 15, 2025 | Pj021 Decision De La Chambre De Recours 352 De Loeb 22 October 1993 T 25392 Gb | - |
| Sep 15, 2025 | Pj020 Decision De La Chambre De Recours 332 De Loeb 13 July T 393 01 Gb | - |
| Sep 15, 2025 | Pj019 Ca Paris 19 January Rg 18 21115 Fr | - |
| Sep 15, 2025 | Pj018 Tj Paris 20 July Rg N 21 10327 Fr | - |
| Sep 15, 2025 | Pj017 Ca Paris 14 November Rg N 1502576 Fr | - |
| Sep 15, 2025 | Pj016 Tj Paris 28 March Rg 2208612 Fr | - |
| Sep 15, 2025 | Pj014 Upc Court Of Appeal 13 August Upccoa4462025 Gb | - |
| Sep 15, 2025 | Pj013 Tj Paris 18 June Rg N 23 02356 Fr | - |
| Sep 15, 2025 | Pj012 Munich Local Division 27 August Upccfi2012024 Gb | - |
| Sep 15, 2025 | Pj011 Tj Paris 27 July Rg N 22 54367 Fr | - |
| Sep 15, 2025 | Pj010 Guidelines For Examination Of The Epo Giv1 Gb | - |
| Sep 15, 2025 | Pj009 Ca Paris 25 May Rg 21 18398 Fr | - |
| Sep 15, 2025 | Pj008 Tj Paris 29 September Rg 21 55930 Fr | - |
| Sep 15, 2025 | Pj007 Tj Paris Ordonnance De Refere 6 October Rg 22 55799 Biogen C Viatris Dmf Fr | - |
| Sep 15, 2025 | Pj006 Cjeu 16 July Genmab V Hungarian Ip Office Spc C 181 24 Gb | - |
| Sep 15, 2025 | Pj005 Accord Cadre Leem Ceps 5 March Fr | - |
| Sep 15, 2025 | Pj004 Regulation No 1768 92 Gb | - |
| Sep 15, 2025 | Pj003 Tj Paris Ordonnance Viatris C Novartis 04 August Fingolimod Rg N 2254655 Fr | - |
| Sep 15, 2025 | Pj002 Ca Paris 14 February Rg 1906114 Fr | - |
| Sep 15, 2025 | Pj001 Decision Du Conseil Constitutionnel N 463 Dc DU 12 December Fr | - |
| Sep 15, 2025 | Pc152 Submissions In High Resolution Gb | - |
| Sep 15, 2025 | Pc151 Declaration Dawid Sierzant DU 15 September Et Annexes Gb | - |
| Sep 15, 2025 | Pc150 4 Aminopyridine C5H6N2 Cid 1727 Pubchem Gb | - |
| Sep 15, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 15, 2025 | Pc148 The Fixing Of The Price And Reimboursement Rate Sante Gouv Fr | - |
| Sep 15, 2025 | Pc146 Letter From Viatris To Mez DATED 2 July Gb | - |
| Sep 15, 2025 | Pc145 Letter From Viatris To Merz Of 10 July Fr | - |
| Sep 15, 2025 | Pc143 Chapter 33 Pymadin Paskov Et Al 1986 Gb | - |
| Sep 15, 2025 | Pc142 Kostadinova And Danchev Gb | - |
| Sep 15, 2025 | Pc141 Sartori Et Al 1994 Gb | - |
| Sep 15, 2025 | Pc140 Olg Munchen Acorda Therapeutics V Ratiopharm 6 October 6 U 3044 22 De | - |
| Sep 15, 2025 | Pc139 Upsto Trademark Status Document Retrieval Pymadin Sopharma Gb | - |
| Sep 15, 2025 | Pc138 Website Of The Faculty Of Medicine In Sofia Bg | - |
| Sep 15, 2025 | Pc137 They Are Looking For A Superpill For Alzheimers Technologies News Standard Bg | - |
| Sep 15, 2025 | Pc136 Russian State Archive Of Scientific And Technical Documentation Ru | - |
| Sep 15, 2025 | Pc135 Communication Between The Ceps And Viatris Fr | - |
| Sep 15, 2025 | Pc134 Patient Leaflet Pymadin Bg | - |
| Sep 15, 2025 | Pc133 Smpc Pymadin Bg | - |
| Sep 15, 2025 | Pc132 Free State Gazette Edition 33 Of 2Iv Unofficial Section Ru | - |
| Sep 15, 2025 | Pc131 Disaster Protection Plan Burgas Region Republic Of Bulgaria Bg | - |
| Sep 15, 2025 | Pc130 4 Aminopiridin Spinal Cord Injury Forum Ru Compressed | - |
| Sep 15, 2025 | Pc129 Iqvia About Us Gb | - |
| Sep 15, 2025 | Pc128 Adverse Exhibit No 503 Toumi Et Al External Reference Pricing Simulation Gb | - |
| Sep 15, 2025 | Pc122 Application For Provisional Measures Gb | - |
| Sep 15, 2025 | Pc121 Acorda V Alkem Trial Transcript Volume B Gb | - |
| Sep 15, 2025 | Pc120 Acorda V Alkem Trial Transcript Volume A Gb | - |
| Sep 15, 2025 | Pc119 Hamilton Et Al 1998 Olanzapine Versus Placebo And Haloperidol Quality Of Life And Efficacy Results On The North Am | - |
| Sep 15, 2025 | Pc118 Overall 1994 Journal Of Clinical Psychology VOL 50 Pages 95 102 Gb | - |
| Sep 15, 2025 | Pc117 Alhainen Et Al 1991 Discrimination Of Tetrahydroaminoacridine Responders By A Single Dose Pharmaco Eeg In Patients | - |
| Sep 15, 2025 | Pc116 Sas Library 1997 Repeated Measures Anova Using Sas Proc Glm Gb | - |
| Sep 15, 2025 | Pc115 Sheeber Et Al 1996 Data Analytic Techniques For Treatment Outcome Studies With Pretest Posttest Measurements An Ex | - |
| Sep 15, 2025 | Pc114 Cook Et Al 1983 Design And Analysis Methods For Longitudinal Research Ann Rev Public Health Gb | - |
| Sep 15, 2025 | Pc113 Vickers Hor Many Repeated Measures In Repeates Measures Designs Statistical Issues For Comparative Trials Bmc | - |
| Sep 15, 2025 | Pc112 Uryniak Et Al Responder Analyses A Phrma Position Paper Statistics In Biopharmaceutical Research VOL 3 N3 Gb | - |
| Sep 15, 2025 | Pc111 Schulz Et Al The Efficacy Of Quetiapine VS Haloperidol And Placebo A Meta Analytic Study Of Efficacy Schizopp | - |
| Sep 15, 2025 | Pc110 Temple 1994 Commun Stat Theory Meth VOL 23 Pages 449 521 Gb | - |
| Sep 15, 2025 | Pc109 Lewis Statistics In Medicine VOL 21 Pages 2931 2938 Gb | - |
| Sep 15, 2025 | Pc108 Weiner 1998 Can J Neurol Sci VOL 25 Pages 93101 Gb | - |
| Sep 15, 2025 | Pc107 Petkau 1998 Seminars In Neurology VOL 18 3 Gb | - |
| Sep 15, 2025 | Pc106 Leber Et DAVIS 1998 Threats To The Validity Of Clinical Trials Employing Enrichment Strategies For Sample Selectio | - |
| Sep 15, 2025 | Pc105 DTX 584 Gb | - |
| Sep 15, 2025 | Pc104 4 Aminopyridine Induces Functional Improvement In Multiple Sclerosis Patients A Neurophysiological Study Gb | - |
| Sep 15, 2025 | Pc103 Stefoski Et Al 1991 4 Aminopyridine In Multiple Sclerosis Prolonged Administration Neurology 1991 Gb | - |
| Sep 15, 2025 | Pc102 Clinical Studies In 20 Questions Atelier Presse Clinical Trials Leem 19 May Fr | - |
| Sep 15, 2025 | Pc101 Report By Dr Christian Wolf DATED 2 September Gb | - |
| Sep 15, 2025 | Pc100 EP1732548B9 Gb | - |
| Sep 15, 2025 | Pc099 Matusik Therapy Nutrients 14 4249 Gb | - |
| Sep 15, 2025 | Pc098 Le Progres Article Patients Deprived Of A Medication Due To A Change Of Packaging 26 June Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 2 2 Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 1 2 Fr | - |
| Sep 15, 2025 | Pc096 Kehl Responder Identification In Clinical Trials June Gb | - |
| Sep 15, 2025 | Pc095 CPMP Points To Consider Multiplicity Issues Clinical Trials Gb | - |
| Sep 15, 2025 | Pc094 Hayes Et Al Pharmacokinetic Studies Of Single And Multiple Oral Doses Of Fampridine VOL 26 N4 Pp 185 192 Gb | - |
| Sep 15, 2025 | Pc093 Hayes Et Al Pharmacokinetics Of An Immediate Release Oral Formulation Of Fampridine 4 Aminopyridine In Normal | - |
| Sep 15, 2025 | Pc092 July 1986 Comment Determiner La Posologie Optimale D Un Medicament Fr | - |
| Sep 15, 2025 | Pc091 Dose Ranging Study Wikipedia Gb | - |
| Sep 15, 2025 | Pc090 Rnb Ccp 033 Fr | - |
| Sep 15, 2025 | Pc089 Rnb EP536Fr | - |
| Sep 15, 2025 | Pc088 Chmp 1999 Clinical Investigation Of Medicinal Products In The Treatment Of Parkinson S Disease CPMP Note For Guida | - |
| Sep 15, 2025 | Pc087 Ccne Opinion 79 Transposition Into French Law Of The European Directive On Clinical Trials Of Medicinal Products F | - |
| Sep 15, 2025 | Pc086 Declaration Of Helsinki Ethical Principles For Medical Research Involving Human Subjects Gb | - |
| Sep 15, 2025 | Pc085 Nuremberg Code Gb | - |
| Sep 15, 2025 | Pc084 Afsep Press Release Of 28 May Fr | - |
| Sep 15, 2025 | Pc083 Barus Et Al Fr | - |
| Sep 15, 2025 | Pc082 Extrait De La Base De Donnees Publique Des Medicaments Fampridine Viatris 10 Mg Fr | - |
| Sep 15, 2025 | Pc081 Icht Topic 9 Guideline On Statistical Principles For Clinical Trials September 1998 Gb | - |
| Sep 15, 2025 | Pc080 Website Of The Foundation For Research Into Multiple Sclerosis Fr | - |
| Sep 15, 2025 | Pc079 Notice On The Prices Of Fampridine Pharmaceutical Specialities Fr | - |
| Sep 15, 2025 | Pc078 Info Sheet Fampyra 10Mg Sustained Release Tablet Fr | - |
| Sep 15, 2025 | Pc077 Accession Of Bulgaria Gb | - |
| Sep 15, 2025 | Pc076 Kehl Responder Identification In Clinical Trials With Censored Data Gb | - |
| Sep 15, 2025 | Pc075 Federal Court Of Canada 15 May Acorda V Pharmascience And Taro T 1416 18 And T 220 19 Gb | - |
| Sep 15, 2025 | Pc074 Usa Delaware District Court 25 April Acorda V Teva Roxane Mylan 14 882 Gb | - |
| Sep 15, 2025 | Pc073 Usa Delaware District Court 31 March Acorda V Roxane 14 882 Lps Gb | - |
| Sep 15, 2025 | Pc072 Germany Teva Revocation Of Patent EP548De | - |
| Sep 15, 2025 | Pc071 Germany Ratiopharm Revocation Of Patent EP536De | - |
| Sep 15, 2025 | Pc070 Germany Ratiopharm Admissibility Of The EP536Invalidity Claim De | - |
| Sep 15, 2025 | Pc069 Board Of Appeal Of The European Patent Office 4 September T 0799 16 Gb | - |
| Sep 15, 2025 | Pc068 Decision Of The Epo EP536Gb Compressed | - |
| Sep 15, 2025 | Pc067 Emea Points To Consider On The Choice Of Non Interiority Margin Gb | - |
| Sep 15, 2025 | Pc066 Emea 27 July Points To Consider On Switching Betweend Superiority And Non Inferiority Gb | - |
| Sep 15, 2025 | Pc064 Usa Court Of Appeal 10 September Acorda V Roxane Et Al Et 2134 Gb | - |
| Sep 15, 2025 | Pc063 Form 10 K Wikipedia Presentation Gb | - |
| Sep 15, 2025 | Pc062 Cohen Postgraduate Medicine September 1999 Gb | - |
| Sep 15, 2025 | Pc061 L Echelle Edss Expanded Disability Status Scale Fr | - |
| Sep 15, 2025 | Pc060 O Brien Journal Of Hypertension Gb | - |
| Sep 15, 2025 | Pc059 Ellen R Girden Anova Repeated Measures 1992 Gb | - |
| Sep 15, 2025 | Pc058 Federal Court Of Appeal Of Canada 8 August Acorda Therapeutics V Pharmascience Taro Pharmaceuticals A 145 20 | - |
| Sep 15, 2025 | Pc057 Fda Chapter I Food And Drug Administration Department Of Health And Human Services Subchapter D Drugs For Human Us | - |
| Sep 15, 2025 | Pc056 Polman Arch Neur VOL 51 November 1994 Gb | - |
| Sep 15, 2025 | Pc055 Sheiner Clin Pharmacol Ther Volume 46 Number 1 July 1989 Gb | - |
| Sep 15, 2025 | Pc054 Norleans Statistical Methods For Clinical Trials Gb Compressed | - |
| Sep 15, 2025 | Pc053 Excerpt From The Fda Website Drug Evaluation Process Gb | - |
| Sep 15, 2025 | Pc052 Schwid Et Al April Gb | - |
| Sep 15, 2025 | Pc051 Kaufman Al The Significant Change For The Timed 25 Foot Walk In The Multiple Sclerosis Functional Composite M | - |
| Sep 15, 2025 | Pc050 Extract From The National Institutes Of Health Website Fda Drug Review And Approval Gb | - |
| Sep 15, 2025 | Pc049 Ca 2 562 277 Gb | - |
| Sep 15, 2025 | Pc048 US8663685Gb | - |
| Sep 15, 2025 | Pc047 US8440703Gb | - |
| Sep 15, 2025 | Pc046 US8354437Gb | - |
| Sep 15, 2025 | Pc045 Declaration Of Dr Ron Cohen Gb | - |
| Sep 15, 2025 | Pc044 US8007826Gb | - |
| Sep 15, 2025 | Pc043 Goodman Diaporama Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc042 Medical Research Council Mrc Scale For Muscle Strength Gb | - |
| Sep 15, 2025 | Pc041 National Multiple Sclerosis Society Timed 25 Foot Walk T25 Fw Gb | - |
| Sep 15, 2025 | Pc040 Ninds Fatigue Severity Scale Fss Gb | - |
| Sep 15, 2025 | Pc039 Wikipedia Page Edss Gb | - |
| Sep 15, 2025 | Pc038 Goodman Poster Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc037 Supplemental Information Disclosure Statement Gb | - |
| Sep 15, 2025 | Pc036 Actrims Ectrims Final Program Gb Compressed | - |
| Sep 15, 2025 | Pc035 List Of References Ids Gb | - |
| Sep 15, 2025 | Pc034 List Of Documents Requested US11102559Gb | - |
| Sep 15, 2025 | Pc033 Acorda Therapeutics Form S1 Gb | - |
| Sep 15, 2025 | Pc032 Form S 1 Presentation Gb | - |
| Sep 15, 2025 | Pc031 Sec Overview Gb | - |
| Sep 15, 2025 | Pc030 Goodman Abstract Poster Gb | - |
| Sep 15, 2025 | Pc029 Shargel 1999 Applied Biopharmaceutics And Pharmacokinetics Chapter 7 Extraits Pages 169 178 179 Gb Compressed | - |
| Sep 15, 2025 | Pc028 VAN Diemen Et Al 1992 August Gb | - |
| Sep 15, 2025 | Pc027 EP0484186B1 Gb | - |
| Sep 15, 2025 | Pc026 Schwid Et Al 1997 The American Academy Of Neurology Volume 48 Pages 817 821 Gb | - |
| Sep 15, 2025 | Pc025 Bever 1994 The American Neurological Association 1994 Volume 23 Page 118 S121 Gb | - |
| Sep 15, 2025 | Pc024 Bever Et Al 1994 June Neurology 44 1054 1059 Gb | - |
| Sep 15, 2025 | Pc023 Davis Et Al 1990 The American Neurological Association 1990 Pages 186 192 Gb | - |
| Sep 15, 2025 | Pc022 Sherratt Et Al 1980 Nature Volume 283 5745 Pages 570 572 Gb | - |
| Sep 15, 2025 | Pc021 List Of Documents Cited In The Oppositions Gb | - |
| Sep 15, 2025 | Pc020 Merz Acquires Fampyra Gb | - |
| Sep 15, 2025 | Pc019 European Medicines Agency Guidelines Ich Topic E4 November 1994 Gb | - |
| Sep 15, 2025 | Pc018 EP536Oral Proceedings Gb | - |
| Sep 15, 2025 | Pc017 Verhagen Et Al Australian Journal Of Physiotherapy VOL 50 Gb | - |
| Sep 15, 2025 | Pc016 Piece Composite Synthese Wikipiedia Sur L Ecart Type Et La Valeur P Fr | - |
| Sep 15, 2025 | Pc015 Marien Et Beaud Guide Pratique Pour L Utilisation De La Statistique En Recherche Fr | - |
| Sep 15, 2025 | Pc014 Journal De La Societe Statistique De Paris 1956 Fr | - |
| Sep 15, 2025 | Pc013 Ting N Introduction And New Drug Development Process In Ting N Editor Dose Finding In Drug Development Springer Ne | - |
| Sep 15, 2025 | Pc012 Pirmohamed Et Al Bmj Volume 316 25 April 1998 Gb | - |
| Sep 15, 2025 | Pc011 Edwards And Aronson The Lancet VOL 356 October 7 Gb | - |
| Sep 15, 2025 | Pc010 Ich Topic E 8 General Considerations For Clinical Trials 17 July 1997 Gb | - |
| Sep 15, 2025 | Pc009 Griffin Et Al The Textbook Of Pharmaceutical Medicine 1993 Pages 221 222 Gb Compressed | - |
| Sep 15, 2025 | Pc008 Bopi 20 November N 1547 Pp 235 237 Et 258 Fr | - |
| Sep 15, 2025 | Pc007 Decision Et Requete De Delivrance Du Ccp N 13 C0033 Fr | - |
| Sep 15, 2025 | Pc006 Demande De Ccp Sur La Base Du Brevet EP2377536Fr | - |
| Sep 15, 2025 | Pc005 EP2377536B2 Gb | - |
| Sep 15, 2025 | Pc004 Fampyra Smpc Gb | - |
| Sep 15, 2025 | Pc003 Commission Implementing Decision Of 27 September C20246926 Gb | - |
| Sep 15, 2025 | Pc002 Rcp Fampridine Viatris Lp 10Mg Fr | - |
| Sep 15, 2025 | Pc001 Extrait Kbis Viatris Sante Fr | - |
| Sep 15, 2025 | Objection Viatris Sante App 339802025 Compressed Signed | - |
| Sep 11, 2025 | Summon Oral Hearing | - |
| Sep 11, 2025 | Order Summon The Oral Hearing | |
| Aug 18, 2025 | Procedural Order Timetable And Summon Oh | |
| Aug 18, 2025 | Hearing Dates | - |
| Aug 14, 2025 | Panel Appointment | - |
| Aug 7, 2025 | Acknowledgement Of Access To Case | - |
| Aug 6, 2025 | Notification Of Service | - |
| Aug 6, 2025 | Digital Tracking La Poste Service Receipt | - |
| Aug 5, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Notice To Accompany Service Of Order For Measures | - |
| Aug 1, 2025 | Letter For Service | - |
| Aug 1, 2025 | Formal Checks Notification Of Positive Outcome | - |
| Aug 1, 2025 | Exhibit No. 701 Application French Translation | - |
| Aug 1, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Aug 1, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Aug 1, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Aug 1, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Aug 1, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Aug 1, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Aug 1, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Aug 1, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Aug 1, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Aug 1, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Aug 1, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Aug 1, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Aug 1, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Aug 1, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Aug 1, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Aug 1, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Aug 1, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Aug 1, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Aug 1, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Aug 1, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Aug 1, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Aug 1, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Aug 1, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Aug 1, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Aug 1, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Aug 1, 2025 | Exhibit No. 401 Goodman Poster | - |
| Aug 1, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Aug 1, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Aug 1, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Aug 1, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Aug 1, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Aug 1, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Aug 1, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Aug 1, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 208 French Spc Register | - |
| Aug 1, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Aug 1, 2025 | Exhibit No. 206 French Patent Register | - |
| Aug 1, 2025 | Exhibit No. 205 EP536Patent | - |
| Aug 1, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Aug 1, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Aug 1, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Aug 1, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Aug 1, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Aug 1, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Aug 1, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Aug 1, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Aug 1, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Aug 1, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Aug 1, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Aug 1, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Aug 1, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Aug 1, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Aug 1, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Aug 1, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Aug 1, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Aug 1, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Aug 1, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Aug 1, 2025 | Exhibit No. 106 Larocca | - |
| Aug 1, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Aug 1, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Aug 1, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Aug 1, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Aug 1, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Aug 1, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Aug 1, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Aug 1, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Aug 1, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Aug 1, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Aug 1, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Aug 1, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Aug 1, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Aug 1, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Aug 1, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Aug 1, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Aug 1, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Aug 1, 2025 | Application For Provisional Measures | - |
| Aug 1, 2025 | Application For Measures Receipt | - |
| Aug 1, 2025 | Application For Measures Acknowledgement | - |
| Jul 31, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Jul 31, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Jul 31, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Jul 31, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Jul 31, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Jul 31, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Jul 31, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Jul 31, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Jul 31, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Jul 31, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Jul 31, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Jul 31, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Jul 31, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Jul 31, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Jul 31, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Jul 31, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Jul 31, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Jul 31, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Jul 31, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Jul 31, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Jul 31, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Jul 31, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Jul 31, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Jul 31, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Jul 31, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Jul 31, 2025 | Exhibit No. 401 Goodman Poster | - |
| Jul 31, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Jul 31, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Jul 31, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Jul 31, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Jul 31, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Jul 31, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Jul 31, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Jul 31, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 208 French Spc Register | - |
| Jul 31, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Jul 31, 2025 | Exhibit No. 206 French Patent Register | - |
| Jul 31, 2025 | Exhibit No. 205 EP536Patent | - |
| Jul 31, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Jul 31, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Jul 31, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Jul 31, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Jul 31, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Jul 31, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Jul 31, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Jul 31, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Jul 31, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Jul 31, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Jul 31, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Jul 31, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Jul 31, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Jul 31, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Jul 31, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Jul 31, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Jul 31, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Jul 31, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Jul 31, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Jul 31, 2025 | Exhibit No. 106 Larocca | - |
| Jul 31, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Jul 31, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Jul 31, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Jul 31, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Jul 31, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Jul 31, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Jul 31, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Jul 31, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Jul 31, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Jul 31, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Jul 31, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Jul 31, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Jul 31, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Jul 31, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Jul 31, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Jul 31, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Jul 31, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Jul 31, 2025 | Application For Provisional Measures | - |
| Oct 10, 2025 | Action.Communication | - |
| Oct 9, 2025 | Receipt | - |
| Oct 9, 2025 | Proof Of Payment | - |
| Oct 9, 2025 | Other Document | - |
| Oct 9, 2025 | Fee | - |
| Oct 9, 2025 | Cover Sheet | - |
| Oct 9, 2025 | Application | - |
| Oct 7, 2025 | Order | - |
| Oct 7, 2025 | Action.Issueorder | - |
| Oct 6, 2025 | Action.Communication | - |
| Oct 5, 2025 | Receipt | - |
| Oct 5, 2025 | Cover Sheet | - |
| Oct 5, 2025 | Application | - |
| Oct 2, 2025 | Receipt | - |
| Oct 2, 2025 | Order | - |
| Oct 2, 2025 | Cover Sheet | - |
| Oct 2, 2025 | Application | - |
| Oct 2, 2025 | Action.Issueorder | - |
| Oct 1, 2025 | Statement Of Reply | - |
| Oct 1, 2025 | Receipt | - |
| Oct 1, 2025 | Exhibit | - |
| Oct 1, 2025 | Cover Sheet | - |
| Oct 1, 2025 | Application | - |
| Sep 26, 2025 | Action.Communication | - |
| Sep 25, 2025 | Receipt | - |
| Sep 25, 2025 | Other Document | - |
| Sep 25, 2025 | Exhibit | - |
| Sep 25, 2025 | Cover Sheet | - |
| Sep 25, 2025 | Action.Communication | - |
| Sep 24, 2025 | Order | - |
| Sep 24, 2025 | Action.Issueorder | - |
| Sep 18, 2025 | Request V.Def Pdf A Signed | - |
| Sep 18, 2025 | Receipt | - |
| Sep 18, 2025 | Pc154 Iqvia Agreement Gb | - |
| Sep 18, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 17, 2025 | Receipt | - |
| Sep 17, 2025 | Procedural Order | |
| Sep 17, 2025 | Outcome Of The Order | - |
| Sep 17, 2025 | Headnote And Keywords | - |
| Sep 16, 2025 | Request For Procedural Order | - |
| Sep 16, 2025 | Receipt | - |
| Sep 16, 2025 | Objection | - |
| Sep 15, 2025 | Pj087 Regulation N 469 Gb | - |
| Sep 15, 2025 | Pj086 Court Of Appeal 10X Genomics Harvard V Nanostring Upc Coa 3352023 Gb | - |
| Sep 15, 2025 | Pj085 Dmf Nl Court Of The Hague 1Ere Instance Nl | - |
| Sep 15, 2025 | Pj084 Dmf Be Cour Dappel De Bruxelles Appel Nl | - |
| Sep 15, 2025 | Pj083 Fingolimod De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj082 Phosphodiesterase Nl Appeal Court Of The Hague Appel Nl | - |
| Sep 15, 2025 | Pj081 Dmf De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj080 Munich Local Division 21 May Upccfi432023 De | - |
| Sep 15, 2025 | Pj079 Ca Paris 9 July N2407962 Fr | - |
| Sep 15, 2025 | Pj078 Case Law Of The Boards Of Appeal Id108 Gb | - |
| Sep 15, 2025 | Pj077 Bonnes Pratiques De Distribution Ansm Bulletin Officiel N20149Bis Fr | - |
| Sep 15, 2025 | Pj076 Upc Court Of Appeal 25 September Upccoa1822024 Gb | - |
| Sep 15, 2025 | Pj075 Guidelines For Examination In The European Patent Office Gvii4Gb | - |
| Sep 15, 2025 | Pj074 Decision De La Chambre De Recours De Loeb DU 4 October T 111003 Gb | - |
| Sep 15, 2025 | Pj073 Epo Boa 10 July Eisai V Stada Lenvatinib T 193423 Gb | - |
| Sep 15, 2025 | Pj072 Hamburg Local Division 3 June Upccfi1512024 Gb | - |
| Sep 15, 2025 | Pj071 Dusseldorf Local Division 30 April Upccfi4632023 Gb | - |
| Sep 15, 2025 | Pj070 Dusseldorf Local Division 9 April Upccfi4522023 De | - |
| Sep 15, 2025 | Pj069 Dusseldorf Local Division VALEO V Magna Upc Cfi 3682024 Gb | - |
| Sep 15, 2025 | Pj068 Court Of Appeal Biolitec V Light Guide Optics Sia Lightguide 24 February Upccoa5402024 Gb | - |
| Sep 15, 2025 | Pj067 Ld Munich 15 November Upc Cfi 152023 Gb | - |
| Sep 15, 2025 | Pj065 Cjeu 28 July Synthon C Mertz Memantine C19509 Gb | - |
| Sep 15, 2025 | Pj064 Cjeu 28 July Generics Uk C Synaptech Galantamine C42709 Gb | - |
| Sep 15, 2025 | Pj063 Cass Com 10 February N1320150 Fr | - |
| Sep 15, 2025 | Pj062 Directive 200448CE Gb | - |
| Sep 15, 2025 | Pj061 Neurim Mylan High Court Of Justice 3 June Ewhc 1362 Gb | - |
| Sep 15, 2025 | Pj060 Decision De La Chambre De Recours De Loeb 13 September T023916 Gb | - |
| Sep 15, 2025 | Pj059 Decision De La Chambre De Recours De Loeb 4 October T250612 Gb | - |
| Sep 15, 2025 | Pj058 Tj Paris Refere 17 June Rg 2153849 Cabazitaxel Sanofi C Ever Pharma Fr | - |
| Sep 15, 2025 | Pj057 Tj Paris 12 May Rg 2153136 Cabazitaxel Sanofi C Teva Fr | - |
| Sep 15, 2025 | Pj056 Santen C 673 18 Gb | - |
| Sep 15, 2025 | Pj055 Tgi Paris 22 September 1407707 Fr | - |
| Sep 15, 2025 | Pj054 Cour Dappel De Paris 14 February 1991 Newtec International C Sfeima Pibd N504 Iiii432 Fr | - |
| Sep 15, 2025 | Pj053 Cour De Cassation 20 November Pourvoi N 1118440 Fr | - |
| Sep 15, 2025 | Pj052 Tgi Paris 6 June Rg N1606916 Fr | - |
| Sep 15, 2025 | Pj051 Tgi Rennes 2 September Rg N9803029 Fr | - |
| Sep 15, 2025 | Pj050 Decision De La Chambre De Recours 3306 De Loeb 30 May T 16596 Fr | - |
| Sep 15, 2025 | Pj049 Decision De La Chambre De Recours 3502 De Loeb 29 October T 33515 Fr | - |
| Sep 15, 2025 | Pj048 Decision De La Chambre De Recours De Loeb 10 November 1988 T038187 Gb | - |
| Sep 15, 2025 | Pj047 Tj Paris 22 June Rg N2002792 Fr | - |
| Sep 15, 2025 | Pj046 Decision De La Chambre De Recours De Loeb 20 September T197909 Gb | - |
| Sep 15, 2025 | Pj045 Decision De La Chambre De Recours De Loeb 1Er April T 140906 Gb | - |
| Sep 15, 2025 | Pj044 Decision De La Chambre De Recours De Loeb DU 28 January T 023715 Gb | - |
| Sep 15, 2025 | Pj043 Basf C25899 Gb | - |
| Sep 15, 2025 | Pj042 Gsk C21013 14 Nov Gb | - |
| Sep 15, 2025 | Pj041 Ca Paris 14 February Rg 1903820 Sandoz C Msd Fr | - |
| Sep 15, 2025 | Pj040 Abraxis C 443 17 21 March Gb | - |
| Sep 15, 2025 | Pj039 Case Law Of The Boards Of Appeal Of The Epo I D74 Try And See Solution Gb | - |
| Sep 15, 2025 | Pj038 Tj Paris 20 January Rg N 1901997 Fr | - |
| Sep 15, 2025 | Pj037 Tj Paris 6 September Rg N2106416 Fr | - |
| Sep 15, 2025 | Pj036 Tj Paris 7 June Rg 2153474 Sanofi C Accord Cabazitaxel Fr | - |
| Sep 15, 2025 | Pj035 Ca Paris 29 October Etypharm C Merck Rg N1803876 Fr | - |
| Sep 15, 2025 | Pj034 Cour Dappel De Paris 18 December Rg N 1710112 Fr | - |
| Sep 15, 2025 | Pj033 Decision De La Chambre De Recours De Loeb 25 July T 025915 Gb | - |
| Sep 15, 2025 | Pj032 Decision De La Chambre De Recours De Loeb 29 May T 009198 Gb | - |
| Sep 15, 2025 | Pj031 Decision De La Chambre De Recours De Loeb 5 October T 33397 Gb | - |
| Sep 15, 2025 | Pj030 Decision De La Chambre De Recours De Loeb 6 October T 91801 Gb | - |
| Sep 15, 2025 | Pj029 Decision De La Chambre De Recours De Loeb 14 February 1989 T 24988 Gb | - |
| Sep 15, 2025 | Pj028 Case Law Of The Boards Of Appeal Of The Epo Id71 Reasonable Expectation Of Success Gb | - |
| Sep 15, 2025 | Pj027 Jurisprudences Francaises Essais De Routine Fr | - |
| Sep 15, 2025 | Pj026 Tgi Paris 7 May Hexal C Boehringer Rg 0812537 Fr | - |
| Sep 15, 2025 | Pj025 Jub Division Centrale De Munich 16 July Sanofi C Amgen Upccfi 12023 Gb | - |
| Sep 15, 2025 | Pj024 Jub Cour Dappel 26 February Nanostring C 10X Genomics Upccoa3352023 Gb | - |
| Sep 15, 2025 | Pj023 Decision De La Chambre De Recours 332 De L Oeb 26 February T 92600 Gb | - |
| Sep 15, 2025 | Pj022 Decision De La Chambre De Recours 332 De Loeb 2 June T 30899 Gb | - |
| Sep 15, 2025 | Pj021 Decision De La Chambre De Recours 352 De Loeb 22 October 1993 T 25392 Gb | - |
| Sep 15, 2025 | Pj020 Decision De La Chambre De Recours 332 De Loeb 13 July T 393 01 Gb | - |
| Sep 15, 2025 | Pj019 Ca Paris 19 January Rg 18 21115 Fr | - |
| Sep 15, 2025 | Pj018 Tj Paris 20 July Rg N 21 10327 Fr | - |
| Sep 15, 2025 | Pj017 Ca Paris 14 November Rg N 1502576 Fr | - |
| Sep 15, 2025 | Pj016 Tj Paris 28 March Rg 2208612 Fr | - |
| Sep 15, 2025 | Pj014 Upc Court Of Appeal 13 August Upccoa4462025 Gb | - |
| Sep 15, 2025 | Pj013 Tj Paris 18 June Rg N 23 02356 Fr | - |
| Sep 15, 2025 | Pj012 Munich Local Division 27 August Upccfi2012024 Gb | - |
| Sep 15, 2025 | Pj011 Tj Paris 27 July Rg N 22 54367 Fr | - |
| Sep 15, 2025 | Pj010 Guidelines For Examination Of The Epo Giv1 Gb | - |
| Sep 15, 2025 | Pj009 Ca Paris 25 May Rg 21 18398 Fr | - |
| Sep 15, 2025 | Pj008 Tj Paris 29 September Rg 21 55930 Fr | - |
| Sep 15, 2025 | Pj007 Tj Paris Ordonnance De Refere 6 October Rg 22 55799 Biogen C Viatris Dmf Fr | - |
| Sep 15, 2025 | Pj006 Cjeu 16 July Genmab V Hungarian Ip Office Spc C 181 24 Gb | - |
| Sep 15, 2025 | Pj005 Accord Cadre Leem Ceps 5 March Fr | - |
| Sep 15, 2025 | Pj004 Regulation No 1768 92 Gb | - |
| Sep 15, 2025 | Pj003 Tj Paris Ordonnance Viatris C Novartis 04 August Fingolimod Rg N 2254655 Fr | - |
| Sep 15, 2025 | Pj002 Ca Paris 14 February Rg 1906114 Fr | - |
| Sep 15, 2025 | Pj001 Decision Du Conseil Constitutionnel N 463 Dc DU 12 December Fr | - |
| Sep 15, 2025 | Pc152 Submissions In High Resolution Gb | - |
| Sep 15, 2025 | Pc151 Declaration Dawid Sierzant DU 15 September Et Annexes Gb | - |
| Sep 15, 2025 | Pc150 4 Aminopyridine C5H6N2 Cid 1727 Pubchem Gb | - |
| Sep 15, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 15, 2025 | Pc148 The Fixing Of The Price And Reimboursement Rate Sante Gouv Fr | - |
| Sep 15, 2025 | Pc146 Letter From Viatris To Mez DATED 2 July Gb | - |
| Sep 15, 2025 | Pc145 Letter From Viatris To Merz Of 10 July Fr | - |
| Sep 15, 2025 | Pc143 Chapter 33 Pymadin Paskov Et Al 1986 Gb | - |
| Sep 15, 2025 | Pc142 Kostadinova And Danchev Gb | - |
| Sep 15, 2025 | Pc141 Sartori Et Al 1994 Gb | - |
| Sep 15, 2025 | Pc140 Olg Munchen Acorda Therapeutics V Ratiopharm 6 October 6 U 3044 22 De | - |
| Sep 15, 2025 | Pc139 Upsto Trademark Status Document Retrieval Pymadin Sopharma Gb | - |
| Sep 15, 2025 | Pc138 Website Of The Faculty Of Medicine In Sofia Bg | - |
| Sep 15, 2025 | Pc137 They Are Looking For A Superpill For Alzheimers Technologies News Standard Bg | - |
| Sep 15, 2025 | Pc136 Russian State Archive Of Scientific And Technical Documentation Ru | - |
| Sep 15, 2025 | Pc135 Communication Between The Ceps And Viatris Fr | - |
| Sep 15, 2025 | Pc134 Patient Leaflet Pymadin Bg | - |
| Sep 15, 2025 | Pc133 Smpc Pymadin Bg | - |
| Sep 15, 2025 | Pc132 Free State Gazette Edition 33 Of 2Iv Unofficial Section Ru | - |
| Sep 15, 2025 | Pc131 Disaster Protection Plan Burgas Region Republic Of Bulgaria Bg | - |
| Sep 15, 2025 | Pc130 4 Aminopiridin Spinal Cord Injury Forum Ru Compressed | - |
| Sep 15, 2025 | Pc129 Iqvia About Us Gb | - |
| Sep 15, 2025 | Pc128 Adverse Exhibit No 503 Toumi Et Al External Reference Pricing Simulation Gb | - |
| Sep 15, 2025 | Pc122 Application For Provisional Measures Gb | - |
| Sep 15, 2025 | Pc121 Acorda V Alkem Trial Transcript Volume B Gb | - |
| Sep 15, 2025 | Pc120 Acorda V Alkem Trial Transcript Volume A Gb | - |
| Sep 15, 2025 | Pc119 Hamilton Et Al 1998 Olanzapine Versus Placebo And Haloperidol Quality Of Life And Efficacy Results On The North Am | - |
| Sep 15, 2025 | Pc118 Overall 1994 Journal Of Clinical Psychology VOL 50 Pages 95 102 Gb | - |
| Sep 15, 2025 | Pc117 Alhainen Et Al 1991 Discrimination Of Tetrahydroaminoacridine Responders By A Single Dose Pharmaco Eeg In Patients | - |
| Sep 15, 2025 | Pc116 Sas Library 1997 Repeated Measures Anova Using Sas Proc Glm Gb | - |
| Sep 15, 2025 | Pc115 Sheeber Et Al 1996 Data Analytic Techniques For Treatment Outcome Studies With Pretest Posttest Measurements An Ex | - |
| Sep 15, 2025 | Pc114 Cook Et Al 1983 Design And Analysis Methods For Longitudinal Research Ann Rev Public Health Gb | - |
| Sep 15, 2025 | Pc113 Vickers Hor Many Repeated Measures In Repeates Measures Designs Statistical Issues For Comparative Trials Bmc | - |
| Sep 15, 2025 | Pc112 Uryniak Et Al Responder Analyses A Phrma Position Paper Statistics In Biopharmaceutical Research VOL 3 N3 Gb | - |
| Sep 15, 2025 | Pc111 Schulz Et Al The Efficacy Of Quetiapine VS Haloperidol And Placebo A Meta Analytic Study Of Efficacy Schizopp | - |
| Sep 15, 2025 | Pc110 Temple 1994 Commun Stat Theory Meth VOL 23 Pages 449 521 Gb | - |
| Sep 15, 2025 | Pc109 Lewis Statistics In Medicine VOL 21 Pages 2931 2938 Gb | - |
| Sep 15, 2025 | Pc108 Weiner 1998 Can J Neurol Sci VOL 25 Pages 93101 Gb | - |
| Sep 15, 2025 | Pc107 Petkau 1998 Seminars In Neurology VOL 18 3 Gb | - |
| Sep 15, 2025 | Pc106 Leber Et DAVIS 1998 Threats To The Validity Of Clinical Trials Employing Enrichment Strategies For Sample Selectio | - |
| Sep 15, 2025 | Pc105 DTX 584 Gb | - |
| Sep 15, 2025 | Pc104 4 Aminopyridine Induces Functional Improvement In Multiple Sclerosis Patients A Neurophysiological Study Gb | - |
| Sep 15, 2025 | Pc103 Stefoski Et Al 1991 4 Aminopyridine In Multiple Sclerosis Prolonged Administration Neurology 1991 Gb | - |
| Sep 15, 2025 | Pc102 Clinical Studies In 20 Questions Atelier Presse Clinical Trials Leem 19 May Fr | - |
| Sep 15, 2025 | Pc101 Report By Dr Christian Wolf DATED 2 September Gb | - |
| Sep 15, 2025 | Pc100 EP1732548B9 Gb | - |
| Sep 15, 2025 | Pc099 Matusik Therapy Nutrients 14 4249 Gb | - |
| Sep 15, 2025 | Pc098 Le Progres Article Patients Deprived Of A Medication Due To A Change Of Packaging 26 June Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 2 2 Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 1 2 Fr | - |
| Sep 15, 2025 | Pc096 Kehl Responder Identification In Clinical Trials June Gb | - |
| Sep 15, 2025 | Pc095 CPMP Points To Consider Multiplicity Issues Clinical Trials Gb | - |
| Sep 15, 2025 | Pc094 Hayes Et Al Pharmacokinetic Studies Of Single And Multiple Oral Doses Of Fampridine VOL 26 N4 Pp 185 192 Gb | - |
| Sep 15, 2025 | Pc093 Hayes Et Al Pharmacokinetics Of An Immediate Release Oral Formulation Of Fampridine 4 Aminopyridine In Normal | - |
| Sep 15, 2025 | Pc092 July 1986 Comment Determiner La Posologie Optimale D Un Medicament Fr | - |
| Sep 15, 2025 | Pc091 Dose Ranging Study Wikipedia Gb | - |
| Sep 15, 2025 | Pc090 Rnb Ccp 033 Fr | - |
| Sep 15, 2025 | Pc089 Rnb EP536Fr | - |
| Sep 15, 2025 | Pc088 Chmp 1999 Clinical Investigation Of Medicinal Products In The Treatment Of Parkinson S Disease CPMP Note For Guida | - |
| Sep 15, 2025 | Pc087 Ccne Opinion 79 Transposition Into French Law Of The European Directive On Clinical Trials Of Medicinal Products F | - |
| Sep 15, 2025 | Pc086 Declaration Of Helsinki Ethical Principles For Medical Research Involving Human Subjects Gb | - |
| Sep 15, 2025 | Pc085 Nuremberg Code Gb | - |
| Sep 15, 2025 | Pc084 Afsep Press Release Of 28 May Fr | - |
| Sep 15, 2025 | Pc083 Barus Et Al Fr | - |
| Sep 15, 2025 | Pc082 Extrait De La Base De Donnees Publique Des Medicaments Fampridine Viatris 10 Mg Fr | - |
| Sep 15, 2025 | Pc081 Icht Topic 9 Guideline On Statistical Principles For Clinical Trials September 1998 Gb | - |
| Sep 15, 2025 | Pc080 Website Of The Foundation For Research Into Multiple Sclerosis Fr | - |
| Sep 15, 2025 | Pc079 Notice On The Prices Of Fampridine Pharmaceutical Specialities Fr | - |
| Sep 15, 2025 | Pc078 Info Sheet Fampyra 10Mg Sustained Release Tablet Fr | - |
| Sep 15, 2025 | Pc077 Accession Of Bulgaria Gb | - |
| Sep 15, 2025 | Pc076 Kehl Responder Identification In Clinical Trials With Censored Data Gb | - |
| Sep 15, 2025 | Pc075 Federal Court Of Canada 15 May Acorda V Pharmascience And Taro T 1416 18 And T 220 19 Gb | - |
| Sep 15, 2025 | Pc074 Usa Delaware District Court 25 April Acorda V Teva Roxane Mylan 14 882 Gb | - |
| Sep 15, 2025 | Pc073 Usa Delaware District Court 31 March Acorda V Roxane 14 882 Lps Gb | - |
| Sep 15, 2025 | Pc072 Germany Teva Revocation Of Patent EP548De | - |
| Sep 15, 2025 | Pc071 Germany Ratiopharm Revocation Of Patent EP536De | - |
| Sep 15, 2025 | Pc070 Germany Ratiopharm Admissibility Of The EP536Invalidity Claim De | - |
| Sep 15, 2025 | Pc069 Board Of Appeal Of The European Patent Office 4 September T 0799 16 Gb | - |
| Sep 15, 2025 | Pc068 Decision Of The Epo EP536Gb Compressed | - |
| Sep 15, 2025 | Pc067 Emea Points To Consider On The Choice Of Non Interiority Margin Gb | - |
| Sep 15, 2025 | Pc066 Emea 27 July Points To Consider On Switching Betweend Superiority And Non Inferiority Gb | - |
| Sep 15, 2025 | Pc064 Usa Court Of Appeal 10 September Acorda V Roxane Et Al Et 2134 Gb | - |
| Sep 15, 2025 | Pc063 Form 10 K Wikipedia Presentation Gb | - |
| Sep 15, 2025 | Pc062 Cohen Postgraduate Medicine September 1999 Gb | - |
| Sep 15, 2025 | Pc061 L Echelle Edss Expanded Disability Status Scale Fr | - |
| Sep 15, 2025 | Pc060 O Brien Journal Of Hypertension Gb | - |
| Sep 15, 2025 | Pc059 Ellen R Girden Anova Repeated Measures 1992 Gb | - |
| Sep 15, 2025 | Pc058 Federal Court Of Appeal Of Canada 8 August Acorda Therapeutics V Pharmascience Taro Pharmaceuticals A 145 20 | - |
| Sep 15, 2025 | Pc057 Fda Chapter I Food And Drug Administration Department Of Health And Human Services Subchapter D Drugs For Human Us | - |
| Sep 15, 2025 | Pc056 Polman Arch Neur VOL 51 November 1994 Gb | - |
| Sep 15, 2025 | Pc055 Sheiner Clin Pharmacol Ther Volume 46 Number 1 July 1989 Gb | - |
| Sep 15, 2025 | Pc054 Norleans Statistical Methods For Clinical Trials Gb Compressed | - |
| Sep 15, 2025 | Pc053 Excerpt From The Fda Website Drug Evaluation Process Gb | - |
| Sep 15, 2025 | Pc052 Schwid Et Al April Gb | - |
| Sep 15, 2025 | Pc051 Kaufman Al The Significant Change For The Timed 25 Foot Walk In The Multiple Sclerosis Functional Composite M | - |
| Sep 15, 2025 | Pc050 Extract From The National Institutes Of Health Website Fda Drug Review And Approval Gb | - |
| Sep 15, 2025 | Pc049 Ca 2 562 277 Gb | - |
| Sep 15, 2025 | Pc048 US8663685Gb | - |
| Sep 15, 2025 | Pc047 US8440703Gb | - |
| Sep 15, 2025 | Pc046 US8354437Gb | - |
| Sep 15, 2025 | Pc045 Declaration Of Dr Ron Cohen Gb | - |
| Sep 15, 2025 | Pc044 US8007826Gb | - |
| Sep 15, 2025 | Pc043 Goodman Diaporama Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc042 Medical Research Council Mrc Scale For Muscle Strength Gb | - |
| Sep 15, 2025 | Pc041 National Multiple Sclerosis Society Timed 25 Foot Walk T25 Fw Gb | - |
| Sep 15, 2025 | Pc040 Ninds Fatigue Severity Scale Fss Gb | - |
| Sep 15, 2025 | Pc039 Wikipedia Page Edss Gb | - |
| Sep 15, 2025 | Pc038 Goodman Poster Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc037 Supplemental Information Disclosure Statement Gb | - |
| Sep 15, 2025 | Pc036 Actrims Ectrims Final Program Gb Compressed | - |
| Sep 15, 2025 | Pc035 List Of References Ids Gb | - |
| Sep 15, 2025 | Pc034 List Of Documents Requested US11102559Gb | - |
| Sep 15, 2025 | Pc033 Acorda Therapeutics Form S1 Gb | - |
| Sep 15, 2025 | Pc032 Form S 1 Presentation Gb | - |
| Sep 15, 2025 | Pc031 Sec Overview Gb | - |
| Sep 15, 2025 | Pc030 Goodman Abstract Poster Gb | - |
| Sep 15, 2025 | Pc029 Shargel 1999 Applied Biopharmaceutics And Pharmacokinetics Chapter 7 Extraits Pages 169 178 179 Gb Compressed | - |
| Sep 15, 2025 | Pc028 VAN Diemen Et Al 1992 August Gb | - |
| Sep 15, 2025 | Pc027 EP0484186B1 Gb | - |
| Sep 15, 2025 | Pc026 Schwid Et Al 1997 The American Academy Of Neurology Volume 48 Pages 817 821 Gb | - |
| Sep 15, 2025 | Pc025 Bever 1994 The American Neurological Association 1994 Volume 23 Page 118 S121 Gb | - |
| Sep 15, 2025 | Pc024 Bever Et Al 1994 June Neurology 44 1054 1059 Gb | - |
| Sep 15, 2025 | Pc023 Davis Et Al 1990 The American Neurological Association 1990 Pages 186 192 Gb | - |
| Sep 15, 2025 | Pc022 Sherratt Et Al 1980 Nature Volume 283 5745 Pages 570 572 Gb | - |
| Sep 15, 2025 | Pc021 List Of Documents Cited In The Oppositions Gb | - |
| Sep 15, 2025 | Pc020 Merz Acquires Fampyra Gb | - |
| Sep 15, 2025 | Pc019 European Medicines Agency Guidelines Ich Topic E4 November 1994 Gb | - |
| Sep 15, 2025 | Pc018 EP536Oral Proceedings Gb | - |
| Sep 15, 2025 | Pc017 Verhagen Et Al Australian Journal Of Physiotherapy VOL 50 Gb | - |
| Sep 15, 2025 | Pc016 Piece Composite Synthese Wikipiedia Sur L Ecart Type Et La Valeur P Fr | - |
| Sep 15, 2025 | Pc015 Marien Et Beaud Guide Pratique Pour L Utilisation De La Statistique En Recherche Fr | - |
| Sep 15, 2025 | Pc014 Journal De La Societe Statistique De Paris 1956 Fr | - |
| Sep 15, 2025 | Pc013 Ting N Introduction And New Drug Development Process In Ting N Editor Dose Finding In Drug Development Springer Ne | - |
| Sep 15, 2025 | Pc012 Pirmohamed Et Al Bmj Volume 316 25 April 1998 Gb | - |
| Sep 15, 2025 | Pc011 Edwards And Aronson The Lancet VOL 356 October 7 Gb | - |
| Sep 15, 2025 | Pc010 Ich Topic E 8 General Considerations For Clinical Trials 17 July 1997 Gb | - |
| Sep 15, 2025 | Pc009 Griffin Et Al The Textbook Of Pharmaceutical Medicine 1993 Pages 221 222 Gb Compressed | - |
| Sep 15, 2025 | Pc008 Bopi 20 November N 1547 Pp 235 237 Et 258 Fr | - |
| Sep 15, 2025 | Pc007 Decision Et Requete De Delivrance Du Ccp N 13 C0033 Fr | - |
| Sep 15, 2025 | Pc006 Demande De Ccp Sur La Base Du Brevet EP2377536Fr | - |
| Sep 15, 2025 | Pc005 EP2377536B2 Gb | - |
| Sep 15, 2025 | Pc004 Fampyra Smpc Gb | - |
| Sep 15, 2025 | Pc003 Commission Implementing Decision Of 27 September C20246926 Gb | - |
| Sep 15, 2025 | Pc002 Rcp Fampridine Viatris Lp 10Mg Fr | - |
| Sep 15, 2025 | Pc001 Extrait Kbis Viatris Sante Fr | - |
| Sep 15, 2025 | Objection Viatris Sante App 339802025 Compressed Signed | - |
| Sep 11, 2025 | Summon Oral Hearing | - |
| Sep 11, 2025 | Order Summon The Oral Hearing | |
| Aug 18, 2025 | Procedural Order Timetable And Summon Oh | |
| Aug 18, 2025 | Hearing Dates | - |
| Aug 14, 2025 | Panel Appointment | - |
| Aug 7, 2025 | Acknowledgement Of Access To Case | - |
| Aug 6, 2025 | Notification Of Service | - |
| Aug 6, 2025 | Digital Tracking La Poste Service Receipt | - |
| Aug 5, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Notice To Accompany Service Of Order For Measures | - |
| Aug 1, 2025 | Letter For Service | - |
| Aug 1, 2025 | Formal Checks Notification Of Positive Outcome | - |
| Aug 1, 2025 | Exhibit No. 701 Application French Translation | - |
| Aug 1, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Aug 1, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Aug 1, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Aug 1, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Aug 1, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Aug 1, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Aug 1, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Aug 1, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Aug 1, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Aug 1, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Aug 1, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Aug 1, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Aug 1, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Aug 1, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Aug 1, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Aug 1, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Aug 1, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Aug 1, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Aug 1, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Aug 1, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Aug 1, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Aug 1, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Aug 1, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Aug 1, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Aug 1, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Aug 1, 2025 | Exhibit No. 401 Goodman Poster | - |
| Aug 1, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Aug 1, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Aug 1, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Aug 1, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Aug 1, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Aug 1, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Aug 1, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Aug 1, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 208 French Spc Register | - |
| Aug 1, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Aug 1, 2025 | Exhibit No. 206 French Patent Register | - |
| Aug 1, 2025 | Exhibit No. 205 EP536Patent | - |
| Aug 1, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Aug 1, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Aug 1, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Aug 1, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Aug 1, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Aug 1, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Aug 1, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Aug 1, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Aug 1, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Aug 1, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Aug 1, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Aug 1, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Aug 1, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Aug 1, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Aug 1, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Aug 1, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Aug 1, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Aug 1, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Aug 1, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Aug 1, 2025 | Exhibit No. 106 Larocca | - |
| Aug 1, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Aug 1, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Aug 1, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Aug 1, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Aug 1, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Aug 1, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Aug 1, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Aug 1, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Aug 1, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Aug 1, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Aug 1, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Aug 1, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Aug 1, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Aug 1, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Aug 1, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Aug 1, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Aug 1, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Aug 1, 2025 | Application For Provisional Measures | - |
| Aug 1, 2025 | Application For Measures Receipt | - |
| Aug 1, 2025 | Application For Measures Acknowledgement | - |
| Jul 31, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Jul 31, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Jul 31, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Jul 31, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Jul 31, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Jul 31, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Jul 31, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Jul 31, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Jul 31, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Jul 31, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Jul 31, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Jul 31, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Jul 31, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Jul 31, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Jul 31, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Jul 31, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Jul 31, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Jul 31, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Jul 31, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Jul 31, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Jul 31, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Jul 31, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Jul 31, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Jul 31, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Jul 31, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Jul 31, 2025 | Exhibit No. 401 Goodman Poster | - |
| Jul 31, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Jul 31, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Jul 31, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Jul 31, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Jul 31, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Jul 31, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Jul 31, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Jul 31, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 208 French Spc Register | - |
| Jul 31, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Jul 31, 2025 | Exhibit No. 206 French Patent Register | - |
| Jul 31, 2025 | Exhibit No. 205 EP536Patent | - |
| Jul 31, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Jul 31, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Jul 31, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Jul 31, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Jul 31, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Jul 31, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Jul 31, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Jul 31, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Jul 31, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Jul 31, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Jul 31, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Jul 31, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Jul 31, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Jul 31, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Jul 31, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Jul 31, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Jul 31, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Jul 31, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Jul 31, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Jul 31, 2025 | Exhibit No. 106 Larocca | - |
| Jul 31, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Jul 31, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Jul 31, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Jul 31, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Jul 31, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Jul 31, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Jul 31, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Jul 31, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Jul 31, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Jul 31, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Jul 31, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Jul 31, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Jul 31, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Jul 31, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Jul 31, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Jul 31, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Jul 31, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Jul 31, 2025 | Application For Provisional Measures | - |
| Oct 10, 2025 | Action.Communication | - |
| Oct 9, 2025 | Receipt | - |
| Oct 9, 2025 | Proof Of Payment | - |
| Oct 9, 2025 | Other Document | - |
| Oct 9, 2025 | Fee | - |
| Oct 9, 2025 | Cover Sheet | - |
| Oct 9, 2025 | Application | - |
| Oct 7, 2025 | Order | - |
| Oct 7, 2025 | Action.Issueorder | - |
| Oct 6, 2025 | Action.Communication | - |
| Oct 5, 2025 | Receipt | - |
| Oct 5, 2025 | Cover Sheet | - |
| Oct 5, 2025 | Application | - |
| Oct 2, 2025 | Receipt | - |
| Oct 2, 2025 | Order | - |
| Oct 2, 2025 | Cover Sheet | - |
| Oct 2, 2025 | Application | - |
| Oct 2, 2025 | Action.Issueorder | - |
| Oct 1, 2025 | Statement Of Reply | - |
| Oct 1, 2025 | Receipt | - |
| Oct 1, 2025 | Exhibit | - |
| Oct 1, 2025 | Cover Sheet | - |
| Oct 1, 2025 | Application | - |
| Sep 26, 2025 | Action.Communication | - |
| Sep 25, 2025 | Receipt | - |
| Sep 25, 2025 | Other Document | - |
| Sep 25, 2025 | Exhibit | - |
| Sep 25, 2025 | Cover Sheet | - |
| Sep 25, 2025 | Action.Communication | - |
| Sep 24, 2025 | Order | - |
| Sep 24, 2025 | Action.Issueorder | - |
| Sep 18, 2025 | Request V.Def Pdf A Signed | - |
| Sep 18, 2025 | Receipt | - |
| Sep 18, 2025 | Pc154 Iqvia Agreement Gb | - |
| Sep 18, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 17, 2025 | Receipt | - |
| Sep 17, 2025 | Procedural Order | |
| Sep 17, 2025 | Outcome Of The Order | - |
| Sep 17, 2025 | Headnote And Keywords | - |
| Sep 16, 2025 | Request For Procedural Order | - |
| Sep 16, 2025 | Receipt | - |
| Sep 16, 2025 | Objection | - |
| Sep 15, 2025 | Pj087 Regulation N 469 Gb | - |
| Sep 15, 2025 | Pj086 Court Of Appeal 10X Genomics Harvard V Nanostring Upc Coa 3352023 Gb | - |
| Sep 15, 2025 | Pj085 Dmf Nl Court Of The Hague 1Ere Instance Nl | - |
| Sep 15, 2025 | Pj084 Dmf Be Cour Dappel De Bruxelles Appel Nl | - |
| Sep 15, 2025 | Pj083 Fingolimod De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj082 Phosphodiesterase Nl Appeal Court Of The Hague Appel Nl | - |
| Sep 15, 2025 | Pj081 Dmf De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj080 Munich Local Division 21 May Upccfi432023 De | - |
| Sep 15, 2025 | Pj079 Ca Paris 9 July N2407962 Fr | - |
| Sep 15, 2025 | Pj078 Case Law Of The Boards Of Appeal Id108 Gb | - |
| Sep 15, 2025 | Pj077 Bonnes Pratiques De Distribution Ansm Bulletin Officiel N20149Bis Fr | - |
| Sep 15, 2025 | Pj076 Upc Court Of Appeal 25 September Upccoa1822024 Gb | - |
| Sep 15, 2025 | Pj075 Guidelines For Examination In The European Patent Office Gvii4Gb | - |
| Sep 15, 2025 | Pj074 Decision De La Chambre De Recours De Loeb DU 4 October T 111003 Gb | - |
| Sep 15, 2025 | Pj073 Epo Boa 10 July Eisai V Stada Lenvatinib T 193423 Gb | - |
| Sep 15, 2025 | Pj072 Hamburg Local Division 3 June Upccfi1512024 Gb | - |
| Sep 15, 2025 | Pj071 Dusseldorf Local Division 30 April Upccfi4632023 Gb | - |
| Sep 15, 2025 | Pj070 Dusseldorf Local Division 9 April Upccfi4522023 De | - |
| Sep 15, 2025 | Pj069 Dusseldorf Local Division VALEO V Magna Upc Cfi 3682024 Gb | - |
| Sep 15, 2025 | Pj068 Court Of Appeal Biolitec V Light Guide Optics Sia Lightguide 24 February Upccoa5402024 Gb | - |
| Sep 15, 2025 | Pj067 Ld Munich 15 November Upc Cfi 152023 Gb | - |
| Sep 15, 2025 | Pj065 Cjeu 28 July Synthon C Mertz Memantine C19509 Gb | - |
| Sep 15, 2025 | Pj064 Cjeu 28 July Generics Uk C Synaptech Galantamine C42709 Gb | - |
| Sep 15, 2025 | Pj063 Cass Com 10 February N1320150 Fr | - |
| Sep 15, 2025 | Pj062 Directive 200448CE Gb | - |
| Sep 15, 2025 | Pj061 Neurim Mylan High Court Of Justice 3 June Ewhc 1362 Gb | - |
| Sep 15, 2025 | Pj060 Decision De La Chambre De Recours De Loeb 13 September T023916 Gb | - |
| Sep 15, 2025 | Pj059 Decision De La Chambre De Recours De Loeb 4 October T250612 Gb | - |
| Sep 15, 2025 | Pj058 Tj Paris Refere 17 June Rg 2153849 Cabazitaxel Sanofi C Ever Pharma Fr | - |
| Sep 15, 2025 | Pj057 Tj Paris 12 May Rg 2153136 Cabazitaxel Sanofi C Teva Fr | - |
| Sep 15, 2025 | Pj056 Santen C 673 18 Gb | - |
| Sep 15, 2025 | Pj055 Tgi Paris 22 September 1407707 Fr | - |
| Sep 15, 2025 | Pj054 Cour Dappel De Paris 14 February 1991 Newtec International C Sfeima Pibd N504 Iiii432 Fr | - |
| Sep 15, 2025 | Pj053 Cour De Cassation 20 November Pourvoi N 1118440 Fr | - |
| Sep 15, 2025 | Pj052 Tgi Paris 6 June Rg N1606916 Fr | - |
| Sep 15, 2025 | Pj051 Tgi Rennes 2 September Rg N9803029 Fr | - |
| Sep 15, 2025 | Pj050 Decision De La Chambre De Recours 3306 De Loeb 30 May T 16596 Fr | - |
| Sep 15, 2025 | Pj049 Decision De La Chambre De Recours 3502 De Loeb 29 October T 33515 Fr | - |
| Sep 15, 2025 | Pj048 Decision De La Chambre De Recours De Loeb 10 November 1988 T038187 Gb | - |
| Sep 15, 2025 | Pj047 Tj Paris 22 June Rg N2002792 Fr | - |
| Sep 15, 2025 | Pj046 Decision De La Chambre De Recours De Loeb 20 September T197909 Gb | - |
| Sep 15, 2025 | Pj045 Decision De La Chambre De Recours De Loeb 1Er April T 140906 Gb | - |
| Sep 15, 2025 | Pj044 Decision De La Chambre De Recours De Loeb DU 28 January T 023715 Gb | - |
| Sep 15, 2025 | Pj043 Basf C25899 Gb | - |
| Sep 15, 2025 | Pj042 Gsk C21013 14 Nov Gb | - |
| Sep 15, 2025 | Pj041 Ca Paris 14 February Rg 1903820 Sandoz C Msd Fr | - |
| Sep 15, 2025 | Pj040 Abraxis C 443 17 21 March Gb | - |
| Sep 15, 2025 | Pj039 Case Law Of The Boards Of Appeal Of The Epo I D74 Try And See Solution Gb | - |
| Sep 15, 2025 | Pj038 Tj Paris 20 January Rg N 1901997 Fr | - |
| Sep 15, 2025 | Pj037 Tj Paris 6 September Rg N2106416 Fr | - |
| Sep 15, 2025 | Pj036 Tj Paris 7 June Rg 2153474 Sanofi C Accord Cabazitaxel Fr | - |
| Sep 15, 2025 | Pj035 Ca Paris 29 October Etypharm C Merck Rg N1803876 Fr | - |
| Sep 15, 2025 | Pj034 Cour Dappel De Paris 18 December Rg N 1710112 Fr | - |
| Sep 15, 2025 | Pj033 Decision De La Chambre De Recours De Loeb 25 July T 025915 Gb | - |
| Sep 15, 2025 | Pj032 Decision De La Chambre De Recours De Loeb 29 May T 009198 Gb | - |
| Sep 15, 2025 | Pj031 Decision De La Chambre De Recours De Loeb 5 October T 33397 Gb | - |
| Sep 15, 2025 | Pj030 Decision De La Chambre De Recours De Loeb 6 October T 91801 Gb | - |
| Sep 15, 2025 | Pj029 Decision De La Chambre De Recours De Loeb 14 February 1989 T 24988 Gb | - |
| Sep 15, 2025 | Pj028 Case Law Of The Boards Of Appeal Of The Epo Id71 Reasonable Expectation Of Success Gb | - |
| Sep 15, 2025 | Pj027 Jurisprudences Francaises Essais De Routine Fr | - |
| Sep 15, 2025 | Pj026 Tgi Paris 7 May Hexal C Boehringer Rg 0812537 Fr | - |
| Sep 15, 2025 | Pj025 Jub Division Centrale De Munich 16 July Sanofi C Amgen Upccfi 12023 Gb | - |
| Sep 15, 2025 | Pj024 Jub Cour Dappel 26 February Nanostring C 10X Genomics Upccoa3352023 Gb | - |
| Sep 15, 2025 | Pj023 Decision De La Chambre De Recours 332 De L Oeb 26 February T 92600 Gb | - |
| Sep 15, 2025 | Pj022 Decision De La Chambre De Recours 332 De Loeb 2 June T 30899 Gb | - |
| Sep 15, 2025 | Pj021 Decision De La Chambre De Recours 352 De Loeb 22 October 1993 T 25392 Gb | - |
| Sep 15, 2025 | Pj020 Decision De La Chambre De Recours 332 De Loeb 13 July T 393 01 Gb | - |
| Sep 15, 2025 | Pj019 Ca Paris 19 January Rg 18 21115 Fr | - |
| Sep 15, 2025 | Pj018 Tj Paris 20 July Rg N 21 10327 Fr | - |
| Sep 15, 2025 | Pj017 Ca Paris 14 November Rg N 1502576 Fr | - |
| Sep 15, 2025 | Pj016 Tj Paris 28 March Rg 2208612 Fr | - |
| Sep 15, 2025 | Pj014 Upc Court Of Appeal 13 August Upccoa4462025 Gb | - |
| Sep 15, 2025 | Pj013 Tj Paris 18 June Rg N 23 02356 Fr | - |
| Sep 15, 2025 | Pj012 Munich Local Division 27 August Upccfi2012024 Gb | - |
| Sep 15, 2025 | Pj011 Tj Paris 27 July Rg N 22 54367 Fr | - |
| Sep 15, 2025 | Pj010 Guidelines For Examination Of The Epo Giv1 Gb | - |
| Sep 15, 2025 | Pj009 Ca Paris 25 May Rg 21 18398 Fr | - |
| Sep 15, 2025 | Pj008 Tj Paris 29 September Rg 21 55930 Fr | - |
| Sep 15, 2025 | Pj007 Tj Paris Ordonnance De Refere 6 October Rg 22 55799 Biogen C Viatris Dmf Fr | - |
| Sep 15, 2025 | Pj006 Cjeu 16 July Genmab V Hungarian Ip Office Spc C 181 24 Gb | - |
| Sep 15, 2025 | Pj005 Accord Cadre Leem Ceps 5 March Fr | - |
| Sep 15, 2025 | Pj004 Regulation No 1768 92 Gb | - |
| Sep 15, 2025 | Pj003 Tj Paris Ordonnance Viatris C Novartis 04 August Fingolimod Rg N 2254655 Fr | - |
| Sep 15, 2025 | Pj002 Ca Paris 14 February Rg 1906114 Fr | - |
| Sep 15, 2025 | Pj001 Decision Du Conseil Constitutionnel N 463 Dc DU 12 December Fr | - |
| Sep 15, 2025 | Pc152 Submissions In High Resolution Gb | - |
| Sep 15, 2025 | Pc151 Declaration Dawid Sierzant DU 15 September Et Annexes Gb | - |
| Sep 15, 2025 | Pc150 4 Aminopyridine C5H6N2 Cid 1727 Pubchem Gb | - |
| Sep 15, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 15, 2025 | Pc148 The Fixing Of The Price And Reimboursement Rate Sante Gouv Fr | - |
| Sep 15, 2025 | Pc146 Letter From Viatris To Mez DATED 2 July Gb | - |
| Sep 15, 2025 | Pc145 Letter From Viatris To Merz Of 10 July Fr | - |
| Sep 15, 2025 | Pc143 Chapter 33 Pymadin Paskov Et Al 1986 Gb | - |
| Sep 15, 2025 | Pc142 Kostadinova And Danchev Gb | - |
| Sep 15, 2025 | Pc141 Sartori Et Al 1994 Gb | - |
| Sep 15, 2025 | Pc140 Olg Munchen Acorda Therapeutics V Ratiopharm 6 October 6 U 3044 22 De | - |
| Sep 15, 2025 | Pc139 Upsto Trademark Status Document Retrieval Pymadin Sopharma Gb | - |
| Sep 15, 2025 | Pc138 Website Of The Faculty Of Medicine In Sofia Bg | - |
| Sep 15, 2025 | Pc137 They Are Looking For A Superpill For Alzheimers Technologies News Standard Bg | - |
| Sep 15, 2025 | Pc136 Russian State Archive Of Scientific And Technical Documentation Ru | - |
| Sep 15, 2025 | Pc135 Communication Between The Ceps And Viatris Fr | - |
| Sep 15, 2025 | Pc134 Patient Leaflet Pymadin Bg | - |
| Sep 15, 2025 | Pc133 Smpc Pymadin Bg | - |
| Sep 15, 2025 | Pc132 Free State Gazette Edition 33 Of 2Iv Unofficial Section Ru | - |
| Sep 15, 2025 | Pc131 Disaster Protection Plan Burgas Region Republic Of Bulgaria Bg | - |
| Sep 15, 2025 | Pc130 4 Aminopiridin Spinal Cord Injury Forum Ru Compressed | - |
| Sep 15, 2025 | Pc129 Iqvia About Us Gb | - |
| Sep 15, 2025 | Pc128 Adverse Exhibit No 503 Toumi Et Al External Reference Pricing Simulation Gb | - |
| Sep 15, 2025 | Pc122 Application For Provisional Measures Gb | - |
| Sep 15, 2025 | Pc121 Acorda V Alkem Trial Transcript Volume B Gb | - |
| Sep 15, 2025 | Pc120 Acorda V Alkem Trial Transcript Volume A Gb | - |
| Sep 15, 2025 | Pc119 Hamilton Et Al 1998 Olanzapine Versus Placebo And Haloperidol Quality Of Life And Efficacy Results On The North Am | - |
| Sep 15, 2025 | Pc118 Overall 1994 Journal Of Clinical Psychology VOL 50 Pages 95 102 Gb | - |
| Sep 15, 2025 | Pc117 Alhainen Et Al 1991 Discrimination Of Tetrahydroaminoacridine Responders By A Single Dose Pharmaco Eeg In Patients | - |
| Sep 15, 2025 | Pc116 Sas Library 1997 Repeated Measures Anova Using Sas Proc Glm Gb | - |
| Sep 15, 2025 | Pc115 Sheeber Et Al 1996 Data Analytic Techniques For Treatment Outcome Studies With Pretest Posttest Measurements An Ex | - |
| Sep 15, 2025 | Pc114 Cook Et Al 1983 Design And Analysis Methods For Longitudinal Research Ann Rev Public Health Gb | - |
| Sep 15, 2025 | Pc113 Vickers Hor Many Repeated Measures In Repeates Measures Designs Statistical Issues For Comparative Trials Bmc | - |
| Sep 15, 2025 | Pc112 Uryniak Et Al Responder Analyses A Phrma Position Paper Statistics In Biopharmaceutical Research VOL 3 N3 Gb | - |
| Sep 15, 2025 | Pc111 Schulz Et Al The Efficacy Of Quetiapine VS Haloperidol And Placebo A Meta Analytic Study Of Efficacy Schizopp | - |
| Sep 15, 2025 | Pc110 Temple 1994 Commun Stat Theory Meth VOL 23 Pages 449 521 Gb | - |
| Sep 15, 2025 | Pc109 Lewis Statistics In Medicine VOL 21 Pages 2931 2938 Gb | - |
| Sep 15, 2025 | Pc108 Weiner 1998 Can J Neurol Sci VOL 25 Pages 93101 Gb | - |
| Sep 15, 2025 | Pc107 Petkau 1998 Seminars In Neurology VOL 18 3 Gb | - |
| Sep 15, 2025 | Pc106 Leber Et DAVIS 1998 Threats To The Validity Of Clinical Trials Employing Enrichment Strategies For Sample Selectio | - |
| Sep 15, 2025 | Pc105 DTX 584 Gb | - |
| Sep 15, 2025 | Pc104 4 Aminopyridine Induces Functional Improvement In Multiple Sclerosis Patients A Neurophysiological Study Gb | - |
| Sep 15, 2025 | Pc103 Stefoski Et Al 1991 4 Aminopyridine In Multiple Sclerosis Prolonged Administration Neurology 1991 Gb | - |
| Sep 15, 2025 | Pc102 Clinical Studies In 20 Questions Atelier Presse Clinical Trials Leem 19 May Fr | - |
| Sep 15, 2025 | Pc101 Report By Dr Christian Wolf DATED 2 September Gb | - |
| Sep 15, 2025 | Pc100 EP1732548B9 Gb | - |
| Sep 15, 2025 | Pc099 Matusik Therapy Nutrients 14 4249 Gb | - |
| Sep 15, 2025 | Pc098 Le Progres Article Patients Deprived Of A Medication Due To A Change Of Packaging 26 June Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 2 2 Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 1 2 Fr | - |
| Sep 15, 2025 | Pc096 Kehl Responder Identification In Clinical Trials June Gb | - |
| Sep 15, 2025 | Pc095 CPMP Points To Consider Multiplicity Issues Clinical Trials Gb | - |
| Sep 15, 2025 | Pc094 Hayes Et Al Pharmacokinetic Studies Of Single And Multiple Oral Doses Of Fampridine VOL 26 N4 Pp 185 192 Gb | - |
| Sep 15, 2025 | Pc093 Hayes Et Al Pharmacokinetics Of An Immediate Release Oral Formulation Of Fampridine 4 Aminopyridine In Normal | - |
| Sep 15, 2025 | Pc092 July 1986 Comment Determiner La Posologie Optimale D Un Medicament Fr | - |
| Sep 15, 2025 | Pc091 Dose Ranging Study Wikipedia Gb | - |
| Sep 15, 2025 | Pc090 Rnb Ccp 033 Fr | - |
| Sep 15, 2025 | Pc089 Rnb EP536Fr | - |
| Sep 15, 2025 | Pc088 Chmp 1999 Clinical Investigation Of Medicinal Products In The Treatment Of Parkinson S Disease CPMP Note For Guida | - |
| Sep 15, 2025 | Pc087 Ccne Opinion 79 Transposition Into French Law Of The European Directive On Clinical Trials Of Medicinal Products F | - |
| Sep 15, 2025 | Pc086 Declaration Of Helsinki Ethical Principles For Medical Research Involving Human Subjects Gb | - |
| Sep 15, 2025 | Pc085 Nuremberg Code Gb | - |
| Sep 15, 2025 | Pc084 Afsep Press Release Of 28 May Fr | - |
| Sep 15, 2025 | Pc083 Barus Et Al Fr | - |
| Sep 15, 2025 | Pc082 Extrait De La Base De Donnees Publique Des Medicaments Fampridine Viatris 10 Mg Fr | - |
| Sep 15, 2025 | Pc081 Icht Topic 9 Guideline On Statistical Principles For Clinical Trials September 1998 Gb | - |
| Sep 15, 2025 | Pc080 Website Of The Foundation For Research Into Multiple Sclerosis Fr | - |
| Sep 15, 2025 | Pc079 Notice On The Prices Of Fampridine Pharmaceutical Specialities Fr | - |
| Sep 15, 2025 | Pc078 Info Sheet Fampyra 10Mg Sustained Release Tablet Fr | - |
| Sep 15, 2025 | Pc077 Accession Of Bulgaria Gb | - |
| Sep 15, 2025 | Pc076 Kehl Responder Identification In Clinical Trials With Censored Data Gb | - |
| Sep 15, 2025 | Pc075 Federal Court Of Canada 15 May Acorda V Pharmascience And Taro T 1416 18 And T 220 19 Gb | - |
| Sep 15, 2025 | Pc074 Usa Delaware District Court 25 April Acorda V Teva Roxane Mylan 14 882 Gb | - |
| Sep 15, 2025 | Pc073 Usa Delaware District Court 31 March Acorda V Roxane 14 882 Lps Gb | - |
| Sep 15, 2025 | Pc072 Germany Teva Revocation Of Patent EP548De | - |
| Sep 15, 2025 | Pc071 Germany Ratiopharm Revocation Of Patent EP536De | - |
| Sep 15, 2025 | Pc070 Germany Ratiopharm Admissibility Of The EP536Invalidity Claim De | - |
| Sep 15, 2025 | Pc069 Board Of Appeal Of The European Patent Office 4 September T 0799 16 Gb | - |
| Sep 15, 2025 | Pc068 Decision Of The Epo EP536Gb Compressed | - |
| Sep 15, 2025 | Pc067 Emea Points To Consider On The Choice Of Non Interiority Margin Gb | - |
| Sep 15, 2025 | Pc066 Emea 27 July Points To Consider On Switching Betweend Superiority And Non Inferiority Gb | - |
| Sep 15, 2025 | Pc064 Usa Court Of Appeal 10 September Acorda V Roxane Et Al Et 2134 Gb | - |
| Sep 15, 2025 | Pc063 Form 10 K Wikipedia Presentation Gb | - |
| Sep 15, 2025 | Pc062 Cohen Postgraduate Medicine September 1999 Gb | - |
| Sep 15, 2025 | Pc061 L Echelle Edss Expanded Disability Status Scale Fr | - |
| Sep 15, 2025 | Pc060 O Brien Journal Of Hypertension Gb | - |
| Sep 15, 2025 | Pc059 Ellen R Girden Anova Repeated Measures 1992 Gb | - |
| Sep 15, 2025 | Pc058 Federal Court Of Appeal Of Canada 8 August Acorda Therapeutics V Pharmascience Taro Pharmaceuticals A 145 20 | - |
| Sep 15, 2025 | Pc057 Fda Chapter I Food And Drug Administration Department Of Health And Human Services Subchapter D Drugs For Human Us | - |
| Sep 15, 2025 | Pc056 Polman Arch Neur VOL 51 November 1994 Gb | - |
| Sep 15, 2025 | Pc055 Sheiner Clin Pharmacol Ther Volume 46 Number 1 July 1989 Gb | - |
| Sep 15, 2025 | Pc054 Norleans Statistical Methods For Clinical Trials Gb Compressed | - |
| Sep 15, 2025 | Pc053 Excerpt From The Fda Website Drug Evaluation Process Gb | - |
| Sep 15, 2025 | Pc052 Schwid Et Al April Gb | - |
| Sep 15, 2025 | Pc051 Kaufman Al The Significant Change For The Timed 25 Foot Walk In The Multiple Sclerosis Functional Composite M | - |
| Sep 15, 2025 | Pc050 Extract From The National Institutes Of Health Website Fda Drug Review And Approval Gb | - |
| Sep 15, 2025 | Pc049 Ca 2 562 277 Gb | - |
| Sep 15, 2025 | Pc048 US8663685Gb | - |
| Sep 15, 2025 | Pc047 US8440703Gb | - |
| Sep 15, 2025 | Pc046 US8354437Gb | - |
| Sep 15, 2025 | Pc045 Declaration Of Dr Ron Cohen Gb | - |
| Sep 15, 2025 | Pc044 US8007826Gb | - |
| Sep 15, 2025 | Pc043 Goodman Diaporama Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc042 Medical Research Council Mrc Scale For Muscle Strength Gb | - |
| Sep 15, 2025 | Pc041 National Multiple Sclerosis Society Timed 25 Foot Walk T25 Fw Gb | - |
| Sep 15, 2025 | Pc040 Ninds Fatigue Severity Scale Fss Gb | - |
| Sep 15, 2025 | Pc039 Wikipedia Page Edss Gb | - |
| Sep 15, 2025 | Pc038 Goodman Poster Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc037 Supplemental Information Disclosure Statement Gb | - |
| Sep 15, 2025 | Pc036 Actrims Ectrims Final Program Gb Compressed | - |
| Sep 15, 2025 | Pc035 List Of References Ids Gb | - |
| Sep 15, 2025 | Pc034 List Of Documents Requested US11102559Gb | - |
| Sep 15, 2025 | Pc033 Acorda Therapeutics Form S1 Gb | - |
| Sep 15, 2025 | Pc032 Form S 1 Presentation Gb | - |
| Sep 15, 2025 | Pc031 Sec Overview Gb | - |
| Sep 15, 2025 | Pc030 Goodman Abstract Poster Gb | - |
| Sep 15, 2025 | Pc029 Shargel 1999 Applied Biopharmaceutics And Pharmacokinetics Chapter 7 Extraits Pages 169 178 179 Gb Compressed | - |
| Sep 15, 2025 | Pc028 VAN Diemen Et Al 1992 August Gb | - |
| Sep 15, 2025 | Pc027 EP0484186B1 Gb | - |
| Sep 15, 2025 | Pc026 Schwid Et Al 1997 The American Academy Of Neurology Volume 48 Pages 817 821 Gb | - |
| Sep 15, 2025 | Pc025 Bever 1994 The American Neurological Association 1994 Volume 23 Page 118 S121 Gb | - |
| Sep 15, 2025 | Pc024 Bever Et Al 1994 June Neurology 44 1054 1059 Gb | - |
| Sep 15, 2025 | Pc023 Davis Et Al 1990 The American Neurological Association 1990 Pages 186 192 Gb | - |
| Sep 15, 2025 | Pc022 Sherratt Et Al 1980 Nature Volume 283 5745 Pages 570 572 Gb | - |
| Sep 15, 2025 | Pc021 List Of Documents Cited In The Oppositions Gb | - |
| Sep 15, 2025 | Pc020 Merz Acquires Fampyra Gb | - |
| Sep 15, 2025 | Pc019 European Medicines Agency Guidelines Ich Topic E4 November 1994 Gb | - |
| Sep 15, 2025 | Pc018 EP536Oral Proceedings Gb | - |
| Sep 15, 2025 | Pc017 Verhagen Et Al Australian Journal Of Physiotherapy VOL 50 Gb | - |
| Sep 15, 2025 | Pc016 Piece Composite Synthese Wikipiedia Sur L Ecart Type Et La Valeur P Fr | - |
| Sep 15, 2025 | Pc015 Marien Et Beaud Guide Pratique Pour L Utilisation De La Statistique En Recherche Fr | - |
| Sep 15, 2025 | Pc014 Journal De La Societe Statistique De Paris 1956 Fr | - |
| Sep 15, 2025 | Pc013 Ting N Introduction And New Drug Development Process In Ting N Editor Dose Finding In Drug Development Springer Ne | - |
| Sep 15, 2025 | Pc012 Pirmohamed Et Al Bmj Volume 316 25 April 1998 Gb | - |
| Sep 15, 2025 | Pc011 Edwards And Aronson The Lancet VOL 356 October 7 Gb | - |
| Sep 15, 2025 | Pc010 Ich Topic E 8 General Considerations For Clinical Trials 17 July 1997 Gb | - |
| Sep 15, 2025 | Pc009 Griffin Et Al The Textbook Of Pharmaceutical Medicine 1993 Pages 221 222 Gb Compressed | - |
| Sep 15, 2025 | Pc008 Bopi 20 November N 1547 Pp 235 237 Et 258 Fr | - |
| Sep 15, 2025 | Pc007 Decision Et Requete De Delivrance Du Ccp N 13 C0033 Fr | - |
| Sep 15, 2025 | Pc006 Demande De Ccp Sur La Base Du Brevet EP2377536Fr | - |
| Sep 15, 2025 | Pc005 EP2377536B2 Gb | - |
| Sep 15, 2025 | Pc004 Fampyra Smpc Gb | - |
| Sep 15, 2025 | Pc003 Commission Implementing Decision Of 27 September C20246926 Gb | - |
| Sep 15, 2025 | Pc002 Rcp Fampridine Viatris Lp 10Mg Fr | - |
| Sep 15, 2025 | Pc001 Extrait Kbis Viatris Sante Fr | - |
| Sep 15, 2025 | Objection Viatris Sante App 339802025 Compressed Signed | - |
| Sep 11, 2025 | Summon Oral Hearing | - |
| Sep 11, 2025 | Order Summon The Oral Hearing | |
| Aug 18, 2025 | Procedural Order Timetable And Summon Oh | |
| Aug 18, 2025 | Hearing Dates | - |
| Aug 14, 2025 | Panel Appointment | - |
| Aug 7, 2025 | Acknowledgement Of Access To Case | - |
| Aug 6, 2025 | Notification Of Service | - |
| Aug 6, 2025 | Digital Tracking La Poste Service Receipt | - |
| Aug 5, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Notice To Accompany Service Of Order For Measures | - |
| Aug 1, 2025 | Letter For Service | - |
| Aug 1, 2025 | Formal Checks Notification Of Positive Outcome | - |
| Aug 1, 2025 | Exhibit No. 701 Application French Translation | - |
| Aug 1, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Aug 1, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Aug 1, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Aug 1, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Aug 1, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Aug 1, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Aug 1, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Aug 1, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Aug 1, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Aug 1, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Aug 1, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Aug 1, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Aug 1, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Aug 1, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Aug 1, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Aug 1, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Aug 1, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Aug 1, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Aug 1, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Aug 1, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Aug 1, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Aug 1, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Aug 1, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Aug 1, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Aug 1, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Aug 1, 2025 | Exhibit No. 401 Goodman Poster | - |
| Aug 1, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Aug 1, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Aug 1, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Aug 1, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Aug 1, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Aug 1, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Aug 1, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Aug 1, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 208 French Spc Register | - |
| Aug 1, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Aug 1, 2025 | Exhibit No. 206 French Patent Register | - |
| Aug 1, 2025 | Exhibit No. 205 EP536Patent | - |
| Aug 1, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Aug 1, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Aug 1, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Aug 1, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Aug 1, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Aug 1, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Aug 1, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Aug 1, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Aug 1, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Aug 1, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Aug 1, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Aug 1, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Aug 1, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Aug 1, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Aug 1, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Aug 1, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Aug 1, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Aug 1, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Aug 1, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Aug 1, 2025 | Exhibit No. 106 Larocca | - |
| Aug 1, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Aug 1, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Aug 1, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Aug 1, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Aug 1, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Aug 1, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Aug 1, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Aug 1, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Aug 1, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Aug 1, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Aug 1, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Aug 1, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Aug 1, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Aug 1, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Aug 1, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Aug 1, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Aug 1, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Aug 1, 2025 | Application For Provisional Measures | - |
| Aug 1, 2025 | Application For Measures Receipt | - |
| Aug 1, 2025 | Application For Measures Acknowledgement | - |
| Jul 31, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Jul 31, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Jul 31, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Jul 31, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Jul 31, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Jul 31, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Jul 31, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Jul 31, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Jul 31, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Jul 31, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Jul 31, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Jul 31, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Jul 31, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Jul 31, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Jul 31, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Jul 31, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Jul 31, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Jul 31, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Jul 31, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Jul 31, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Jul 31, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Jul 31, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Jul 31, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Jul 31, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Jul 31, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Jul 31, 2025 | Exhibit No. 401 Goodman Poster | - |
| Jul 31, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Jul 31, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Jul 31, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Jul 31, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Jul 31, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Jul 31, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Jul 31, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Jul 31, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 208 French Spc Register | - |
| Jul 31, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Jul 31, 2025 | Exhibit No. 206 French Patent Register | - |
| Jul 31, 2025 | Exhibit No. 205 EP536Patent | - |
| Jul 31, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Jul 31, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Jul 31, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Jul 31, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Jul 31, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Jul 31, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Jul 31, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Jul 31, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Jul 31, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Jul 31, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Jul 31, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Jul 31, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Jul 31, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Jul 31, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Jul 31, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Jul 31, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Jul 31, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Jul 31, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Jul 31, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Jul 31, 2025 | Exhibit No. 106 Larocca | - |
| Jul 31, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Jul 31, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Jul 31, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Jul 31, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Jul 31, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Jul 31, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Jul 31, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Jul 31, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Jul 31, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Jul 31, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Jul 31, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Jul 31, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Jul 31, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Jul 31, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Jul 31, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Jul 31, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Jul 31, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Jul 31, 2025 | Application For Provisional Measures | - |
| Oct 10, 2025 | Action.Communication | - |
| Oct 9, 2025 | Receipt | - |
| Oct 9, 2025 | Proof Of Payment | - |
| Oct 9, 2025 | Other Document | - |
| Oct 9, 2025 | Fee | - |
| Oct 9, 2025 | Cover Sheet | - |
| Oct 9, 2025 | Application | - |
| Oct 7, 2025 | Order | - |
| Oct 7, 2025 | Action.Issueorder | - |
| Oct 6, 2025 | Action.Communication | - |
| Oct 5, 2025 | Receipt | - |
| Oct 5, 2025 | Cover Sheet | - |
| Oct 5, 2025 | Application | - |
| Oct 2, 2025 | Receipt | - |
| Oct 2, 2025 | Order | - |
| Oct 2, 2025 | Cover Sheet | - |
| Oct 2, 2025 | Application | - |
| Oct 2, 2025 | Action.Issueorder | - |
| Oct 1, 2025 | Statement Of Reply | - |
| Oct 1, 2025 | Receipt | - |
| Oct 1, 2025 | Exhibit | - |
| Oct 1, 2025 | Cover Sheet | - |
| Oct 1, 2025 | Application | - |
| Sep 26, 2025 | Action.Communication | - |
| Sep 25, 2025 | Receipt | - |
| Sep 25, 2025 | Other Document | - |
| Sep 25, 2025 | Exhibit | - |
| Sep 25, 2025 | Cover Sheet | - |
| Sep 25, 2025 | Action.Communication | - |
| Sep 24, 2025 | Order | - |
| Sep 24, 2025 | Action.Issueorder | - |
| Sep 18, 2025 | Request V.Def Pdf A Signed | - |
| Sep 18, 2025 | Receipt | - |
| Sep 18, 2025 | Pc154 Iqvia Agreement Gb | - |
| Sep 18, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 17, 2025 | Receipt | - |
| Sep 17, 2025 | Procedural Order | |
| Sep 17, 2025 | Outcome Of The Order | - |
| Sep 17, 2025 | Headnote And Keywords | - |
| Sep 16, 2025 | Request For Procedural Order | - |
| Sep 16, 2025 | Receipt | - |
| Sep 16, 2025 | Objection | - |
| Sep 15, 2025 | Pj087 Regulation N 469 Gb | - |
| Sep 15, 2025 | Pj086 Court Of Appeal 10X Genomics Harvard V Nanostring Upc Coa 3352023 Gb | - |
| Sep 15, 2025 | Pj085 Dmf Nl Court Of The Hague 1Ere Instance Nl | - |
| Sep 15, 2025 | Pj084 Dmf Be Cour Dappel De Bruxelles Appel Nl | - |
| Sep 15, 2025 | Pj083 Fingolimod De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj082 Phosphodiesterase Nl Appeal Court Of The Hague Appel Nl | - |
| Sep 15, 2025 | Pj081 Dmf De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj080 Munich Local Division 21 May Upccfi432023 De | - |
| Sep 15, 2025 | Pj079 Ca Paris 9 July N2407962 Fr | - |
| Sep 15, 2025 | Pj078 Case Law Of The Boards Of Appeal Id108 Gb | - |
| Sep 15, 2025 | Pj077 Bonnes Pratiques De Distribution Ansm Bulletin Officiel N20149Bis Fr | - |
| Sep 15, 2025 | Pj076 Upc Court Of Appeal 25 September Upccoa1822024 Gb | - |
| Sep 15, 2025 | Pj075 Guidelines For Examination In The European Patent Office Gvii4Gb | - |
| Sep 15, 2025 | Pj074 Decision De La Chambre De Recours De Loeb DU 4 October T 111003 Gb | - |
| Sep 15, 2025 | Pj073 Epo Boa 10 July Eisai V Stada Lenvatinib T 193423 Gb | - |
| Sep 15, 2025 | Pj072 Hamburg Local Division 3 June Upccfi1512024 Gb | - |
| Sep 15, 2025 | Pj071 Dusseldorf Local Division 30 April Upccfi4632023 Gb | - |
| Sep 15, 2025 | Pj070 Dusseldorf Local Division 9 April Upccfi4522023 De | - |
| Sep 15, 2025 | Pj069 Dusseldorf Local Division VALEO V Magna Upc Cfi 3682024 Gb | - |
| Sep 15, 2025 | Pj068 Court Of Appeal Biolitec V Light Guide Optics Sia Lightguide 24 February Upccoa5402024 Gb | - |
| Sep 15, 2025 | Pj067 Ld Munich 15 November Upc Cfi 152023 Gb | - |
| Sep 15, 2025 | Pj065 Cjeu 28 July Synthon C Mertz Memantine C19509 Gb | - |
| Sep 15, 2025 | Pj064 Cjeu 28 July Generics Uk C Synaptech Galantamine C42709 Gb | - |
| Sep 15, 2025 | Pj063 Cass Com 10 February N1320150 Fr | - |
| Sep 15, 2025 | Pj062 Directive 200448CE Gb | - |
| Sep 15, 2025 | Pj061 Neurim Mylan High Court Of Justice 3 June Ewhc 1362 Gb | - |
| Sep 15, 2025 | Pj060 Decision De La Chambre De Recours De Loeb 13 September T023916 Gb | - |
| Sep 15, 2025 | Pj059 Decision De La Chambre De Recours De Loeb 4 October T250612 Gb | - |
| Sep 15, 2025 | Pj058 Tj Paris Refere 17 June Rg 2153849 Cabazitaxel Sanofi C Ever Pharma Fr | - |
| Sep 15, 2025 | Pj057 Tj Paris 12 May Rg 2153136 Cabazitaxel Sanofi C Teva Fr | - |
| Sep 15, 2025 | Pj056 Santen C 673 18 Gb | - |
| Sep 15, 2025 | Pj055 Tgi Paris 22 September 1407707 Fr | - |
| Sep 15, 2025 | Pj054 Cour Dappel De Paris 14 February 1991 Newtec International C Sfeima Pibd N504 Iiii432 Fr | - |
| Sep 15, 2025 | Pj053 Cour De Cassation 20 November Pourvoi N 1118440 Fr | - |
| Sep 15, 2025 | Pj052 Tgi Paris 6 June Rg N1606916 Fr | - |
| Sep 15, 2025 | Pj051 Tgi Rennes 2 September Rg N9803029 Fr | - |
| Sep 15, 2025 | Pj050 Decision De La Chambre De Recours 3306 De Loeb 30 May T 16596 Fr | - |
| Sep 15, 2025 | Pj049 Decision De La Chambre De Recours 3502 De Loeb 29 October T 33515 Fr | - |
| Sep 15, 2025 | Pj048 Decision De La Chambre De Recours De Loeb 10 November 1988 T038187 Gb | - |
| Sep 15, 2025 | Pj047 Tj Paris 22 June Rg N2002792 Fr | - |
| Sep 15, 2025 | Pj046 Decision De La Chambre De Recours De Loeb 20 September T197909 Gb | - |
| Sep 15, 2025 | Pj045 Decision De La Chambre De Recours De Loeb 1Er April T 140906 Gb | - |
| Sep 15, 2025 | Pj044 Decision De La Chambre De Recours De Loeb DU 28 January T 023715 Gb | - |
| Sep 15, 2025 | Pj043 Basf C25899 Gb | - |
| Sep 15, 2025 | Pj042 Gsk C21013 14 Nov Gb | - |
| Sep 15, 2025 | Pj041 Ca Paris 14 February Rg 1903820 Sandoz C Msd Fr | - |
| Sep 15, 2025 | Pj040 Abraxis C 443 17 21 March Gb | - |
| Sep 15, 2025 | Pj039 Case Law Of The Boards Of Appeal Of The Epo I D74 Try And See Solution Gb | - |
| Sep 15, 2025 | Pj038 Tj Paris 20 January Rg N 1901997 Fr | - |
| Sep 15, 2025 | Pj037 Tj Paris 6 September Rg N2106416 Fr | - |
| Sep 15, 2025 | Pj036 Tj Paris 7 June Rg 2153474 Sanofi C Accord Cabazitaxel Fr | - |
| Sep 15, 2025 | Pj035 Ca Paris 29 October Etypharm C Merck Rg N1803876 Fr | - |
| Sep 15, 2025 | Pj034 Cour Dappel De Paris 18 December Rg N 1710112 Fr | - |
| Sep 15, 2025 | Pj033 Decision De La Chambre De Recours De Loeb 25 July T 025915 Gb | - |
| Sep 15, 2025 | Pj032 Decision De La Chambre De Recours De Loeb 29 May T 009198 Gb | - |
| Sep 15, 2025 | Pj031 Decision De La Chambre De Recours De Loeb 5 October T 33397 Gb | - |
| Sep 15, 2025 | Pj030 Decision De La Chambre De Recours De Loeb 6 October T 91801 Gb | - |
| Sep 15, 2025 | Pj029 Decision De La Chambre De Recours De Loeb 14 February 1989 T 24988 Gb | - |
| Sep 15, 2025 | Pj028 Case Law Of The Boards Of Appeal Of The Epo Id71 Reasonable Expectation Of Success Gb | - |
| Sep 15, 2025 | Pj027 Jurisprudences Francaises Essais De Routine Fr | - |
| Sep 15, 2025 | Pj026 Tgi Paris 7 May Hexal C Boehringer Rg 0812537 Fr | - |
| Sep 15, 2025 | Pj025 Jub Division Centrale De Munich 16 July Sanofi C Amgen Upccfi 12023 Gb | - |
| Sep 15, 2025 | Pj024 Jub Cour Dappel 26 February Nanostring C 10X Genomics Upccoa3352023 Gb | - |
| Sep 15, 2025 | Pj023 Decision De La Chambre De Recours 332 De L Oeb 26 February T 92600 Gb | - |
| Sep 15, 2025 | Pj022 Decision De La Chambre De Recours 332 De Loeb 2 June T 30899 Gb | - |
| Sep 15, 2025 | Pj021 Decision De La Chambre De Recours 352 De Loeb 22 October 1993 T 25392 Gb | - |
| Sep 15, 2025 | Pj020 Decision De La Chambre De Recours 332 De Loeb 13 July T 393 01 Gb | - |
| Sep 15, 2025 | Pj019 Ca Paris 19 January Rg 18 21115 Fr | - |
| Sep 15, 2025 | Pj018 Tj Paris 20 July Rg N 21 10327 Fr | - |
| Sep 15, 2025 | Pj017 Ca Paris 14 November Rg N 1502576 Fr | - |
| Sep 15, 2025 | Pj016 Tj Paris 28 March Rg 2208612 Fr | - |
| Sep 15, 2025 | Pj014 Upc Court Of Appeal 13 August Upccoa4462025 Gb | - |
| Sep 15, 2025 | Pj013 Tj Paris 18 June Rg N 23 02356 Fr | - |
| Sep 15, 2025 | Pj012 Munich Local Division 27 August Upccfi2012024 Gb | - |
| Sep 15, 2025 | Pj011 Tj Paris 27 July Rg N 22 54367 Fr | - |
| Sep 15, 2025 | Pj010 Guidelines For Examination Of The Epo Giv1 Gb | - |
| Sep 15, 2025 | Pj009 Ca Paris 25 May Rg 21 18398 Fr | - |
| Sep 15, 2025 | Pj008 Tj Paris 29 September Rg 21 55930 Fr | - |
| Sep 15, 2025 | Pj007 Tj Paris Ordonnance De Refere 6 October Rg 22 55799 Biogen C Viatris Dmf Fr | - |
| Sep 15, 2025 | Pj006 Cjeu 16 July Genmab V Hungarian Ip Office Spc C 181 24 Gb | - |
| Sep 15, 2025 | Pj005 Accord Cadre Leem Ceps 5 March Fr | - |
| Sep 15, 2025 | Pj004 Regulation No 1768 92 Gb | - |
| Sep 15, 2025 | Pj003 Tj Paris Ordonnance Viatris C Novartis 04 August Fingolimod Rg N 2254655 Fr | - |
| Sep 15, 2025 | Pj002 Ca Paris 14 February Rg 1906114 Fr | - |
| Sep 15, 2025 | Pj001 Decision Du Conseil Constitutionnel N 463 Dc DU 12 December Fr | - |
| Sep 15, 2025 | Pc152 Submissions In High Resolution Gb | - |
| Sep 15, 2025 | Pc151 Declaration Dawid Sierzant DU 15 September Et Annexes Gb | - |
| Sep 15, 2025 | Pc150 4 Aminopyridine C5H6N2 Cid 1727 Pubchem Gb | - |
| Sep 15, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 15, 2025 | Pc148 The Fixing Of The Price And Reimboursement Rate Sante Gouv Fr | - |
| Sep 15, 2025 | Pc146 Letter From Viatris To Mez DATED 2 July Gb | - |
| Sep 15, 2025 | Pc145 Letter From Viatris To Merz Of 10 July Fr | - |
| Sep 15, 2025 | Pc143 Chapter 33 Pymadin Paskov Et Al 1986 Gb | - |
| Sep 15, 2025 | Pc142 Kostadinova And Danchev Gb | - |
| Sep 15, 2025 | Pc141 Sartori Et Al 1994 Gb | - |
| Sep 15, 2025 | Pc140 Olg Munchen Acorda Therapeutics V Ratiopharm 6 October 6 U 3044 22 De | - |
| Sep 15, 2025 | Pc139 Upsto Trademark Status Document Retrieval Pymadin Sopharma Gb | - |
| Sep 15, 2025 | Pc138 Website Of The Faculty Of Medicine In Sofia Bg | - |
| Sep 15, 2025 | Pc137 They Are Looking For A Superpill For Alzheimers Technologies News Standard Bg | - |
| Sep 15, 2025 | Pc136 Russian State Archive Of Scientific And Technical Documentation Ru | - |
| Sep 15, 2025 | Pc135 Communication Between The Ceps And Viatris Fr | - |
| Sep 15, 2025 | Pc134 Patient Leaflet Pymadin Bg | - |
| Sep 15, 2025 | Pc133 Smpc Pymadin Bg | - |
| Sep 15, 2025 | Pc132 Free State Gazette Edition 33 Of 2Iv Unofficial Section Ru | - |
| Sep 15, 2025 | Pc131 Disaster Protection Plan Burgas Region Republic Of Bulgaria Bg | - |
| Sep 15, 2025 | Pc130 4 Aminopiridin Spinal Cord Injury Forum Ru Compressed | - |
| Sep 15, 2025 | Pc129 Iqvia About Us Gb | - |
| Sep 15, 2025 | Pc128 Adverse Exhibit No 503 Toumi Et Al External Reference Pricing Simulation Gb | - |
| Sep 15, 2025 | Pc122 Application For Provisional Measures Gb | - |
| Sep 15, 2025 | Pc121 Acorda V Alkem Trial Transcript Volume B Gb | - |
| Sep 15, 2025 | Pc120 Acorda V Alkem Trial Transcript Volume A Gb | - |
| Sep 15, 2025 | Pc119 Hamilton Et Al 1998 Olanzapine Versus Placebo And Haloperidol Quality Of Life And Efficacy Results On The North Am | - |
| Sep 15, 2025 | Pc118 Overall 1994 Journal Of Clinical Psychology VOL 50 Pages 95 102 Gb | - |
| Sep 15, 2025 | Pc117 Alhainen Et Al 1991 Discrimination Of Tetrahydroaminoacridine Responders By A Single Dose Pharmaco Eeg In Patients | - |
| Sep 15, 2025 | Pc116 Sas Library 1997 Repeated Measures Anova Using Sas Proc Glm Gb | - |
| Sep 15, 2025 | Pc115 Sheeber Et Al 1996 Data Analytic Techniques For Treatment Outcome Studies With Pretest Posttest Measurements An Ex | - |
| Sep 15, 2025 | Pc114 Cook Et Al 1983 Design And Analysis Methods For Longitudinal Research Ann Rev Public Health Gb | - |
| Sep 15, 2025 | Pc113 Vickers Hor Many Repeated Measures In Repeates Measures Designs Statistical Issues For Comparative Trials Bmc | - |
| Sep 15, 2025 | Pc112 Uryniak Et Al Responder Analyses A Phrma Position Paper Statistics In Biopharmaceutical Research VOL 3 N3 Gb | - |
| Sep 15, 2025 | Pc111 Schulz Et Al The Efficacy Of Quetiapine VS Haloperidol And Placebo A Meta Analytic Study Of Efficacy Schizopp | - |
| Sep 15, 2025 | Pc110 Temple 1994 Commun Stat Theory Meth VOL 23 Pages 449 521 Gb | - |
| Sep 15, 2025 | Pc109 Lewis Statistics In Medicine VOL 21 Pages 2931 2938 Gb | - |
| Sep 15, 2025 | Pc108 Weiner 1998 Can J Neurol Sci VOL 25 Pages 93101 Gb | - |
| Sep 15, 2025 | Pc107 Petkau 1998 Seminars In Neurology VOL 18 3 Gb | - |
| Sep 15, 2025 | Pc106 Leber Et DAVIS 1998 Threats To The Validity Of Clinical Trials Employing Enrichment Strategies For Sample Selectio | - |
| Sep 15, 2025 | Pc105 DTX 584 Gb | - |
| Sep 15, 2025 | Pc104 4 Aminopyridine Induces Functional Improvement In Multiple Sclerosis Patients A Neurophysiological Study Gb | - |
| Sep 15, 2025 | Pc103 Stefoski Et Al 1991 4 Aminopyridine In Multiple Sclerosis Prolonged Administration Neurology 1991 Gb | - |
| Sep 15, 2025 | Pc102 Clinical Studies In 20 Questions Atelier Presse Clinical Trials Leem 19 May Fr | - |
| Sep 15, 2025 | Pc101 Report By Dr Christian Wolf DATED 2 September Gb | - |
| Sep 15, 2025 | Pc100 EP1732548B9 Gb | - |
| Sep 15, 2025 | Pc099 Matusik Therapy Nutrients 14 4249 Gb | - |
| Sep 15, 2025 | Pc098 Le Progres Article Patients Deprived Of A Medication Due To A Change Of Packaging 26 June Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 2 2 Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 1 2 Fr | - |
| Sep 15, 2025 | Pc096 Kehl Responder Identification In Clinical Trials June Gb | - |
| Sep 15, 2025 | Pc095 CPMP Points To Consider Multiplicity Issues Clinical Trials Gb | - |
| Sep 15, 2025 | Pc094 Hayes Et Al Pharmacokinetic Studies Of Single And Multiple Oral Doses Of Fampridine VOL 26 N4 Pp 185 192 Gb | - |
| Sep 15, 2025 | Pc093 Hayes Et Al Pharmacokinetics Of An Immediate Release Oral Formulation Of Fampridine 4 Aminopyridine In Normal | - |
| Sep 15, 2025 | Pc092 July 1986 Comment Determiner La Posologie Optimale D Un Medicament Fr | - |
| Sep 15, 2025 | Pc091 Dose Ranging Study Wikipedia Gb | - |
| Sep 15, 2025 | Pc090 Rnb Ccp 033 Fr | - |
| Sep 15, 2025 | Pc089 Rnb EP536Fr | - |
| Sep 15, 2025 | Pc088 Chmp 1999 Clinical Investigation Of Medicinal Products In The Treatment Of Parkinson S Disease CPMP Note For Guida | - |
| Sep 15, 2025 | Pc087 Ccne Opinion 79 Transposition Into French Law Of The European Directive On Clinical Trials Of Medicinal Products F | - |
| Sep 15, 2025 | Pc086 Declaration Of Helsinki Ethical Principles For Medical Research Involving Human Subjects Gb | - |
| Sep 15, 2025 | Pc085 Nuremberg Code Gb | - |
| Sep 15, 2025 | Pc084 Afsep Press Release Of 28 May Fr | - |
| Sep 15, 2025 | Pc083 Barus Et Al Fr | - |
| Sep 15, 2025 | Pc082 Extrait De La Base De Donnees Publique Des Medicaments Fampridine Viatris 10 Mg Fr | - |
| Sep 15, 2025 | Pc081 Icht Topic 9 Guideline On Statistical Principles For Clinical Trials September 1998 Gb | - |
| Sep 15, 2025 | Pc080 Website Of The Foundation For Research Into Multiple Sclerosis Fr | - |
| Sep 15, 2025 | Pc079 Notice On The Prices Of Fampridine Pharmaceutical Specialities Fr | - |
| Sep 15, 2025 | Pc078 Info Sheet Fampyra 10Mg Sustained Release Tablet Fr | - |
| Sep 15, 2025 | Pc077 Accession Of Bulgaria Gb | - |
| Sep 15, 2025 | Pc076 Kehl Responder Identification In Clinical Trials With Censored Data Gb | - |
| Sep 15, 2025 | Pc075 Federal Court Of Canada 15 May Acorda V Pharmascience And Taro T 1416 18 And T 220 19 Gb | - |
| Sep 15, 2025 | Pc074 Usa Delaware District Court 25 April Acorda V Teva Roxane Mylan 14 882 Gb | - |
| Sep 15, 2025 | Pc073 Usa Delaware District Court 31 March Acorda V Roxane 14 882 Lps Gb | - |
| Sep 15, 2025 | Pc072 Germany Teva Revocation Of Patent EP548De | - |
| Sep 15, 2025 | Pc071 Germany Ratiopharm Revocation Of Patent EP536De | - |
| Sep 15, 2025 | Pc070 Germany Ratiopharm Admissibility Of The EP536Invalidity Claim De | - |
| Sep 15, 2025 | Pc069 Board Of Appeal Of The European Patent Office 4 September T 0799 16 Gb | - |
| Sep 15, 2025 | Pc068 Decision Of The Epo EP536Gb Compressed | - |
| Sep 15, 2025 | Pc067 Emea Points To Consider On The Choice Of Non Interiority Margin Gb | - |
| Sep 15, 2025 | Pc066 Emea 27 July Points To Consider On Switching Betweend Superiority And Non Inferiority Gb | - |
| Sep 15, 2025 | Pc064 Usa Court Of Appeal 10 September Acorda V Roxane Et Al Et 2134 Gb | - |
| Sep 15, 2025 | Pc063 Form 10 K Wikipedia Presentation Gb | - |
| Sep 15, 2025 | Pc062 Cohen Postgraduate Medicine September 1999 Gb | - |
| Sep 15, 2025 | Pc061 L Echelle Edss Expanded Disability Status Scale Fr | - |
| Sep 15, 2025 | Pc060 O Brien Journal Of Hypertension Gb | - |
| Sep 15, 2025 | Pc059 Ellen R Girden Anova Repeated Measures 1992 Gb | - |
| Sep 15, 2025 | Pc058 Federal Court Of Appeal Of Canada 8 August Acorda Therapeutics V Pharmascience Taro Pharmaceuticals A 145 20 | - |
| Sep 15, 2025 | Pc057 Fda Chapter I Food And Drug Administration Department Of Health And Human Services Subchapter D Drugs For Human Us | - |
| Sep 15, 2025 | Pc056 Polman Arch Neur VOL 51 November 1994 Gb | - |
| Sep 15, 2025 | Pc055 Sheiner Clin Pharmacol Ther Volume 46 Number 1 July 1989 Gb | - |
| Sep 15, 2025 | Pc054 Norleans Statistical Methods For Clinical Trials Gb Compressed | - |
| Sep 15, 2025 | Pc053 Excerpt From The Fda Website Drug Evaluation Process Gb | - |
| Sep 15, 2025 | Pc052 Schwid Et Al April Gb | - |
| Sep 15, 2025 | Pc051 Kaufman Al The Significant Change For The Timed 25 Foot Walk In The Multiple Sclerosis Functional Composite M | - |
| Sep 15, 2025 | Pc050 Extract From The National Institutes Of Health Website Fda Drug Review And Approval Gb | - |
| Sep 15, 2025 | Pc049 Ca 2 562 277 Gb | - |
| Sep 15, 2025 | Pc048 US8663685Gb | - |
| Sep 15, 2025 | Pc047 US8440703Gb | - |
| Sep 15, 2025 | Pc046 US8354437Gb | - |
| Sep 15, 2025 | Pc045 Declaration Of Dr Ron Cohen Gb | - |
| Sep 15, 2025 | Pc044 US8007826Gb | - |
| Sep 15, 2025 | Pc043 Goodman Diaporama Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc042 Medical Research Council Mrc Scale For Muscle Strength Gb | - |
| Sep 15, 2025 | Pc041 National Multiple Sclerosis Society Timed 25 Foot Walk T25 Fw Gb | - |
| Sep 15, 2025 | Pc040 Ninds Fatigue Severity Scale Fss Gb | - |
| Sep 15, 2025 | Pc039 Wikipedia Page Edss Gb | - |
| Sep 15, 2025 | Pc038 Goodman Poster Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc037 Supplemental Information Disclosure Statement Gb | - |
| Sep 15, 2025 | Pc036 Actrims Ectrims Final Program Gb Compressed | - |
| Sep 15, 2025 | Pc035 List Of References Ids Gb | - |
| Sep 15, 2025 | Pc034 List Of Documents Requested US11102559Gb | - |
| Sep 15, 2025 | Pc033 Acorda Therapeutics Form S1 Gb | - |
| Sep 15, 2025 | Pc032 Form S 1 Presentation Gb | - |
| Sep 15, 2025 | Pc031 Sec Overview Gb | - |
| Sep 15, 2025 | Pc030 Goodman Abstract Poster Gb | - |
| Sep 15, 2025 | Pc029 Shargel 1999 Applied Biopharmaceutics And Pharmacokinetics Chapter 7 Extraits Pages 169 178 179 Gb Compressed | - |
| Sep 15, 2025 | Pc028 VAN Diemen Et Al 1992 August Gb | - |
| Sep 15, 2025 | Pc027 EP0484186B1 Gb | - |
| Sep 15, 2025 | Pc026 Schwid Et Al 1997 The American Academy Of Neurology Volume 48 Pages 817 821 Gb | - |
| Sep 15, 2025 | Pc025 Bever 1994 The American Neurological Association 1994 Volume 23 Page 118 S121 Gb | - |
| Sep 15, 2025 | Pc024 Bever Et Al 1994 June Neurology 44 1054 1059 Gb | - |
| Sep 15, 2025 | Pc023 Davis Et Al 1990 The American Neurological Association 1990 Pages 186 192 Gb | - |
| Sep 15, 2025 | Pc022 Sherratt Et Al 1980 Nature Volume 283 5745 Pages 570 572 Gb | - |
| Sep 15, 2025 | Pc021 List Of Documents Cited In The Oppositions Gb | - |
| Sep 15, 2025 | Pc020 Merz Acquires Fampyra Gb | - |
| Sep 15, 2025 | Pc019 European Medicines Agency Guidelines Ich Topic E4 November 1994 Gb | - |
| Sep 15, 2025 | Pc018 EP536Oral Proceedings Gb | - |
| Sep 15, 2025 | Pc017 Verhagen Et Al Australian Journal Of Physiotherapy VOL 50 Gb | - |
| Sep 15, 2025 | Pc016 Piece Composite Synthese Wikipiedia Sur L Ecart Type Et La Valeur P Fr | - |
| Sep 15, 2025 | Pc015 Marien Et Beaud Guide Pratique Pour L Utilisation De La Statistique En Recherche Fr | - |
| Sep 15, 2025 | Pc014 Journal De La Societe Statistique De Paris 1956 Fr | - |
| Sep 15, 2025 | Pc013 Ting N Introduction And New Drug Development Process In Ting N Editor Dose Finding In Drug Development Springer Ne | - |
| Sep 15, 2025 | Pc012 Pirmohamed Et Al Bmj Volume 316 25 April 1998 Gb | - |
| Sep 15, 2025 | Pc011 Edwards And Aronson The Lancet VOL 356 October 7 Gb | - |
| Sep 15, 2025 | Pc010 Ich Topic E 8 General Considerations For Clinical Trials 17 July 1997 Gb | - |
| Sep 15, 2025 | Pc009 Griffin Et Al The Textbook Of Pharmaceutical Medicine 1993 Pages 221 222 Gb Compressed | - |
| Sep 15, 2025 | Pc008 Bopi 20 November N 1547 Pp 235 237 Et 258 Fr | - |
| Sep 15, 2025 | Pc007 Decision Et Requete De Delivrance Du Ccp N 13 C0033 Fr | - |
| Sep 15, 2025 | Pc006 Demande De Ccp Sur La Base Du Brevet EP2377536Fr | - |
| Sep 15, 2025 | Pc005 EP2377536B2 Gb | - |
| Sep 15, 2025 | Pc004 Fampyra Smpc Gb | - |
| Sep 15, 2025 | Pc003 Commission Implementing Decision Of 27 September C20246926 Gb | - |
| Sep 15, 2025 | Pc002 Rcp Fampridine Viatris Lp 10Mg Fr | - |
| Sep 15, 2025 | Pc001 Extrait Kbis Viatris Sante Fr | - |
| Sep 15, 2025 | Objection Viatris Sante App 339802025 Compressed Signed | - |
| Sep 11, 2025 | Summon Oral Hearing | - |
| Sep 11, 2025 | Order Summon The Oral Hearing | |
| Aug 18, 2025 | Procedural Order Timetable And Summon Oh | |
| Aug 18, 2025 | Hearing Dates | - |
| Aug 14, 2025 | Panel Appointment | - |
| Aug 7, 2025 | Acknowledgement Of Access To Case | - |
| Aug 6, 2025 | Notification Of Service | - |
| Aug 6, 2025 | Digital Tracking La Poste Service Receipt | - |
| Aug 5, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Notice To Accompany Service Of Order For Measures | - |
| Aug 1, 2025 | Letter For Service | - |
| Aug 1, 2025 | Formal Checks Notification Of Positive Outcome | - |
| Aug 1, 2025 | Exhibit No. 701 Application French Translation | - |
| Aug 1, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Aug 1, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Aug 1, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Aug 1, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Aug 1, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Aug 1, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Aug 1, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Aug 1, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Aug 1, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Aug 1, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Aug 1, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Aug 1, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Aug 1, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Aug 1, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Aug 1, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Aug 1, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Aug 1, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Aug 1, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Aug 1, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Aug 1, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Aug 1, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Aug 1, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Aug 1, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Aug 1, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Aug 1, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Aug 1, 2025 | Exhibit No. 401 Goodman Poster | - |
| Aug 1, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Aug 1, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Aug 1, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Aug 1, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Aug 1, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Aug 1, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Aug 1, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Aug 1, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 208 French Spc Register | - |
| Aug 1, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Aug 1, 2025 | Exhibit No. 206 French Patent Register | - |
| Aug 1, 2025 | Exhibit No. 205 EP536Patent | - |
| Aug 1, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Aug 1, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Aug 1, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Aug 1, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Aug 1, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Aug 1, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Aug 1, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Aug 1, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Aug 1, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Aug 1, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Aug 1, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Aug 1, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Aug 1, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Aug 1, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Aug 1, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Aug 1, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Aug 1, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Aug 1, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Aug 1, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Aug 1, 2025 | Exhibit No. 106 Larocca | - |
| Aug 1, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Aug 1, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Aug 1, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Aug 1, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Aug 1, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Aug 1, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Aug 1, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Aug 1, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Aug 1, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Aug 1, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Aug 1, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Aug 1, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Aug 1, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Aug 1, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Aug 1, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Aug 1, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Aug 1, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Aug 1, 2025 | Application For Provisional Measures | - |
| Aug 1, 2025 | Application For Measures Receipt | - |
| Aug 1, 2025 | Application For Measures Acknowledgement | - |
| Jul 31, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Jul 31, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Jul 31, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Jul 31, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Jul 31, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Jul 31, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Jul 31, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Jul 31, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Jul 31, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Jul 31, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Jul 31, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Jul 31, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Jul 31, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Jul 31, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Jul 31, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Jul 31, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Jul 31, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Jul 31, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Jul 31, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Jul 31, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Jul 31, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Jul 31, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Jul 31, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Jul 31, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Jul 31, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Jul 31, 2025 | Exhibit No. 401 Goodman Poster | - |
| Jul 31, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Jul 31, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Jul 31, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Jul 31, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Jul 31, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Jul 31, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Jul 31, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Jul 31, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 208 French Spc Register | - |
| Jul 31, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Jul 31, 2025 | Exhibit No. 206 French Patent Register | - |
| Jul 31, 2025 | Exhibit No. 205 EP536Patent | - |
| Jul 31, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Jul 31, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Jul 31, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Jul 31, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Jul 31, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Jul 31, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Jul 31, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Jul 31, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Jul 31, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Jul 31, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Jul 31, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Jul 31, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Jul 31, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Jul 31, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Jul 31, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Jul 31, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Jul 31, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Jul 31, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Jul 31, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Jul 31, 2025 | Exhibit No. 106 Larocca | - |
| Jul 31, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Jul 31, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Jul 31, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Jul 31, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Jul 31, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Jul 31, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Jul 31, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Jul 31, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Jul 31, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Jul 31, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Jul 31, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Jul 31, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Jul 31, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Jul 31, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Jul 31, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Jul 31, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Jul 31, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Jul 31, 2025 | Application For Provisional Measures | - |
| Oct 10, 2025 | Action.Communication | - |
| Oct 9, 2025 | Receipt | - |
| Oct 9, 2025 | Proof Of Payment | - |
| Oct 9, 2025 | Other Document | - |
| Oct 9, 2025 | Fee | - |
| Oct 9, 2025 | Cover Sheet | - |
| Oct 9, 2025 | Application | - |
| Oct 7, 2025 | Order | - |
| Oct 7, 2025 | Action.Issueorder | - |
| Oct 6, 2025 | Action.Communication | - |
| Oct 5, 2025 | Receipt | - |
| Oct 5, 2025 | Cover Sheet | - |
| Oct 5, 2025 | Application | - |
| Oct 2, 2025 | Receipt | - |
| Oct 2, 2025 | Order | - |
| Oct 2, 2025 | Cover Sheet | - |
| Oct 2, 2025 | Application | - |
| Oct 2, 2025 | Action.Issueorder | - |
| Oct 1, 2025 | Statement Of Reply | - |
| Oct 1, 2025 | Receipt | - |
| Oct 1, 2025 | Exhibit | - |
| Oct 1, 2025 | Cover Sheet | - |
| Oct 1, 2025 | Application | - |
| Sep 26, 2025 | Action.Communication | - |
| Sep 25, 2025 | Receipt | - |
| Sep 25, 2025 | Other Document | - |
| Sep 25, 2025 | Exhibit | - |
| Sep 25, 2025 | Cover Sheet | - |
| Sep 25, 2025 | Action.Communication | - |
| Sep 24, 2025 | Order | - |
| Sep 24, 2025 | Action.Issueorder | - |
| Sep 18, 2025 | Request V.Def Pdf A Signed | - |
| Sep 18, 2025 | Receipt | - |
| Sep 18, 2025 | Pc154 Iqvia Agreement Gb | - |
| Sep 18, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 17, 2025 | Receipt | - |
| Sep 17, 2025 | Procedural Order | |
| Sep 17, 2025 | Outcome Of The Order | - |
| Sep 17, 2025 | Headnote And Keywords | - |
| Sep 16, 2025 | Request For Procedural Order | - |
| Sep 16, 2025 | Receipt | - |
| Sep 16, 2025 | Objection | - |
| Sep 15, 2025 | Pj087 Regulation N 469 Gb | - |
| Sep 15, 2025 | Pj086 Court Of Appeal 10X Genomics Harvard V Nanostring Upc Coa 3352023 Gb | - |
| Sep 15, 2025 | Pj085 Dmf Nl Court Of The Hague 1Ere Instance Nl | - |
| Sep 15, 2025 | Pj084 Dmf Be Cour Dappel De Bruxelles Appel Nl | - |
| Sep 15, 2025 | Pj083 Fingolimod De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj082 Phosphodiesterase Nl Appeal Court Of The Hague Appel Nl | - |
| Sep 15, 2025 | Pj081 Dmf De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj080 Munich Local Division 21 May Upccfi432023 De | - |
| Sep 15, 2025 | Pj079 Ca Paris 9 July N2407962 Fr | - |
| Sep 15, 2025 | Pj078 Case Law Of The Boards Of Appeal Id108 Gb | - |
| Sep 15, 2025 | Pj077 Bonnes Pratiques De Distribution Ansm Bulletin Officiel N20149Bis Fr | - |
| Sep 15, 2025 | Pj076 Upc Court Of Appeal 25 September Upccoa1822024 Gb | - |
| Sep 15, 2025 | Pj075 Guidelines For Examination In The European Patent Office Gvii4Gb | - |
| Sep 15, 2025 | Pj074 Decision De La Chambre De Recours De Loeb DU 4 October T 111003 Gb | - |
| Sep 15, 2025 | Pj073 Epo Boa 10 July Eisai V Stada Lenvatinib T 193423 Gb | - |
| Sep 15, 2025 | Pj072 Hamburg Local Division 3 June Upccfi1512024 Gb | - |
| Sep 15, 2025 | Pj071 Dusseldorf Local Division 30 April Upccfi4632023 Gb | - |
| Sep 15, 2025 | Pj070 Dusseldorf Local Division 9 April Upccfi4522023 De | - |
| Sep 15, 2025 | Pj069 Dusseldorf Local Division VALEO V Magna Upc Cfi 3682024 Gb | - |
| Sep 15, 2025 | Pj068 Court Of Appeal Biolitec V Light Guide Optics Sia Lightguide 24 February Upccoa5402024 Gb | - |
| Sep 15, 2025 | Pj067 Ld Munich 15 November Upc Cfi 152023 Gb | - |
| Sep 15, 2025 | Pj065 Cjeu 28 July Synthon C Mertz Memantine C19509 Gb | - |
| Sep 15, 2025 | Pj064 Cjeu 28 July Generics Uk C Synaptech Galantamine C42709 Gb | - |
| Sep 15, 2025 | Pj063 Cass Com 10 February N1320150 Fr | - |
| Sep 15, 2025 | Pj062 Directive 200448CE Gb | - |
| Sep 15, 2025 | Pj061 Neurim Mylan High Court Of Justice 3 June Ewhc 1362 Gb | - |
| Sep 15, 2025 | Pj060 Decision De La Chambre De Recours De Loeb 13 September T023916 Gb | - |
| Sep 15, 2025 | Pj059 Decision De La Chambre De Recours De Loeb 4 October T250612 Gb | - |
| Sep 15, 2025 | Pj058 Tj Paris Refere 17 June Rg 2153849 Cabazitaxel Sanofi C Ever Pharma Fr | - |
| Sep 15, 2025 | Pj057 Tj Paris 12 May Rg 2153136 Cabazitaxel Sanofi C Teva Fr | - |
| Sep 15, 2025 | Pj056 Santen C 673 18 Gb | - |
| Sep 15, 2025 | Pj055 Tgi Paris 22 September 1407707 Fr | - |
| Sep 15, 2025 | Pj054 Cour Dappel De Paris 14 February 1991 Newtec International C Sfeima Pibd N504 Iiii432 Fr | - |
| Sep 15, 2025 | Pj053 Cour De Cassation 20 November Pourvoi N 1118440 Fr | - |
| Sep 15, 2025 | Pj052 Tgi Paris 6 June Rg N1606916 Fr | - |
| Sep 15, 2025 | Pj051 Tgi Rennes 2 September Rg N9803029 Fr | - |
| Sep 15, 2025 | Pj050 Decision De La Chambre De Recours 3306 De Loeb 30 May T 16596 Fr | - |
| Sep 15, 2025 | Pj049 Decision De La Chambre De Recours 3502 De Loeb 29 October T 33515 Fr | - |
| Sep 15, 2025 | Pj048 Decision De La Chambre De Recours De Loeb 10 November 1988 T038187 Gb | - |
| Sep 15, 2025 | Pj047 Tj Paris 22 June Rg N2002792 Fr | - |
| Sep 15, 2025 | Pj046 Decision De La Chambre De Recours De Loeb 20 September T197909 Gb | - |
| Sep 15, 2025 | Pj045 Decision De La Chambre De Recours De Loeb 1Er April T 140906 Gb | - |
| Sep 15, 2025 | Pj044 Decision De La Chambre De Recours De Loeb DU 28 January T 023715 Gb | - |
| Sep 15, 2025 | Pj043 Basf C25899 Gb | - |
| Sep 15, 2025 | Pj042 Gsk C21013 14 Nov Gb | - |
| Sep 15, 2025 | Pj041 Ca Paris 14 February Rg 1903820 Sandoz C Msd Fr | - |
| Sep 15, 2025 | Pj040 Abraxis C 443 17 21 March Gb | - |
| Sep 15, 2025 | Pj039 Case Law Of The Boards Of Appeal Of The Epo I D74 Try And See Solution Gb | - |
| Sep 15, 2025 | Pj038 Tj Paris 20 January Rg N 1901997 Fr | - |
| Sep 15, 2025 | Pj037 Tj Paris 6 September Rg N2106416 Fr | - |
| Sep 15, 2025 | Pj036 Tj Paris 7 June Rg 2153474 Sanofi C Accord Cabazitaxel Fr | - |
| Sep 15, 2025 | Pj035 Ca Paris 29 October Etypharm C Merck Rg N1803876 Fr | - |
| Sep 15, 2025 | Pj034 Cour Dappel De Paris 18 December Rg N 1710112 Fr | - |
| Sep 15, 2025 | Pj033 Decision De La Chambre De Recours De Loeb 25 July T 025915 Gb | - |
| Sep 15, 2025 | Pj032 Decision De La Chambre De Recours De Loeb 29 May T 009198 Gb | - |
| Sep 15, 2025 | Pj031 Decision De La Chambre De Recours De Loeb 5 October T 33397 Gb | - |
| Sep 15, 2025 | Pj030 Decision De La Chambre De Recours De Loeb 6 October T 91801 Gb | - |
| Sep 15, 2025 | Pj029 Decision De La Chambre De Recours De Loeb 14 February 1989 T 24988 Gb | - |
| Sep 15, 2025 | Pj028 Case Law Of The Boards Of Appeal Of The Epo Id71 Reasonable Expectation Of Success Gb | - |
| Sep 15, 2025 | Pj027 Jurisprudences Francaises Essais De Routine Fr | - |
| Sep 15, 2025 | Pj026 Tgi Paris 7 May Hexal C Boehringer Rg 0812537 Fr | - |
| Sep 15, 2025 | Pj025 Jub Division Centrale De Munich 16 July Sanofi C Amgen Upccfi 12023 Gb | - |
| Sep 15, 2025 | Pj024 Jub Cour Dappel 26 February Nanostring C 10X Genomics Upccoa3352023 Gb | - |
| Sep 15, 2025 | Pj023 Decision De La Chambre De Recours 332 De L Oeb 26 February T 92600 Gb | - |
| Sep 15, 2025 | Pj022 Decision De La Chambre De Recours 332 De Loeb 2 June T 30899 Gb | - |
| Sep 15, 2025 | Pj021 Decision De La Chambre De Recours 352 De Loeb 22 October 1993 T 25392 Gb | - |
| Sep 15, 2025 | Pj020 Decision De La Chambre De Recours 332 De Loeb 13 July T 393 01 Gb | - |
| Sep 15, 2025 | Pj019 Ca Paris 19 January Rg 18 21115 Fr | - |
| Sep 15, 2025 | Pj018 Tj Paris 20 July Rg N 21 10327 Fr | - |
| Sep 15, 2025 | Pj017 Ca Paris 14 November Rg N 1502576 Fr | - |
| Sep 15, 2025 | Pj016 Tj Paris 28 March Rg 2208612 Fr | - |
| Sep 15, 2025 | Pj014 Upc Court Of Appeal 13 August Upccoa4462025 Gb | - |
| Sep 15, 2025 | Pj013 Tj Paris 18 June Rg N 23 02356 Fr | - |
| Sep 15, 2025 | Pj012 Munich Local Division 27 August Upccfi2012024 Gb | - |
| Sep 15, 2025 | Pj011 Tj Paris 27 July Rg N 22 54367 Fr | - |
| Sep 15, 2025 | Pj010 Guidelines For Examination Of The Epo Giv1 Gb | - |
| Sep 15, 2025 | Pj009 Ca Paris 25 May Rg 21 18398 Fr | - |
| Sep 15, 2025 | Pj008 Tj Paris 29 September Rg 21 55930 Fr | - |
| Sep 15, 2025 | Pj007 Tj Paris Ordonnance De Refere 6 October Rg 22 55799 Biogen C Viatris Dmf Fr | - |
| Sep 15, 2025 | Pj006 Cjeu 16 July Genmab V Hungarian Ip Office Spc C 181 24 Gb | - |
| Sep 15, 2025 | Pj005 Accord Cadre Leem Ceps 5 March Fr | - |
| Sep 15, 2025 | Pj004 Regulation No 1768 92 Gb | - |
| Sep 15, 2025 | Pj003 Tj Paris Ordonnance Viatris C Novartis 04 August Fingolimod Rg N 2254655 Fr | - |
| Sep 15, 2025 | Pj002 Ca Paris 14 February Rg 1906114 Fr | - |
| Sep 15, 2025 | Pj001 Decision Du Conseil Constitutionnel N 463 Dc DU 12 December Fr | - |
| Sep 15, 2025 | Pc152 Submissions In High Resolution Gb | - |
| Sep 15, 2025 | Pc151 Declaration Dawid Sierzant DU 15 September Et Annexes Gb | - |
| Sep 15, 2025 | Pc150 4 Aminopyridine C5H6N2 Cid 1727 Pubchem Gb | - |
| Sep 15, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 15, 2025 | Pc148 The Fixing Of The Price And Reimboursement Rate Sante Gouv Fr | - |
| Sep 15, 2025 | Pc146 Letter From Viatris To Mez DATED 2 July Gb | - |
| Sep 15, 2025 | Pc145 Letter From Viatris To Merz Of 10 July Fr | - |
| Sep 15, 2025 | Pc143 Chapter 33 Pymadin Paskov Et Al 1986 Gb | - |
| Sep 15, 2025 | Pc142 Kostadinova And Danchev Gb | - |
| Sep 15, 2025 | Pc141 Sartori Et Al 1994 Gb | - |
| Sep 15, 2025 | Pc140 Olg Munchen Acorda Therapeutics V Ratiopharm 6 October 6 U 3044 22 De | - |
| Sep 15, 2025 | Pc139 Upsto Trademark Status Document Retrieval Pymadin Sopharma Gb | - |
| Sep 15, 2025 | Pc138 Website Of The Faculty Of Medicine In Sofia Bg | - |
| Sep 15, 2025 | Pc137 They Are Looking For A Superpill For Alzheimers Technologies News Standard Bg | - |
| Sep 15, 2025 | Pc136 Russian State Archive Of Scientific And Technical Documentation Ru | - |
| Sep 15, 2025 | Pc135 Communication Between The Ceps And Viatris Fr | - |
| Sep 15, 2025 | Pc134 Patient Leaflet Pymadin Bg | - |
| Sep 15, 2025 | Pc133 Smpc Pymadin Bg | - |
| Sep 15, 2025 | Pc132 Free State Gazette Edition 33 Of 2Iv Unofficial Section Ru | - |
| Sep 15, 2025 | Pc131 Disaster Protection Plan Burgas Region Republic Of Bulgaria Bg | - |
| Sep 15, 2025 | Pc130 4 Aminopiridin Spinal Cord Injury Forum Ru Compressed | - |
| Sep 15, 2025 | Pc129 Iqvia About Us Gb | - |
| Sep 15, 2025 | Pc128 Adverse Exhibit No 503 Toumi Et Al External Reference Pricing Simulation Gb | - |
| Sep 15, 2025 | Pc122 Application For Provisional Measures Gb | - |
| Sep 15, 2025 | Pc121 Acorda V Alkem Trial Transcript Volume B Gb | - |
| Sep 15, 2025 | Pc120 Acorda V Alkem Trial Transcript Volume A Gb | - |
| Sep 15, 2025 | Pc119 Hamilton Et Al 1998 Olanzapine Versus Placebo And Haloperidol Quality Of Life And Efficacy Results On The North Am | - |
| Sep 15, 2025 | Pc118 Overall 1994 Journal Of Clinical Psychology VOL 50 Pages 95 102 Gb | - |
| Sep 15, 2025 | Pc117 Alhainen Et Al 1991 Discrimination Of Tetrahydroaminoacridine Responders By A Single Dose Pharmaco Eeg In Patients | - |
| Sep 15, 2025 | Pc116 Sas Library 1997 Repeated Measures Anova Using Sas Proc Glm Gb | - |
| Sep 15, 2025 | Pc115 Sheeber Et Al 1996 Data Analytic Techniques For Treatment Outcome Studies With Pretest Posttest Measurements An Ex | - |
| Sep 15, 2025 | Pc114 Cook Et Al 1983 Design And Analysis Methods For Longitudinal Research Ann Rev Public Health Gb | - |
| Sep 15, 2025 | Pc113 Vickers Hor Many Repeated Measures In Repeates Measures Designs Statistical Issues For Comparative Trials Bmc | - |
| Sep 15, 2025 | Pc112 Uryniak Et Al Responder Analyses A Phrma Position Paper Statistics In Biopharmaceutical Research VOL 3 N3 Gb | - |
| Sep 15, 2025 | Pc111 Schulz Et Al The Efficacy Of Quetiapine VS Haloperidol And Placebo A Meta Analytic Study Of Efficacy Schizopp | - |
| Sep 15, 2025 | Pc110 Temple 1994 Commun Stat Theory Meth VOL 23 Pages 449 521 Gb | - |
| Sep 15, 2025 | Pc109 Lewis Statistics In Medicine VOL 21 Pages 2931 2938 Gb | - |
| Sep 15, 2025 | Pc108 Weiner 1998 Can J Neurol Sci VOL 25 Pages 93101 Gb | - |
| Sep 15, 2025 | Pc107 Petkau 1998 Seminars In Neurology VOL 18 3 Gb | - |
| Sep 15, 2025 | Pc106 Leber Et DAVIS 1998 Threats To The Validity Of Clinical Trials Employing Enrichment Strategies For Sample Selectio | - |
| Sep 15, 2025 | Pc105 DTX 584 Gb | - |
| Sep 15, 2025 | Pc104 4 Aminopyridine Induces Functional Improvement In Multiple Sclerosis Patients A Neurophysiological Study Gb | - |
| Sep 15, 2025 | Pc103 Stefoski Et Al 1991 4 Aminopyridine In Multiple Sclerosis Prolonged Administration Neurology 1991 Gb | - |
| Sep 15, 2025 | Pc102 Clinical Studies In 20 Questions Atelier Presse Clinical Trials Leem 19 May Fr | - |
| Sep 15, 2025 | Pc101 Report By Dr Christian Wolf DATED 2 September Gb | - |
| Sep 15, 2025 | Pc100 EP1732548B9 Gb | - |
| Sep 15, 2025 | Pc099 Matusik Therapy Nutrients 14 4249 Gb | - |
| Sep 15, 2025 | Pc098 Le Progres Article Patients Deprived Of A Medication Due To A Change Of Packaging 26 June Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 2 2 Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 1 2 Fr | - |
| Sep 15, 2025 | Pc096 Kehl Responder Identification In Clinical Trials June Gb | - |
| Sep 15, 2025 | Pc095 CPMP Points To Consider Multiplicity Issues Clinical Trials Gb | - |
| Sep 15, 2025 | Pc094 Hayes Et Al Pharmacokinetic Studies Of Single And Multiple Oral Doses Of Fampridine VOL 26 N4 Pp 185 192 Gb | - |
| Sep 15, 2025 | Pc093 Hayes Et Al Pharmacokinetics Of An Immediate Release Oral Formulation Of Fampridine 4 Aminopyridine In Normal | - |
| Sep 15, 2025 | Pc092 July 1986 Comment Determiner La Posologie Optimale D Un Medicament Fr | - |
| Sep 15, 2025 | Pc091 Dose Ranging Study Wikipedia Gb | - |
| Sep 15, 2025 | Pc090 Rnb Ccp 033 Fr | - |
| Sep 15, 2025 | Pc089 Rnb EP536Fr | - |
| Sep 15, 2025 | Pc088 Chmp 1999 Clinical Investigation Of Medicinal Products In The Treatment Of Parkinson S Disease CPMP Note For Guida | - |
| Sep 15, 2025 | Pc087 Ccne Opinion 79 Transposition Into French Law Of The European Directive On Clinical Trials Of Medicinal Products F | - |
| Sep 15, 2025 | Pc086 Declaration Of Helsinki Ethical Principles For Medical Research Involving Human Subjects Gb | - |
| Sep 15, 2025 | Pc085 Nuremberg Code Gb | - |
| Sep 15, 2025 | Pc084 Afsep Press Release Of 28 May Fr | - |
| Sep 15, 2025 | Pc083 Barus Et Al Fr | - |
| Sep 15, 2025 | Pc082 Extrait De La Base De Donnees Publique Des Medicaments Fampridine Viatris 10 Mg Fr | - |
| Sep 15, 2025 | Pc081 Icht Topic 9 Guideline On Statistical Principles For Clinical Trials September 1998 Gb | - |
| Sep 15, 2025 | Pc080 Website Of The Foundation For Research Into Multiple Sclerosis Fr | - |
| Sep 15, 2025 | Pc079 Notice On The Prices Of Fampridine Pharmaceutical Specialities Fr | - |
| Sep 15, 2025 | Pc078 Info Sheet Fampyra 10Mg Sustained Release Tablet Fr | - |
| Sep 15, 2025 | Pc077 Accession Of Bulgaria Gb | - |
| Sep 15, 2025 | Pc076 Kehl Responder Identification In Clinical Trials With Censored Data Gb | - |
| Sep 15, 2025 | Pc075 Federal Court Of Canada 15 May Acorda V Pharmascience And Taro T 1416 18 And T 220 19 Gb | - |
| Sep 15, 2025 | Pc074 Usa Delaware District Court 25 April Acorda V Teva Roxane Mylan 14 882 Gb | - |
| Sep 15, 2025 | Pc073 Usa Delaware District Court 31 March Acorda V Roxane 14 882 Lps Gb | - |
| Sep 15, 2025 | Pc072 Germany Teva Revocation Of Patent EP548De | - |
| Sep 15, 2025 | Pc071 Germany Ratiopharm Revocation Of Patent EP536De | - |
| Sep 15, 2025 | Pc070 Germany Ratiopharm Admissibility Of The EP536Invalidity Claim De | - |
| Sep 15, 2025 | Pc069 Board Of Appeal Of The European Patent Office 4 September T 0799 16 Gb | - |
| Sep 15, 2025 | Pc068 Decision Of The Epo EP536Gb Compressed | - |
| Sep 15, 2025 | Pc067 Emea Points To Consider On The Choice Of Non Interiority Margin Gb | - |
| Sep 15, 2025 | Pc066 Emea 27 July Points To Consider On Switching Betweend Superiority And Non Inferiority Gb | - |
| Sep 15, 2025 | Pc064 Usa Court Of Appeal 10 September Acorda V Roxane Et Al Et 2134 Gb | - |
| Sep 15, 2025 | Pc063 Form 10 K Wikipedia Presentation Gb | - |
| Sep 15, 2025 | Pc062 Cohen Postgraduate Medicine September 1999 Gb | - |
| Sep 15, 2025 | Pc061 L Echelle Edss Expanded Disability Status Scale Fr | - |
| Sep 15, 2025 | Pc060 O Brien Journal Of Hypertension Gb | - |
| Sep 15, 2025 | Pc059 Ellen R Girden Anova Repeated Measures 1992 Gb | - |
| Sep 15, 2025 | Pc058 Federal Court Of Appeal Of Canada 8 August Acorda Therapeutics V Pharmascience Taro Pharmaceuticals A 145 20 | - |
| Sep 15, 2025 | Pc057 Fda Chapter I Food And Drug Administration Department Of Health And Human Services Subchapter D Drugs For Human Us | - |
| Sep 15, 2025 | Pc056 Polman Arch Neur VOL 51 November 1994 Gb | - |
| Sep 15, 2025 | Pc055 Sheiner Clin Pharmacol Ther Volume 46 Number 1 July 1989 Gb | - |
| Sep 15, 2025 | Pc054 Norleans Statistical Methods For Clinical Trials Gb Compressed | - |
| Sep 15, 2025 | Pc053 Excerpt From The Fda Website Drug Evaluation Process Gb | - |
| Sep 15, 2025 | Pc052 Schwid Et Al April Gb | - |
| Sep 15, 2025 | Pc051 Kaufman Al The Significant Change For The Timed 25 Foot Walk In The Multiple Sclerosis Functional Composite M | - |
| Sep 15, 2025 | Pc050 Extract From The National Institutes Of Health Website Fda Drug Review And Approval Gb | - |
| Sep 15, 2025 | Pc049 Ca 2 562 277 Gb | - |
| Sep 15, 2025 | Pc048 US8663685Gb | - |
| Sep 15, 2025 | Pc047 US8440703Gb | - |
| Sep 15, 2025 | Pc046 US8354437Gb | - |
| Sep 15, 2025 | Pc045 Declaration Of Dr Ron Cohen Gb | - |
| Sep 15, 2025 | Pc044 US8007826Gb | - |
| Sep 15, 2025 | Pc043 Goodman Diaporama Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc042 Medical Research Council Mrc Scale For Muscle Strength Gb | - |
| Sep 15, 2025 | Pc041 National Multiple Sclerosis Society Timed 25 Foot Walk T25 Fw Gb | - |
| Sep 15, 2025 | Pc040 Ninds Fatigue Severity Scale Fss Gb | - |
| Sep 15, 2025 | Pc039 Wikipedia Page Edss Gb | - |
| Sep 15, 2025 | Pc038 Goodman Poster Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc037 Supplemental Information Disclosure Statement Gb | - |
| Sep 15, 2025 | Pc036 Actrims Ectrims Final Program Gb Compressed | - |
| Sep 15, 2025 | Pc035 List Of References Ids Gb | - |
| Sep 15, 2025 | Pc034 List Of Documents Requested US11102559Gb | - |
| Sep 15, 2025 | Pc033 Acorda Therapeutics Form S1 Gb | - |
| Sep 15, 2025 | Pc032 Form S 1 Presentation Gb | - |
| Sep 15, 2025 | Pc031 Sec Overview Gb | - |
| Sep 15, 2025 | Pc030 Goodman Abstract Poster Gb | - |
| Sep 15, 2025 | Pc029 Shargel 1999 Applied Biopharmaceutics And Pharmacokinetics Chapter 7 Extraits Pages 169 178 179 Gb Compressed | - |
| Sep 15, 2025 | Pc028 VAN Diemen Et Al 1992 August Gb | - |
| Sep 15, 2025 | Pc027 EP0484186B1 Gb | - |
| Sep 15, 2025 | Pc026 Schwid Et Al 1997 The American Academy Of Neurology Volume 48 Pages 817 821 Gb | - |
| Sep 15, 2025 | Pc025 Bever 1994 The American Neurological Association 1994 Volume 23 Page 118 S121 Gb | - |
| Sep 15, 2025 | Pc024 Bever Et Al 1994 June Neurology 44 1054 1059 Gb | - |
| Sep 15, 2025 | Pc023 Davis Et Al 1990 The American Neurological Association 1990 Pages 186 192 Gb | - |
| Sep 15, 2025 | Pc022 Sherratt Et Al 1980 Nature Volume 283 5745 Pages 570 572 Gb | - |
| Sep 15, 2025 | Pc021 List Of Documents Cited In The Oppositions Gb | - |
| Sep 15, 2025 | Pc020 Merz Acquires Fampyra Gb | - |
| Sep 15, 2025 | Pc019 European Medicines Agency Guidelines Ich Topic E4 November 1994 Gb | - |
| Sep 15, 2025 | Pc018 EP536Oral Proceedings Gb | - |
| Sep 15, 2025 | Pc017 Verhagen Et Al Australian Journal Of Physiotherapy VOL 50 Gb | - |
| Sep 15, 2025 | Pc016 Piece Composite Synthese Wikipiedia Sur L Ecart Type Et La Valeur P Fr | - |
| Sep 15, 2025 | Pc015 Marien Et Beaud Guide Pratique Pour L Utilisation De La Statistique En Recherche Fr | - |
| Sep 15, 2025 | Pc014 Journal De La Societe Statistique De Paris 1956 Fr | - |
| Sep 15, 2025 | Pc013 Ting N Introduction And New Drug Development Process In Ting N Editor Dose Finding In Drug Development Springer Ne | - |
| Sep 15, 2025 | Pc012 Pirmohamed Et Al Bmj Volume 316 25 April 1998 Gb | - |
| Sep 15, 2025 | Pc011 Edwards And Aronson The Lancet VOL 356 October 7 Gb | - |
| Sep 15, 2025 | Pc010 Ich Topic E 8 General Considerations For Clinical Trials 17 July 1997 Gb | - |
| Sep 15, 2025 | Pc009 Griffin Et Al The Textbook Of Pharmaceutical Medicine 1993 Pages 221 222 Gb Compressed | - |
| Sep 15, 2025 | Pc008 Bopi 20 November N 1547 Pp 235 237 Et 258 Fr | - |
| Sep 15, 2025 | Pc007 Decision Et Requete De Delivrance Du Ccp N 13 C0033 Fr | - |
| Sep 15, 2025 | Pc006 Demande De Ccp Sur La Base Du Brevet EP2377536Fr | - |
| Sep 15, 2025 | Pc005 EP2377536B2 Gb | - |
| Sep 15, 2025 | Pc004 Fampyra Smpc Gb | - |
| Sep 15, 2025 | Pc003 Commission Implementing Decision Of 27 September C20246926 Gb | - |
| Sep 15, 2025 | Pc002 Rcp Fampridine Viatris Lp 10Mg Fr | - |
| Sep 15, 2025 | Pc001 Extrait Kbis Viatris Sante Fr | - |
| Sep 15, 2025 | Objection Viatris Sante App 339802025 Compressed Signed | - |
| Sep 11, 2025 | Summon Oral Hearing | - |
| Sep 11, 2025 | Order Summon The Oral Hearing | |
| Aug 18, 2025 | Procedural Order Timetable And Summon Oh | |
| Aug 18, 2025 | Hearing Dates | - |
| Aug 14, 2025 | Panel Appointment | - |
| Aug 7, 2025 | Acknowledgement Of Access To Case | - |
| Aug 6, 2025 | Notification Of Service | - |
| Aug 6, 2025 | Digital Tracking La Poste Service Receipt | - |
| Aug 5, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Notice To Accompany Service Of Order For Measures | - |
| Aug 1, 2025 | Letter For Service | - |
| Aug 1, 2025 | Formal Checks Notification Of Positive Outcome | - |
| Aug 1, 2025 | Exhibit No. 701 Application French Translation | - |
| Aug 1, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Aug 1, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Aug 1, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Aug 1, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Aug 1, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Aug 1, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Aug 1, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Aug 1, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Aug 1, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Aug 1, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Aug 1, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Aug 1, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Aug 1, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Aug 1, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Aug 1, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Aug 1, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Aug 1, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Aug 1, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Aug 1, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Aug 1, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Aug 1, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Aug 1, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Aug 1, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Aug 1, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Aug 1, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Aug 1, 2025 | Exhibit No. 401 Goodman Poster | - |
| Aug 1, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Aug 1, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Aug 1, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Aug 1, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Aug 1, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Aug 1, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Aug 1, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Aug 1, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 208 French Spc Register | - |
| Aug 1, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Aug 1, 2025 | Exhibit No. 206 French Patent Register | - |
| Aug 1, 2025 | Exhibit No. 205 EP536Patent | - |
| Aug 1, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Aug 1, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Aug 1, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Aug 1, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Aug 1, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Aug 1, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Aug 1, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Aug 1, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Aug 1, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Aug 1, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Aug 1, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Aug 1, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Aug 1, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Aug 1, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Aug 1, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Aug 1, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Aug 1, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Aug 1, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Aug 1, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Aug 1, 2025 | Exhibit No. 106 Larocca | - |
| Aug 1, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Aug 1, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Aug 1, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Aug 1, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Aug 1, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Aug 1, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Aug 1, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Aug 1, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Aug 1, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Aug 1, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Aug 1, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Aug 1, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Aug 1, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Aug 1, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Aug 1, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Aug 1, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Aug 1, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Aug 1, 2025 | Application For Provisional Measures | - |
| Aug 1, 2025 | Application For Measures Receipt | - |
| Aug 1, 2025 | Application For Measures Acknowledgement | - |
| Jul 31, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Jul 31, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Jul 31, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Jul 31, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Jul 31, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Jul 31, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Jul 31, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Jul 31, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Jul 31, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Jul 31, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Jul 31, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Jul 31, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Jul 31, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Jul 31, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Jul 31, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Jul 31, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Jul 31, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Jul 31, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Jul 31, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Jul 31, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Jul 31, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Jul 31, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Jul 31, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Jul 31, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Jul 31, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Jul 31, 2025 | Exhibit No. 401 Goodman Poster | - |
| Jul 31, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Jul 31, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Jul 31, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Jul 31, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Jul 31, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Jul 31, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Jul 31, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Jul 31, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 208 French Spc Register | - |
| Jul 31, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Jul 31, 2025 | Exhibit No. 206 French Patent Register | - |
| Jul 31, 2025 | Exhibit No. 205 EP536Patent | - |
| Jul 31, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Jul 31, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Jul 31, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Jul 31, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Jul 31, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Jul 31, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Jul 31, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Jul 31, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Jul 31, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Jul 31, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Jul 31, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Jul 31, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Jul 31, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Jul 31, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Jul 31, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Jul 31, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Jul 31, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Jul 31, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Jul 31, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Jul 31, 2025 | Exhibit No. 106 Larocca | - |
| Jul 31, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Jul 31, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Jul 31, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Jul 31, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Jul 31, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Jul 31, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Jul 31, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Jul 31, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Jul 31, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Jul 31, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Jul 31, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Jul 31, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Jul 31, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Jul 31, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Jul 31, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Jul 31, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Jul 31, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Jul 31, 2025 | Application For Provisional Measures | - |
| Oct 10, 2025 | Action.Communication | - |
| Oct 9, 2025 | Receipt | - |
| Oct 9, 2025 | Proof Of Payment | - |
| Oct 9, 2025 | Other Document | - |
| Oct 9, 2025 | Fee | - |
| Oct 9, 2025 | Cover Sheet | - |
| Oct 9, 2025 | Application | - |
| Oct 7, 2025 | Order | - |
| Oct 7, 2025 | Action.Issueorder | - |
| Oct 6, 2025 | Action.Communication | - |
| Oct 5, 2025 | Receipt | - |
| Oct 5, 2025 | Cover Sheet | - |
| Oct 5, 2025 | Application | - |
| Oct 2, 2025 | Receipt | - |
| Oct 2, 2025 | Order | - |
| Oct 2, 2025 | Cover Sheet | - |
| Oct 2, 2025 | Application | - |
| Oct 2, 2025 | Action.Issueorder | - |
| Oct 1, 2025 | Statement Of Reply | - |
| Oct 1, 2025 | Receipt | - |
| Oct 1, 2025 | Exhibit | - |
| Oct 1, 2025 | Cover Sheet | - |
| Oct 1, 2025 | Application | - |
| Sep 26, 2025 | Action.Communication | - |
| Sep 25, 2025 | Receipt | - |
| Sep 25, 2025 | Other Document | - |
| Sep 25, 2025 | Exhibit | - |
| Sep 25, 2025 | Cover Sheet | - |
| Sep 25, 2025 | Action.Communication | - |
| Sep 24, 2025 | Order | - |
| Sep 24, 2025 | Action.Issueorder | - |
| Sep 18, 2025 | Request V.Def Pdf A Signed | - |
| Sep 18, 2025 | Receipt | - |
| Sep 18, 2025 | Pc154 Iqvia Agreement Gb | - |
| Sep 18, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 17, 2025 | Receipt | - |
| Sep 17, 2025 | Procedural Order | |
| Sep 17, 2025 | Outcome Of The Order | - |
| Sep 17, 2025 | Headnote And Keywords | - |
| Sep 16, 2025 | Request For Procedural Order | - |
| Sep 16, 2025 | Receipt | - |
| Sep 16, 2025 | Objection | - |
| Sep 15, 2025 | Pj087 Regulation N 469 Gb | - |
| Sep 15, 2025 | Pj086 Court Of Appeal 10X Genomics Harvard V Nanostring Upc Coa 3352023 Gb | - |
| Sep 15, 2025 | Pj085 Dmf Nl Court Of The Hague 1Ere Instance Nl | - |
| Sep 15, 2025 | Pj084 Dmf Be Cour Dappel De Bruxelles Appel Nl | - |
| Sep 15, 2025 | Pj083 Fingolimod De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj082 Phosphodiesterase Nl Appeal Court Of The Hague Appel Nl | - |
| Sep 15, 2025 | Pj081 Dmf De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj080 Munich Local Division 21 May Upccfi432023 De | - |
| Sep 15, 2025 | Pj079 Ca Paris 9 July N2407962 Fr | - |
| Sep 15, 2025 | Pj078 Case Law Of The Boards Of Appeal Id108 Gb | - |
| Sep 15, 2025 | Pj077 Bonnes Pratiques De Distribution Ansm Bulletin Officiel N20149Bis Fr | - |
| Sep 15, 2025 | Pj076 Upc Court Of Appeal 25 September Upccoa1822024 Gb | - |
| Sep 15, 2025 | Pj075 Guidelines For Examination In The European Patent Office Gvii4Gb | - |
| Sep 15, 2025 | Pj074 Decision De La Chambre De Recours De Loeb DU 4 October T 111003 Gb | - |
| Sep 15, 2025 | Pj073 Epo Boa 10 July Eisai V Stada Lenvatinib T 193423 Gb | - |
| Sep 15, 2025 | Pj072 Hamburg Local Division 3 June Upccfi1512024 Gb | - |
| Sep 15, 2025 | Pj071 Dusseldorf Local Division 30 April Upccfi4632023 Gb | - |
| Sep 15, 2025 | Pj070 Dusseldorf Local Division 9 April Upccfi4522023 De | - |
| Sep 15, 2025 | Pj069 Dusseldorf Local Division VALEO V Magna Upc Cfi 3682024 Gb | - |
| Sep 15, 2025 | Pj068 Court Of Appeal Biolitec V Light Guide Optics Sia Lightguide 24 February Upccoa5402024 Gb | - |
| Sep 15, 2025 | Pj067 Ld Munich 15 November Upc Cfi 152023 Gb | - |
| Sep 15, 2025 | Pj065 Cjeu 28 July Synthon C Mertz Memantine C19509 Gb | - |
| Sep 15, 2025 | Pj064 Cjeu 28 July Generics Uk C Synaptech Galantamine C42709 Gb | - |
| Sep 15, 2025 | Pj063 Cass Com 10 February N1320150 Fr | - |
| Sep 15, 2025 | Pj062 Directive 200448CE Gb | - |
| Sep 15, 2025 | Pj061 Neurim Mylan High Court Of Justice 3 June Ewhc 1362 Gb | - |
| Sep 15, 2025 | Pj060 Decision De La Chambre De Recours De Loeb 13 September T023916 Gb | - |
| Sep 15, 2025 | Pj059 Decision De La Chambre De Recours De Loeb 4 October T250612 Gb | - |
| Sep 15, 2025 | Pj058 Tj Paris Refere 17 June Rg 2153849 Cabazitaxel Sanofi C Ever Pharma Fr | - |
| Sep 15, 2025 | Pj057 Tj Paris 12 May Rg 2153136 Cabazitaxel Sanofi C Teva Fr | - |
| Sep 15, 2025 | Pj056 Santen C 673 18 Gb | - |
| Sep 15, 2025 | Pj055 Tgi Paris 22 September 1407707 Fr | - |
| Sep 15, 2025 | Pj054 Cour Dappel De Paris 14 February 1991 Newtec International C Sfeima Pibd N504 Iiii432 Fr | - |
| Sep 15, 2025 | Pj053 Cour De Cassation 20 November Pourvoi N 1118440 Fr | - |
| Sep 15, 2025 | Pj052 Tgi Paris 6 June Rg N1606916 Fr | - |
| Sep 15, 2025 | Pj051 Tgi Rennes 2 September Rg N9803029 Fr | - |
| Sep 15, 2025 | Pj050 Decision De La Chambre De Recours 3306 De Loeb 30 May T 16596 Fr | - |
| Sep 15, 2025 | Pj049 Decision De La Chambre De Recours 3502 De Loeb 29 October T 33515 Fr | - |
| Sep 15, 2025 | Pj048 Decision De La Chambre De Recours De Loeb 10 November 1988 T038187 Gb | - |
| Sep 15, 2025 | Pj047 Tj Paris 22 June Rg N2002792 Fr | - |
| Sep 15, 2025 | Pj046 Decision De La Chambre De Recours De Loeb 20 September T197909 Gb | - |
| Sep 15, 2025 | Pj045 Decision De La Chambre De Recours De Loeb 1Er April T 140906 Gb | - |
| Sep 15, 2025 | Pj044 Decision De La Chambre De Recours De Loeb DU 28 January T 023715 Gb | - |
| Sep 15, 2025 | Pj043 Basf C25899 Gb | - |
| Sep 15, 2025 | Pj042 Gsk C21013 14 Nov Gb | - |
| Sep 15, 2025 | Pj041 Ca Paris 14 February Rg 1903820 Sandoz C Msd Fr | - |
| Sep 15, 2025 | Pj040 Abraxis C 443 17 21 March Gb | - |
| Sep 15, 2025 | Pj039 Case Law Of The Boards Of Appeal Of The Epo I D74 Try And See Solution Gb | - |
| Sep 15, 2025 | Pj038 Tj Paris 20 January Rg N 1901997 Fr | - |
| Sep 15, 2025 | Pj037 Tj Paris 6 September Rg N2106416 Fr | - |
| Sep 15, 2025 | Pj036 Tj Paris 7 June Rg 2153474 Sanofi C Accord Cabazitaxel Fr | - |
| Sep 15, 2025 | Pj035 Ca Paris 29 October Etypharm C Merck Rg N1803876 Fr | - |
| Sep 15, 2025 | Pj034 Cour Dappel De Paris 18 December Rg N 1710112 Fr | - |
| Sep 15, 2025 | Pj033 Decision De La Chambre De Recours De Loeb 25 July T 025915 Gb | - |
| Sep 15, 2025 | Pj032 Decision De La Chambre De Recours De Loeb 29 May T 009198 Gb | - |
| Sep 15, 2025 | Pj031 Decision De La Chambre De Recours De Loeb 5 October T 33397 Gb | - |
| Sep 15, 2025 | Pj030 Decision De La Chambre De Recours De Loeb 6 October T 91801 Gb | - |
| Sep 15, 2025 | Pj029 Decision De La Chambre De Recours De Loeb 14 February 1989 T 24988 Gb | - |
| Sep 15, 2025 | Pj028 Case Law Of The Boards Of Appeal Of The Epo Id71 Reasonable Expectation Of Success Gb | - |
| Sep 15, 2025 | Pj027 Jurisprudences Francaises Essais De Routine Fr | - |
| Sep 15, 2025 | Pj026 Tgi Paris 7 May Hexal C Boehringer Rg 0812537 Fr | - |
| Sep 15, 2025 | Pj025 Jub Division Centrale De Munich 16 July Sanofi C Amgen Upccfi 12023 Gb | - |
| Sep 15, 2025 | Pj024 Jub Cour Dappel 26 February Nanostring C 10X Genomics Upccoa3352023 Gb | - |
| Sep 15, 2025 | Pj023 Decision De La Chambre De Recours 332 De L Oeb 26 February T 92600 Gb | - |
| Sep 15, 2025 | Pj022 Decision De La Chambre De Recours 332 De Loeb 2 June T 30899 Gb | - |
| Sep 15, 2025 | Pj021 Decision De La Chambre De Recours 352 De Loeb 22 October 1993 T 25392 Gb | - |
| Sep 15, 2025 | Pj020 Decision De La Chambre De Recours 332 De Loeb 13 July T 393 01 Gb | - |
| Sep 15, 2025 | Pj019 Ca Paris 19 January Rg 18 21115 Fr | - |
| Sep 15, 2025 | Pj018 Tj Paris 20 July Rg N 21 10327 Fr | - |
| Sep 15, 2025 | Pj017 Ca Paris 14 November Rg N 1502576 Fr | - |
| Sep 15, 2025 | Pj016 Tj Paris 28 March Rg 2208612 Fr | - |
| Sep 15, 2025 | Pj014 Upc Court Of Appeal 13 August Upccoa4462025 Gb | - |
| Sep 15, 2025 | Pj013 Tj Paris 18 June Rg N 23 02356 Fr | - |
| Sep 15, 2025 | Pj012 Munich Local Division 27 August Upccfi2012024 Gb | - |
| Sep 15, 2025 | Pj011 Tj Paris 27 July Rg N 22 54367 Fr | - |
| Sep 15, 2025 | Pj010 Guidelines For Examination Of The Epo Giv1 Gb | - |
| Sep 15, 2025 | Pj009 Ca Paris 25 May Rg 21 18398 Fr | - |
| Sep 15, 2025 | Pj008 Tj Paris 29 September Rg 21 55930 Fr | - |
| Sep 15, 2025 | Pj007 Tj Paris Ordonnance De Refere 6 October Rg 22 55799 Biogen C Viatris Dmf Fr | - |
| Sep 15, 2025 | Pj006 Cjeu 16 July Genmab V Hungarian Ip Office Spc C 181 24 Gb | - |
| Sep 15, 2025 | Pj005 Accord Cadre Leem Ceps 5 March Fr | - |
| Sep 15, 2025 | Pj004 Regulation No 1768 92 Gb | - |
| Sep 15, 2025 | Pj003 Tj Paris Ordonnance Viatris C Novartis 04 August Fingolimod Rg N 2254655 Fr | - |
| Sep 15, 2025 | Pj002 Ca Paris 14 February Rg 1906114 Fr | - |
| Sep 15, 2025 | Pj001 Decision Du Conseil Constitutionnel N 463 Dc DU 12 December Fr | - |
| Sep 15, 2025 | Pc152 Submissions In High Resolution Gb | - |
| Sep 15, 2025 | Pc151 Declaration Dawid Sierzant DU 15 September Et Annexes Gb | - |
| Sep 15, 2025 | Pc150 4 Aminopyridine C5H6N2 Cid 1727 Pubchem Gb | - |
| Sep 15, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 15, 2025 | Pc148 The Fixing Of The Price And Reimboursement Rate Sante Gouv Fr | - |
| Sep 15, 2025 | Pc146 Letter From Viatris To Mez DATED 2 July Gb | - |
| Sep 15, 2025 | Pc145 Letter From Viatris To Merz Of 10 July Fr | - |
| Sep 15, 2025 | Pc143 Chapter 33 Pymadin Paskov Et Al 1986 Gb | - |
| Sep 15, 2025 | Pc142 Kostadinova And Danchev Gb | - |
| Sep 15, 2025 | Pc141 Sartori Et Al 1994 Gb | - |
| Sep 15, 2025 | Pc140 Olg Munchen Acorda Therapeutics V Ratiopharm 6 October 6 U 3044 22 De | - |
| Sep 15, 2025 | Pc139 Upsto Trademark Status Document Retrieval Pymadin Sopharma Gb | - |
| Sep 15, 2025 | Pc138 Website Of The Faculty Of Medicine In Sofia Bg | - |
| Sep 15, 2025 | Pc137 They Are Looking For A Superpill For Alzheimers Technologies News Standard Bg | - |
| Sep 15, 2025 | Pc136 Russian State Archive Of Scientific And Technical Documentation Ru | - |
| Sep 15, 2025 | Pc135 Communication Between The Ceps And Viatris Fr | - |
| Sep 15, 2025 | Pc134 Patient Leaflet Pymadin Bg | - |
| Sep 15, 2025 | Pc133 Smpc Pymadin Bg | - |
| Sep 15, 2025 | Pc132 Free State Gazette Edition 33 Of 2Iv Unofficial Section Ru | - |
| Sep 15, 2025 | Pc131 Disaster Protection Plan Burgas Region Republic Of Bulgaria Bg | - |
| Sep 15, 2025 | Pc130 4 Aminopiridin Spinal Cord Injury Forum Ru Compressed | - |
| Sep 15, 2025 | Pc129 Iqvia About Us Gb | - |
| Sep 15, 2025 | Pc128 Adverse Exhibit No 503 Toumi Et Al External Reference Pricing Simulation Gb | - |
| Sep 15, 2025 | Pc122 Application For Provisional Measures Gb | - |
| Sep 15, 2025 | Pc121 Acorda V Alkem Trial Transcript Volume B Gb | - |
| Sep 15, 2025 | Pc120 Acorda V Alkem Trial Transcript Volume A Gb | - |
| Sep 15, 2025 | Pc119 Hamilton Et Al 1998 Olanzapine Versus Placebo And Haloperidol Quality Of Life And Efficacy Results On The North Am | - |
| Sep 15, 2025 | Pc118 Overall 1994 Journal Of Clinical Psychology VOL 50 Pages 95 102 Gb | - |
| Sep 15, 2025 | Pc117 Alhainen Et Al 1991 Discrimination Of Tetrahydroaminoacridine Responders By A Single Dose Pharmaco Eeg In Patients | - |
| Sep 15, 2025 | Pc116 Sas Library 1997 Repeated Measures Anova Using Sas Proc Glm Gb | - |
| Sep 15, 2025 | Pc115 Sheeber Et Al 1996 Data Analytic Techniques For Treatment Outcome Studies With Pretest Posttest Measurements An Ex | - |
| Sep 15, 2025 | Pc114 Cook Et Al 1983 Design And Analysis Methods For Longitudinal Research Ann Rev Public Health Gb | - |
| Sep 15, 2025 | Pc113 Vickers Hor Many Repeated Measures In Repeates Measures Designs Statistical Issues For Comparative Trials Bmc | - |
| Sep 15, 2025 | Pc112 Uryniak Et Al Responder Analyses A Phrma Position Paper Statistics In Biopharmaceutical Research VOL 3 N3 Gb | - |
| Sep 15, 2025 | Pc111 Schulz Et Al The Efficacy Of Quetiapine VS Haloperidol And Placebo A Meta Analytic Study Of Efficacy Schizopp | - |
| Sep 15, 2025 | Pc110 Temple 1994 Commun Stat Theory Meth VOL 23 Pages 449 521 Gb | - |
| Sep 15, 2025 | Pc109 Lewis Statistics In Medicine VOL 21 Pages 2931 2938 Gb | - |
| Sep 15, 2025 | Pc108 Weiner 1998 Can J Neurol Sci VOL 25 Pages 93101 Gb | - |
| Sep 15, 2025 | Pc107 Petkau 1998 Seminars In Neurology VOL 18 3 Gb | - |
| Sep 15, 2025 | Pc106 Leber Et DAVIS 1998 Threats To The Validity Of Clinical Trials Employing Enrichment Strategies For Sample Selectio | - |
| Sep 15, 2025 | Pc105 DTX 584 Gb | - |
| Sep 15, 2025 | Pc104 4 Aminopyridine Induces Functional Improvement In Multiple Sclerosis Patients A Neurophysiological Study Gb | - |
| Sep 15, 2025 | Pc103 Stefoski Et Al 1991 4 Aminopyridine In Multiple Sclerosis Prolonged Administration Neurology 1991 Gb | - |
| Sep 15, 2025 | Pc102 Clinical Studies In 20 Questions Atelier Presse Clinical Trials Leem 19 May Fr | - |
| Sep 15, 2025 | Pc101 Report By Dr Christian Wolf DATED 2 September Gb | - |
| Sep 15, 2025 | Pc100 EP1732548B9 Gb | - |
| Sep 15, 2025 | Pc099 Matusik Therapy Nutrients 14 4249 Gb | - |
| Sep 15, 2025 | Pc098 Le Progres Article Patients Deprived Of A Medication Due To A Change Of Packaging 26 June Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 2 2 Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 1 2 Fr | - |
| Sep 15, 2025 | Pc096 Kehl Responder Identification In Clinical Trials June Gb | - |
| Sep 15, 2025 | Pc095 CPMP Points To Consider Multiplicity Issues Clinical Trials Gb | - |
| Sep 15, 2025 | Pc094 Hayes Et Al Pharmacokinetic Studies Of Single And Multiple Oral Doses Of Fampridine VOL 26 N4 Pp 185 192 Gb | - |
| Sep 15, 2025 | Pc093 Hayes Et Al Pharmacokinetics Of An Immediate Release Oral Formulation Of Fampridine 4 Aminopyridine In Normal | - |
| Sep 15, 2025 | Pc092 July 1986 Comment Determiner La Posologie Optimale D Un Medicament Fr | - |
| Sep 15, 2025 | Pc091 Dose Ranging Study Wikipedia Gb | - |
| Sep 15, 2025 | Pc090 Rnb Ccp 033 Fr | - |
| Sep 15, 2025 | Pc089 Rnb EP536Fr | - |
| Sep 15, 2025 | Pc088 Chmp 1999 Clinical Investigation Of Medicinal Products In The Treatment Of Parkinson S Disease CPMP Note For Guida | - |
| Sep 15, 2025 | Pc087 Ccne Opinion 79 Transposition Into French Law Of The European Directive On Clinical Trials Of Medicinal Products F | - |
| Sep 15, 2025 | Pc086 Declaration Of Helsinki Ethical Principles For Medical Research Involving Human Subjects Gb | - |
| Sep 15, 2025 | Pc085 Nuremberg Code Gb | - |
| Sep 15, 2025 | Pc084 Afsep Press Release Of 28 May Fr | - |
| Sep 15, 2025 | Pc083 Barus Et Al Fr | - |
| Sep 15, 2025 | Pc082 Extrait De La Base De Donnees Publique Des Medicaments Fampridine Viatris 10 Mg Fr | - |
| Sep 15, 2025 | Pc081 Icht Topic 9 Guideline On Statistical Principles For Clinical Trials September 1998 Gb | - |
| Sep 15, 2025 | Pc080 Website Of The Foundation For Research Into Multiple Sclerosis Fr | - |
| Sep 15, 2025 | Pc079 Notice On The Prices Of Fampridine Pharmaceutical Specialities Fr | - |
| Sep 15, 2025 | Pc078 Info Sheet Fampyra 10Mg Sustained Release Tablet Fr | - |
| Sep 15, 2025 | Pc077 Accession Of Bulgaria Gb | - |
| Sep 15, 2025 | Pc076 Kehl Responder Identification In Clinical Trials With Censored Data Gb | - |
| Sep 15, 2025 | Pc075 Federal Court Of Canada 15 May Acorda V Pharmascience And Taro T 1416 18 And T 220 19 Gb | - |
| Sep 15, 2025 | Pc074 Usa Delaware District Court 25 April Acorda V Teva Roxane Mylan 14 882 Gb | - |
| Sep 15, 2025 | Pc073 Usa Delaware District Court 31 March Acorda V Roxane 14 882 Lps Gb | - |
| Sep 15, 2025 | Pc072 Germany Teva Revocation Of Patent EP548De | - |
| Sep 15, 2025 | Pc071 Germany Ratiopharm Revocation Of Patent EP536De | - |
| Sep 15, 2025 | Pc070 Germany Ratiopharm Admissibility Of The EP536Invalidity Claim De | - |
| Sep 15, 2025 | Pc069 Board Of Appeal Of The European Patent Office 4 September T 0799 16 Gb | - |
| Sep 15, 2025 | Pc068 Decision Of The Epo EP536Gb Compressed | - |
| Sep 15, 2025 | Pc067 Emea Points To Consider On The Choice Of Non Interiority Margin Gb | - |
| Sep 15, 2025 | Pc066 Emea 27 July Points To Consider On Switching Betweend Superiority And Non Inferiority Gb | - |
| Sep 15, 2025 | Pc064 Usa Court Of Appeal 10 September Acorda V Roxane Et Al Et 2134 Gb | - |
| Sep 15, 2025 | Pc063 Form 10 K Wikipedia Presentation Gb | - |
| Sep 15, 2025 | Pc062 Cohen Postgraduate Medicine September 1999 Gb | - |
| Sep 15, 2025 | Pc061 L Echelle Edss Expanded Disability Status Scale Fr | - |
| Sep 15, 2025 | Pc060 O Brien Journal Of Hypertension Gb | - |
| Sep 15, 2025 | Pc059 Ellen R Girden Anova Repeated Measures 1992 Gb | - |
| Sep 15, 2025 | Pc058 Federal Court Of Appeal Of Canada 8 August Acorda Therapeutics V Pharmascience Taro Pharmaceuticals A 145 20 | - |
| Sep 15, 2025 | Pc057 Fda Chapter I Food And Drug Administration Department Of Health And Human Services Subchapter D Drugs For Human Us | - |
| Sep 15, 2025 | Pc056 Polman Arch Neur VOL 51 November 1994 Gb | - |
| Sep 15, 2025 | Pc055 Sheiner Clin Pharmacol Ther Volume 46 Number 1 July 1989 Gb | - |
| Sep 15, 2025 | Pc054 Norleans Statistical Methods For Clinical Trials Gb Compressed | - |
| Sep 15, 2025 | Pc053 Excerpt From The Fda Website Drug Evaluation Process Gb | - |
| Sep 15, 2025 | Pc052 Schwid Et Al April Gb | - |
| Sep 15, 2025 | Pc051 Kaufman Al The Significant Change For The Timed 25 Foot Walk In The Multiple Sclerosis Functional Composite M | - |
| Sep 15, 2025 | Pc050 Extract From The National Institutes Of Health Website Fda Drug Review And Approval Gb | - |
| Sep 15, 2025 | Pc049 Ca 2 562 277 Gb | - |
| Sep 15, 2025 | Pc048 US8663685Gb | - |
| Sep 15, 2025 | Pc047 US8440703Gb | - |
| Sep 15, 2025 | Pc046 US8354437Gb | - |
| Sep 15, 2025 | Pc045 Declaration Of Dr Ron Cohen Gb | - |
| Sep 15, 2025 | Pc044 US8007826Gb | - |
| Sep 15, 2025 | Pc043 Goodman Diaporama Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc042 Medical Research Council Mrc Scale For Muscle Strength Gb | - |
| Sep 15, 2025 | Pc041 National Multiple Sclerosis Society Timed 25 Foot Walk T25 Fw Gb | - |
| Sep 15, 2025 | Pc040 Ninds Fatigue Severity Scale Fss Gb | - |
| Sep 15, 2025 | Pc039 Wikipedia Page Edss Gb | - |
| Sep 15, 2025 | Pc038 Goodman Poster Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc037 Supplemental Information Disclosure Statement Gb | - |
| Sep 15, 2025 | Pc036 Actrims Ectrims Final Program Gb Compressed | - |
| Sep 15, 2025 | Pc035 List Of References Ids Gb | - |
| Sep 15, 2025 | Pc034 List Of Documents Requested US11102559Gb | - |
| Sep 15, 2025 | Pc033 Acorda Therapeutics Form S1 Gb | - |
| Sep 15, 2025 | Pc032 Form S 1 Presentation Gb | - |
| Sep 15, 2025 | Pc031 Sec Overview Gb | - |
| Sep 15, 2025 | Pc030 Goodman Abstract Poster Gb | - |
| Sep 15, 2025 | Pc029 Shargel 1999 Applied Biopharmaceutics And Pharmacokinetics Chapter 7 Extraits Pages 169 178 179 Gb Compressed | - |
| Sep 15, 2025 | Pc028 VAN Diemen Et Al 1992 August Gb | - |
| Sep 15, 2025 | Pc027 EP0484186B1 Gb | - |
| Sep 15, 2025 | Pc026 Schwid Et Al 1997 The American Academy Of Neurology Volume 48 Pages 817 821 Gb | - |
| Sep 15, 2025 | Pc025 Bever 1994 The American Neurological Association 1994 Volume 23 Page 118 S121 Gb | - |
| Sep 15, 2025 | Pc024 Bever Et Al 1994 June Neurology 44 1054 1059 Gb | - |
| Sep 15, 2025 | Pc023 Davis Et Al 1990 The American Neurological Association 1990 Pages 186 192 Gb | - |
| Sep 15, 2025 | Pc022 Sherratt Et Al 1980 Nature Volume 283 5745 Pages 570 572 Gb | - |
| Sep 15, 2025 | Pc021 List Of Documents Cited In The Oppositions Gb | - |
| Sep 15, 2025 | Pc020 Merz Acquires Fampyra Gb | - |
| Sep 15, 2025 | Pc019 European Medicines Agency Guidelines Ich Topic E4 November 1994 Gb | - |
| Sep 15, 2025 | Pc018 EP536Oral Proceedings Gb | - |
| Sep 15, 2025 | Pc017 Verhagen Et Al Australian Journal Of Physiotherapy VOL 50 Gb | - |
| Sep 15, 2025 | Pc016 Piece Composite Synthese Wikipiedia Sur L Ecart Type Et La Valeur P Fr | - |
| Sep 15, 2025 | Pc015 Marien Et Beaud Guide Pratique Pour L Utilisation De La Statistique En Recherche Fr | - |
| Sep 15, 2025 | Pc014 Journal De La Societe Statistique De Paris 1956 Fr | - |
| Sep 15, 2025 | Pc013 Ting N Introduction And New Drug Development Process In Ting N Editor Dose Finding In Drug Development Springer Ne | - |
| Sep 15, 2025 | Pc012 Pirmohamed Et Al Bmj Volume 316 25 April 1998 Gb | - |
| Sep 15, 2025 | Pc011 Edwards And Aronson The Lancet VOL 356 October 7 Gb | - |
| Sep 15, 2025 | Pc010 Ich Topic E 8 General Considerations For Clinical Trials 17 July 1997 Gb | - |
| Sep 15, 2025 | Pc009 Griffin Et Al The Textbook Of Pharmaceutical Medicine 1993 Pages 221 222 Gb Compressed | - |
| Sep 15, 2025 | Pc008 Bopi 20 November N 1547 Pp 235 237 Et 258 Fr | - |
| Sep 15, 2025 | Pc007 Decision Et Requete De Delivrance Du Ccp N 13 C0033 Fr | - |
| Sep 15, 2025 | Pc006 Demande De Ccp Sur La Base Du Brevet EP2377536Fr | - |
| Sep 15, 2025 | Pc005 EP2377536B2 Gb | - |
| Sep 15, 2025 | Pc004 Fampyra Smpc Gb | - |
| Sep 15, 2025 | Pc003 Commission Implementing Decision Of 27 September C20246926 Gb | - |
| Sep 15, 2025 | Pc002 Rcp Fampridine Viatris Lp 10Mg Fr | - |
| Sep 15, 2025 | Pc001 Extrait Kbis Viatris Sante Fr | - |
| Sep 15, 2025 | Objection Viatris Sante App 339802025 Compressed Signed | - |
| Sep 11, 2025 | Summon Oral Hearing | - |
| Sep 11, 2025 | Order Summon The Oral Hearing | |
| Aug 18, 2025 | Procedural Order Timetable And Summon Oh | |
| Aug 18, 2025 | Hearing Dates | - |
| Aug 14, 2025 | Panel Appointment | - |
| Aug 7, 2025 | Acknowledgement Of Access To Case | - |
| Aug 6, 2025 | Notification Of Service | - |
| Aug 6, 2025 | Digital Tracking La Poste Service Receipt | - |
| Aug 5, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Notice To Accompany Service Of Order For Measures | - |
| Aug 1, 2025 | Letter For Service | - |
| Aug 1, 2025 | Formal Checks Notification Of Positive Outcome | - |
| Aug 1, 2025 | Exhibit No. 701 Application French Translation | - |
| Aug 1, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Aug 1, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Aug 1, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Aug 1, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Aug 1, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Aug 1, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Aug 1, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Aug 1, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Aug 1, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Aug 1, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Aug 1, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Aug 1, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Aug 1, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Aug 1, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Aug 1, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Aug 1, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Aug 1, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Aug 1, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Aug 1, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Aug 1, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Aug 1, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Aug 1, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Aug 1, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Aug 1, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Aug 1, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Aug 1, 2025 | Exhibit No. 401 Goodman Poster | - |
| Aug 1, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Aug 1, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Aug 1, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Aug 1, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Aug 1, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Aug 1, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Aug 1, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Aug 1, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 208 French Spc Register | - |
| Aug 1, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Aug 1, 2025 | Exhibit No. 206 French Patent Register | - |
| Aug 1, 2025 | Exhibit No. 205 EP536Patent | - |
| Aug 1, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Aug 1, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Aug 1, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Aug 1, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Aug 1, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Aug 1, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Aug 1, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Aug 1, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Aug 1, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Aug 1, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Aug 1, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Aug 1, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Aug 1, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Aug 1, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Aug 1, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Aug 1, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Aug 1, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Aug 1, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Aug 1, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Aug 1, 2025 | Exhibit No. 106 Larocca | - |
| Aug 1, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Aug 1, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Aug 1, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Aug 1, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Aug 1, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Aug 1, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Aug 1, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Aug 1, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Aug 1, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Aug 1, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Aug 1, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Aug 1, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Aug 1, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Aug 1, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Aug 1, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Aug 1, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Aug 1, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Aug 1, 2025 | Application For Provisional Measures | - |
| Aug 1, 2025 | Application For Measures Receipt | - |
| Aug 1, 2025 | Application For Measures Acknowledgement | - |
| Jul 31, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Jul 31, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Jul 31, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Jul 31, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Jul 31, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Jul 31, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Jul 31, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Jul 31, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Jul 31, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Jul 31, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Jul 31, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Jul 31, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Jul 31, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Jul 31, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Jul 31, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Jul 31, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Jul 31, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Jul 31, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Jul 31, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Jul 31, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Jul 31, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Jul 31, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Jul 31, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Jul 31, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Jul 31, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Jul 31, 2025 | Exhibit No. 401 Goodman Poster | - |
| Jul 31, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Jul 31, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Jul 31, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Jul 31, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Jul 31, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Jul 31, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Jul 31, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Jul 31, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 208 French Spc Register | - |
| Jul 31, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Jul 31, 2025 | Exhibit No. 206 French Patent Register | - |
| Jul 31, 2025 | Exhibit No. 205 EP536Patent | - |
| Jul 31, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Jul 31, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Jul 31, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Jul 31, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Jul 31, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Jul 31, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Jul 31, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Jul 31, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Jul 31, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Jul 31, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Jul 31, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Jul 31, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Jul 31, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Jul 31, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Jul 31, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Jul 31, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Jul 31, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Jul 31, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Jul 31, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Jul 31, 2025 | Exhibit No. 106 Larocca | - |
| Jul 31, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Jul 31, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Jul 31, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Jul 31, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Jul 31, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Jul 31, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Jul 31, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Jul 31, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Jul 31, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Jul 31, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Jul 31, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Jul 31, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Jul 31, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Jul 31, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Jul 31, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Jul 31, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Jul 31, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Jul 31, 2025 | Application For Provisional Measures | - |
| Oct 10, 2025 | Action.Communication | - |
| Oct 9, 2025 | Receipt | - |
| Oct 9, 2025 | Proof Of Payment | - |
| Oct 9, 2025 | Other Document | - |
| Oct 9, 2025 | Fee | - |
| Oct 9, 2025 | Cover Sheet | - |
| Oct 9, 2025 | Application | - |
| Oct 7, 2025 | Order | - |
| Oct 7, 2025 | Action.Issueorder | - |
| Oct 6, 2025 | Action.Communication | - |
| Oct 5, 2025 | Receipt | - |
| Oct 5, 2025 | Cover Sheet | - |
| Oct 5, 2025 | Application | - |
| Oct 2, 2025 | Receipt | - |
| Oct 2, 2025 | Order | - |
| Oct 2, 2025 | Cover Sheet | - |
| Oct 2, 2025 | Application | - |
| Oct 2, 2025 | Action.Issueorder | - |
| Oct 1, 2025 | Statement Of Reply | - |
| Oct 1, 2025 | Receipt | - |
| Oct 1, 2025 | Exhibit | - |
| Oct 1, 2025 | Cover Sheet | - |
| Oct 1, 2025 | Application | - |
| Sep 26, 2025 | Action.Communication | - |
| Sep 25, 2025 | Receipt | - |
| Sep 25, 2025 | Other Document | - |
| Sep 25, 2025 | Exhibit | - |
| Sep 25, 2025 | Cover Sheet | - |
| Sep 25, 2025 | Action.Communication | - |
| Sep 24, 2025 | Order | - |
| Sep 24, 2025 | Action.Issueorder | - |
| Sep 18, 2025 | Request V.Def Pdf A Signed | - |
| Sep 18, 2025 | Receipt | - |
| Sep 18, 2025 | Pc154 Iqvia Agreement Gb | - |
| Sep 18, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 17, 2025 | Receipt | - |
| Sep 17, 2025 | Procedural Order | |
| Sep 17, 2025 | Outcome Of The Order | - |
| Sep 17, 2025 | Headnote And Keywords | - |
| Sep 16, 2025 | Request For Procedural Order | - |
| Sep 16, 2025 | Receipt | - |
| Sep 16, 2025 | Objection | - |
| Sep 15, 2025 | Pj087 Regulation N 469 Gb | - |
| Sep 15, 2025 | Pj086 Court Of Appeal 10X Genomics Harvard V Nanostring Upc Coa 3352023 Gb | - |
| Sep 15, 2025 | Pj085 Dmf Nl Court Of The Hague 1Ere Instance Nl | - |
| Sep 15, 2025 | Pj084 Dmf Be Cour Dappel De Bruxelles Appel Nl | - |
| Sep 15, 2025 | Pj083 Fingolimod De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj082 Phosphodiesterase Nl Appeal Court Of The Hague Appel Nl | - |
| Sep 15, 2025 | Pj081 Dmf De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj080 Munich Local Division 21 May Upccfi432023 De | - |
| Sep 15, 2025 | Pj079 Ca Paris 9 July N2407962 Fr | - |
| Sep 15, 2025 | Pj078 Case Law Of The Boards Of Appeal Id108 Gb | - |
| Sep 15, 2025 | Pj077 Bonnes Pratiques De Distribution Ansm Bulletin Officiel N20149Bis Fr | - |
| Sep 15, 2025 | Pj076 Upc Court Of Appeal 25 September Upccoa1822024 Gb | - |
| Sep 15, 2025 | Pj075 Guidelines For Examination In The European Patent Office Gvii4Gb | - |
| Sep 15, 2025 | Pj074 Decision De La Chambre De Recours De Loeb DU 4 October T 111003 Gb | - |
| Sep 15, 2025 | Pj073 Epo Boa 10 July Eisai V Stada Lenvatinib T 193423 Gb | - |
| Sep 15, 2025 | Pj072 Hamburg Local Division 3 June Upccfi1512024 Gb | - |
| Sep 15, 2025 | Pj071 Dusseldorf Local Division 30 April Upccfi4632023 Gb | - |
| Sep 15, 2025 | Pj070 Dusseldorf Local Division 9 April Upccfi4522023 De | - |
| Sep 15, 2025 | Pj069 Dusseldorf Local Division VALEO V Magna Upc Cfi 3682024 Gb | - |
| Sep 15, 2025 | Pj068 Court Of Appeal Biolitec V Light Guide Optics Sia Lightguide 24 February Upccoa5402024 Gb | - |
| Sep 15, 2025 | Pj067 Ld Munich 15 November Upc Cfi 152023 Gb | - |
| Sep 15, 2025 | Pj065 Cjeu 28 July Synthon C Mertz Memantine C19509 Gb | - |
| Sep 15, 2025 | Pj064 Cjeu 28 July Generics Uk C Synaptech Galantamine C42709 Gb | - |
| Sep 15, 2025 | Pj063 Cass Com 10 February N1320150 Fr | - |
| Sep 15, 2025 | Pj062 Directive 200448CE Gb | - |
| Sep 15, 2025 | Pj061 Neurim Mylan High Court Of Justice 3 June Ewhc 1362 Gb | - |
| Sep 15, 2025 | Pj060 Decision De La Chambre De Recours De Loeb 13 September T023916 Gb | - |
| Sep 15, 2025 | Pj059 Decision De La Chambre De Recours De Loeb 4 October T250612 Gb | - |
| Sep 15, 2025 | Pj058 Tj Paris Refere 17 June Rg 2153849 Cabazitaxel Sanofi C Ever Pharma Fr | - |
| Sep 15, 2025 | Pj057 Tj Paris 12 May Rg 2153136 Cabazitaxel Sanofi C Teva Fr | - |
| Sep 15, 2025 | Pj056 Santen C 673 18 Gb | - |
| Sep 15, 2025 | Pj055 Tgi Paris 22 September 1407707 Fr | - |
| Sep 15, 2025 | Pj054 Cour Dappel De Paris 14 February 1991 Newtec International C Sfeima Pibd N504 Iiii432 Fr | - |
| Sep 15, 2025 | Pj053 Cour De Cassation 20 November Pourvoi N 1118440 Fr | - |
| Sep 15, 2025 | Pj052 Tgi Paris 6 June Rg N1606916 Fr | - |
| Sep 15, 2025 | Pj051 Tgi Rennes 2 September Rg N9803029 Fr | - |
| Sep 15, 2025 | Pj050 Decision De La Chambre De Recours 3306 De Loeb 30 May T 16596 Fr | - |
| Sep 15, 2025 | Pj049 Decision De La Chambre De Recours 3502 De Loeb 29 October T 33515 Fr | - |
| Sep 15, 2025 | Pj048 Decision De La Chambre De Recours De Loeb 10 November 1988 T038187 Gb | - |
| Sep 15, 2025 | Pj047 Tj Paris 22 June Rg N2002792 Fr | - |
| Sep 15, 2025 | Pj046 Decision De La Chambre De Recours De Loeb 20 September T197909 Gb | - |
| Sep 15, 2025 | Pj045 Decision De La Chambre De Recours De Loeb 1Er April T 140906 Gb | - |
| Sep 15, 2025 | Pj044 Decision De La Chambre De Recours De Loeb DU 28 January T 023715 Gb | - |
| Sep 15, 2025 | Pj043 Basf C25899 Gb | - |
| Sep 15, 2025 | Pj042 Gsk C21013 14 Nov Gb | - |
| Sep 15, 2025 | Pj041 Ca Paris 14 February Rg 1903820 Sandoz C Msd Fr | - |
| Sep 15, 2025 | Pj040 Abraxis C 443 17 21 March Gb | - |
| Sep 15, 2025 | Pj039 Case Law Of The Boards Of Appeal Of The Epo I D74 Try And See Solution Gb | - |
| Sep 15, 2025 | Pj038 Tj Paris 20 January Rg N 1901997 Fr | - |
| Sep 15, 2025 | Pj037 Tj Paris 6 September Rg N2106416 Fr | - |
| Sep 15, 2025 | Pj036 Tj Paris 7 June Rg 2153474 Sanofi C Accord Cabazitaxel Fr | - |
| Sep 15, 2025 | Pj035 Ca Paris 29 October Etypharm C Merck Rg N1803876 Fr | - |
| Sep 15, 2025 | Pj034 Cour Dappel De Paris 18 December Rg N 1710112 Fr | - |
| Sep 15, 2025 | Pj033 Decision De La Chambre De Recours De Loeb 25 July T 025915 Gb | - |
| Sep 15, 2025 | Pj032 Decision De La Chambre De Recours De Loeb 29 May T 009198 Gb | - |
| Sep 15, 2025 | Pj031 Decision De La Chambre De Recours De Loeb 5 October T 33397 Gb | - |
| Sep 15, 2025 | Pj030 Decision De La Chambre De Recours De Loeb 6 October T 91801 Gb | - |
| Sep 15, 2025 | Pj029 Decision De La Chambre De Recours De Loeb 14 February 1989 T 24988 Gb | - |
| Sep 15, 2025 | Pj028 Case Law Of The Boards Of Appeal Of The Epo Id71 Reasonable Expectation Of Success Gb | - |
| Sep 15, 2025 | Pj027 Jurisprudences Francaises Essais De Routine Fr | - |
| Sep 15, 2025 | Pj026 Tgi Paris 7 May Hexal C Boehringer Rg 0812537 Fr | - |
| Sep 15, 2025 | Pj025 Jub Division Centrale De Munich 16 July Sanofi C Amgen Upccfi 12023 Gb | - |
| Sep 15, 2025 | Pj024 Jub Cour Dappel 26 February Nanostring C 10X Genomics Upccoa3352023 Gb | - |
| Sep 15, 2025 | Pj023 Decision De La Chambre De Recours 332 De L Oeb 26 February T 92600 Gb | - |
| Sep 15, 2025 | Pj022 Decision De La Chambre De Recours 332 De Loeb 2 June T 30899 Gb | - |
| Sep 15, 2025 | Pj021 Decision De La Chambre De Recours 352 De Loeb 22 October 1993 T 25392 Gb | - |
| Sep 15, 2025 | Pj020 Decision De La Chambre De Recours 332 De Loeb 13 July T 393 01 Gb | - |
| Sep 15, 2025 | Pj019 Ca Paris 19 January Rg 18 21115 Fr | - |
| Sep 15, 2025 | Pj018 Tj Paris 20 July Rg N 21 10327 Fr | - |
| Sep 15, 2025 | Pj017 Ca Paris 14 November Rg N 1502576 Fr | - |
| Sep 15, 2025 | Pj016 Tj Paris 28 March Rg 2208612 Fr | - |
| Sep 15, 2025 | Pj014 Upc Court Of Appeal 13 August Upccoa4462025 Gb | - |
| Sep 15, 2025 | Pj013 Tj Paris 18 June Rg N 23 02356 Fr | - |
| Sep 15, 2025 | Pj012 Munich Local Division 27 August Upccfi2012024 Gb | - |
| Sep 15, 2025 | Pj011 Tj Paris 27 July Rg N 22 54367 Fr | - |
| Sep 15, 2025 | Pj010 Guidelines For Examination Of The Epo Giv1 Gb | - |
| Sep 15, 2025 | Pj009 Ca Paris 25 May Rg 21 18398 Fr | - |
| Sep 15, 2025 | Pj008 Tj Paris 29 September Rg 21 55930 Fr | - |
| Sep 15, 2025 | Pj007 Tj Paris Ordonnance De Refere 6 October Rg 22 55799 Biogen C Viatris Dmf Fr | - |
| Sep 15, 2025 | Pj006 Cjeu 16 July Genmab V Hungarian Ip Office Spc C 181 24 Gb | - |
| Sep 15, 2025 | Pj005 Accord Cadre Leem Ceps 5 March Fr | - |
| Sep 15, 2025 | Pj004 Regulation No 1768 92 Gb | - |
| Sep 15, 2025 | Pj003 Tj Paris Ordonnance Viatris C Novartis 04 August Fingolimod Rg N 2254655 Fr | - |
| Sep 15, 2025 | Pj002 Ca Paris 14 February Rg 1906114 Fr | - |
| Sep 15, 2025 | Pj001 Decision Du Conseil Constitutionnel N 463 Dc DU 12 December Fr | - |
| Sep 15, 2025 | Pc152 Submissions In High Resolution Gb | - |
| Sep 15, 2025 | Pc151 Declaration Dawid Sierzant DU 15 September Et Annexes Gb | - |
| Sep 15, 2025 | Pc150 4 Aminopyridine C5H6N2 Cid 1727 Pubchem Gb | - |
| Sep 15, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 15, 2025 | Pc148 The Fixing Of The Price And Reimboursement Rate Sante Gouv Fr | - |
| Sep 15, 2025 | Pc146 Letter From Viatris To Mez DATED 2 July Gb | - |
| Sep 15, 2025 | Pc145 Letter From Viatris To Merz Of 10 July Fr | - |
| Sep 15, 2025 | Pc143 Chapter 33 Pymadin Paskov Et Al 1986 Gb | - |
| Sep 15, 2025 | Pc142 Kostadinova And Danchev Gb | - |
| Sep 15, 2025 | Pc141 Sartori Et Al 1994 Gb | - |
| Sep 15, 2025 | Pc140 Olg Munchen Acorda Therapeutics V Ratiopharm 6 October 6 U 3044 22 De | - |
| Sep 15, 2025 | Pc139 Upsto Trademark Status Document Retrieval Pymadin Sopharma Gb | - |
| Sep 15, 2025 | Pc138 Website Of The Faculty Of Medicine In Sofia Bg | - |
| Sep 15, 2025 | Pc137 They Are Looking For A Superpill For Alzheimers Technologies News Standard Bg | - |
| Sep 15, 2025 | Pc136 Russian State Archive Of Scientific And Technical Documentation Ru | - |
| Sep 15, 2025 | Pc135 Communication Between The Ceps And Viatris Fr | - |
| Sep 15, 2025 | Pc134 Patient Leaflet Pymadin Bg | - |
| Sep 15, 2025 | Pc133 Smpc Pymadin Bg | - |
| Sep 15, 2025 | Pc132 Free State Gazette Edition 33 Of 2Iv Unofficial Section Ru | - |
| Sep 15, 2025 | Pc131 Disaster Protection Plan Burgas Region Republic Of Bulgaria Bg | - |
| Sep 15, 2025 | Pc130 4 Aminopiridin Spinal Cord Injury Forum Ru Compressed | - |
| Sep 15, 2025 | Pc129 Iqvia About Us Gb | - |
| Sep 15, 2025 | Pc128 Adverse Exhibit No 503 Toumi Et Al External Reference Pricing Simulation Gb | - |
| Sep 15, 2025 | Pc122 Application For Provisional Measures Gb | - |
| Sep 15, 2025 | Pc121 Acorda V Alkem Trial Transcript Volume B Gb | - |
| Sep 15, 2025 | Pc120 Acorda V Alkem Trial Transcript Volume A Gb | - |
| Sep 15, 2025 | Pc119 Hamilton Et Al 1998 Olanzapine Versus Placebo And Haloperidol Quality Of Life And Efficacy Results On The North Am | - |
| Sep 15, 2025 | Pc118 Overall 1994 Journal Of Clinical Psychology VOL 50 Pages 95 102 Gb | - |
| Sep 15, 2025 | Pc117 Alhainen Et Al 1991 Discrimination Of Tetrahydroaminoacridine Responders By A Single Dose Pharmaco Eeg In Patients | - |
| Sep 15, 2025 | Pc116 Sas Library 1997 Repeated Measures Anova Using Sas Proc Glm Gb | - |
| Sep 15, 2025 | Pc115 Sheeber Et Al 1996 Data Analytic Techniques For Treatment Outcome Studies With Pretest Posttest Measurements An Ex | - |
| Sep 15, 2025 | Pc114 Cook Et Al 1983 Design And Analysis Methods For Longitudinal Research Ann Rev Public Health Gb | - |
| Sep 15, 2025 | Pc113 Vickers Hor Many Repeated Measures In Repeates Measures Designs Statistical Issues For Comparative Trials Bmc | - |
| Sep 15, 2025 | Pc112 Uryniak Et Al Responder Analyses A Phrma Position Paper Statistics In Biopharmaceutical Research VOL 3 N3 Gb | - |
| Sep 15, 2025 | Pc111 Schulz Et Al The Efficacy Of Quetiapine VS Haloperidol And Placebo A Meta Analytic Study Of Efficacy Schizopp | - |
| Sep 15, 2025 | Pc110 Temple 1994 Commun Stat Theory Meth VOL 23 Pages 449 521 Gb | - |
| Sep 15, 2025 | Pc109 Lewis Statistics In Medicine VOL 21 Pages 2931 2938 Gb | - |
| Sep 15, 2025 | Pc108 Weiner 1998 Can J Neurol Sci VOL 25 Pages 93101 Gb | - |
| Sep 15, 2025 | Pc107 Petkau 1998 Seminars In Neurology VOL 18 3 Gb | - |
| Sep 15, 2025 | Pc106 Leber Et DAVIS 1998 Threats To The Validity Of Clinical Trials Employing Enrichment Strategies For Sample Selectio | - |
| Sep 15, 2025 | Pc105 DTX 584 Gb | - |
| Sep 15, 2025 | Pc104 4 Aminopyridine Induces Functional Improvement In Multiple Sclerosis Patients A Neurophysiological Study Gb | - |
| Sep 15, 2025 | Pc103 Stefoski Et Al 1991 4 Aminopyridine In Multiple Sclerosis Prolonged Administration Neurology 1991 Gb | - |
| Sep 15, 2025 | Pc102 Clinical Studies In 20 Questions Atelier Presse Clinical Trials Leem 19 May Fr | - |
| Sep 15, 2025 | Pc101 Report By Dr Christian Wolf DATED 2 September Gb | - |
| Sep 15, 2025 | Pc100 EP1732548B9 Gb | - |
| Sep 15, 2025 | Pc099 Matusik Therapy Nutrients 14 4249 Gb | - |
| Sep 15, 2025 | Pc098 Le Progres Article Patients Deprived Of A Medication Due To A Change Of Packaging 26 June Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 2 2 Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 1 2 Fr | - |
| Sep 15, 2025 | Pc096 Kehl Responder Identification In Clinical Trials June Gb | - |
| Sep 15, 2025 | Pc095 CPMP Points To Consider Multiplicity Issues Clinical Trials Gb | - |
| Sep 15, 2025 | Pc094 Hayes Et Al Pharmacokinetic Studies Of Single And Multiple Oral Doses Of Fampridine VOL 26 N4 Pp 185 192 Gb | - |
| Sep 15, 2025 | Pc093 Hayes Et Al Pharmacokinetics Of An Immediate Release Oral Formulation Of Fampridine 4 Aminopyridine In Normal | - |
| Sep 15, 2025 | Pc092 July 1986 Comment Determiner La Posologie Optimale D Un Medicament Fr | - |
| Sep 15, 2025 | Pc091 Dose Ranging Study Wikipedia Gb | - |
| Sep 15, 2025 | Pc090 Rnb Ccp 033 Fr | - |
| Sep 15, 2025 | Pc089 Rnb EP536Fr | - |
| Sep 15, 2025 | Pc088 Chmp 1999 Clinical Investigation Of Medicinal Products In The Treatment Of Parkinson S Disease CPMP Note For Guida | - |
| Sep 15, 2025 | Pc087 Ccne Opinion 79 Transposition Into French Law Of The European Directive On Clinical Trials Of Medicinal Products F | - |
| Sep 15, 2025 | Pc086 Declaration Of Helsinki Ethical Principles For Medical Research Involving Human Subjects Gb | - |
| Sep 15, 2025 | Pc085 Nuremberg Code Gb | - |
| Sep 15, 2025 | Pc084 Afsep Press Release Of 28 May Fr | - |
| Sep 15, 2025 | Pc083 Barus Et Al Fr | - |
| Sep 15, 2025 | Pc082 Extrait De La Base De Donnees Publique Des Medicaments Fampridine Viatris 10 Mg Fr | - |
| Sep 15, 2025 | Pc081 Icht Topic 9 Guideline On Statistical Principles For Clinical Trials September 1998 Gb | - |
| Sep 15, 2025 | Pc080 Website Of The Foundation For Research Into Multiple Sclerosis Fr | - |
| Sep 15, 2025 | Pc079 Notice On The Prices Of Fampridine Pharmaceutical Specialities Fr | - |
| Sep 15, 2025 | Pc078 Info Sheet Fampyra 10Mg Sustained Release Tablet Fr | - |
| Sep 15, 2025 | Pc077 Accession Of Bulgaria Gb | - |
| Sep 15, 2025 | Pc076 Kehl Responder Identification In Clinical Trials With Censored Data Gb | - |
| Sep 15, 2025 | Pc075 Federal Court Of Canada 15 May Acorda V Pharmascience And Taro T 1416 18 And T 220 19 Gb | - |
| Sep 15, 2025 | Pc074 Usa Delaware District Court 25 April Acorda V Teva Roxane Mylan 14 882 Gb | - |
| Sep 15, 2025 | Pc073 Usa Delaware District Court 31 March Acorda V Roxane 14 882 Lps Gb | - |
| Sep 15, 2025 | Pc072 Germany Teva Revocation Of Patent EP548De | - |
| Sep 15, 2025 | Pc071 Germany Ratiopharm Revocation Of Patent EP536De | - |
| Sep 15, 2025 | Pc070 Germany Ratiopharm Admissibility Of The EP536Invalidity Claim De | - |
| Sep 15, 2025 | Pc069 Board Of Appeal Of The European Patent Office 4 September T 0799 16 Gb | - |
| Sep 15, 2025 | Pc068 Decision Of The Epo EP536Gb Compressed | - |
| Sep 15, 2025 | Pc067 Emea Points To Consider On The Choice Of Non Interiority Margin Gb | - |
| Sep 15, 2025 | Pc066 Emea 27 July Points To Consider On Switching Betweend Superiority And Non Inferiority Gb | - |
| Sep 15, 2025 | Pc064 Usa Court Of Appeal 10 September Acorda V Roxane Et Al Et 2134 Gb | - |
| Sep 15, 2025 | Pc063 Form 10 K Wikipedia Presentation Gb | - |
| Sep 15, 2025 | Pc062 Cohen Postgraduate Medicine September 1999 Gb | - |
| Sep 15, 2025 | Pc061 L Echelle Edss Expanded Disability Status Scale Fr | - |
| Sep 15, 2025 | Pc060 O Brien Journal Of Hypertension Gb | - |
| Sep 15, 2025 | Pc059 Ellen R Girden Anova Repeated Measures 1992 Gb | - |
| Sep 15, 2025 | Pc058 Federal Court Of Appeal Of Canada 8 August Acorda Therapeutics V Pharmascience Taro Pharmaceuticals A 145 20 | - |
| Sep 15, 2025 | Pc057 Fda Chapter I Food And Drug Administration Department Of Health And Human Services Subchapter D Drugs For Human Us | - |
| Sep 15, 2025 | Pc056 Polman Arch Neur VOL 51 November 1994 Gb | - |
| Sep 15, 2025 | Pc055 Sheiner Clin Pharmacol Ther Volume 46 Number 1 July 1989 Gb | - |
| Sep 15, 2025 | Pc054 Norleans Statistical Methods For Clinical Trials Gb Compressed | - |
| Sep 15, 2025 | Pc053 Excerpt From The Fda Website Drug Evaluation Process Gb | - |
| Sep 15, 2025 | Pc052 Schwid Et Al April Gb | - |
| Sep 15, 2025 | Pc051 Kaufman Al The Significant Change For The Timed 25 Foot Walk In The Multiple Sclerosis Functional Composite M | - |
| Sep 15, 2025 | Pc050 Extract From The National Institutes Of Health Website Fda Drug Review And Approval Gb | - |
| Sep 15, 2025 | Pc049 Ca 2 562 277 Gb | - |
| Sep 15, 2025 | Pc048 US8663685Gb | - |
| Sep 15, 2025 | Pc047 US8440703Gb | - |
| Sep 15, 2025 | Pc046 US8354437Gb | - |
| Sep 15, 2025 | Pc045 Declaration Of Dr Ron Cohen Gb | - |
| Sep 15, 2025 | Pc044 US8007826Gb | - |
| Sep 15, 2025 | Pc043 Goodman Diaporama Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc042 Medical Research Council Mrc Scale For Muscle Strength Gb | - |
| Sep 15, 2025 | Pc041 National Multiple Sclerosis Society Timed 25 Foot Walk T25 Fw Gb | - |
| Sep 15, 2025 | Pc040 Ninds Fatigue Severity Scale Fss Gb | - |
| Sep 15, 2025 | Pc039 Wikipedia Page Edss Gb | - |
| Sep 15, 2025 | Pc038 Goodman Poster Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc037 Supplemental Information Disclosure Statement Gb | - |
| Sep 15, 2025 | Pc036 Actrims Ectrims Final Program Gb Compressed | - |
| Sep 15, 2025 | Pc035 List Of References Ids Gb | - |
| Sep 15, 2025 | Pc034 List Of Documents Requested US11102559Gb | - |
| Sep 15, 2025 | Pc033 Acorda Therapeutics Form S1 Gb | - |
| Sep 15, 2025 | Pc032 Form S 1 Presentation Gb | - |
| Sep 15, 2025 | Pc031 Sec Overview Gb | - |
| Sep 15, 2025 | Pc030 Goodman Abstract Poster Gb | - |
| Sep 15, 2025 | Pc029 Shargel 1999 Applied Biopharmaceutics And Pharmacokinetics Chapter 7 Extraits Pages 169 178 179 Gb Compressed | - |
| Sep 15, 2025 | Pc028 VAN Diemen Et Al 1992 August Gb | - |
| Sep 15, 2025 | Pc027 EP0484186B1 Gb | - |
| Sep 15, 2025 | Pc026 Schwid Et Al 1997 The American Academy Of Neurology Volume 48 Pages 817 821 Gb | - |
| Sep 15, 2025 | Pc025 Bever 1994 The American Neurological Association 1994 Volume 23 Page 118 S121 Gb | - |
| Sep 15, 2025 | Pc024 Bever Et Al 1994 June Neurology 44 1054 1059 Gb | - |
| Sep 15, 2025 | Pc023 Davis Et Al 1990 The American Neurological Association 1990 Pages 186 192 Gb | - |
| Sep 15, 2025 | Pc022 Sherratt Et Al 1980 Nature Volume 283 5745 Pages 570 572 Gb | - |
| Sep 15, 2025 | Pc021 List Of Documents Cited In The Oppositions Gb | - |
| Sep 15, 2025 | Pc020 Merz Acquires Fampyra Gb | - |
| Sep 15, 2025 | Pc019 European Medicines Agency Guidelines Ich Topic E4 November 1994 Gb | - |
| Sep 15, 2025 | Pc018 EP536Oral Proceedings Gb | - |
| Sep 15, 2025 | Pc017 Verhagen Et Al Australian Journal Of Physiotherapy VOL 50 Gb | - |
| Sep 15, 2025 | Pc016 Piece Composite Synthese Wikipiedia Sur L Ecart Type Et La Valeur P Fr | - |
| Sep 15, 2025 | Pc015 Marien Et Beaud Guide Pratique Pour L Utilisation De La Statistique En Recherche Fr | - |
| Sep 15, 2025 | Pc014 Journal De La Societe Statistique De Paris 1956 Fr | - |
| Sep 15, 2025 | Pc013 Ting N Introduction And New Drug Development Process In Ting N Editor Dose Finding In Drug Development Springer Ne | - |
| Sep 15, 2025 | Pc012 Pirmohamed Et Al Bmj Volume 316 25 April 1998 Gb | - |
| Sep 15, 2025 | Pc011 Edwards And Aronson The Lancet VOL 356 October 7 Gb | - |
| Sep 15, 2025 | Pc010 Ich Topic E 8 General Considerations For Clinical Trials 17 July 1997 Gb | - |
| Sep 15, 2025 | Pc009 Griffin Et Al The Textbook Of Pharmaceutical Medicine 1993 Pages 221 222 Gb Compressed | - |
| Sep 15, 2025 | Pc008 Bopi 20 November N 1547 Pp 235 237 Et 258 Fr | - |
| Sep 15, 2025 | Pc007 Decision Et Requete De Delivrance Du Ccp N 13 C0033 Fr | - |
| Sep 15, 2025 | Pc006 Demande De Ccp Sur La Base Du Brevet EP2377536Fr | - |
| Sep 15, 2025 | Pc005 EP2377536B2 Gb | - |
| Sep 15, 2025 | Pc004 Fampyra Smpc Gb | - |
| Sep 15, 2025 | Pc003 Commission Implementing Decision Of 27 September C20246926 Gb | - |
| Sep 15, 2025 | Pc002 Rcp Fampridine Viatris Lp 10Mg Fr | - |
| Sep 15, 2025 | Pc001 Extrait Kbis Viatris Sante Fr | - |
| Sep 15, 2025 | Objection Viatris Sante App 339802025 Compressed Signed | - |
| Sep 11, 2025 | Summon Oral Hearing | - |
| Sep 11, 2025 | Order Summon The Oral Hearing | |
| Aug 18, 2025 | Procedural Order Timetable And Summon Oh | |
| Aug 18, 2025 | Hearing Dates | - |
| Aug 14, 2025 | Panel Appointment | - |
| Aug 7, 2025 | Acknowledgement Of Access To Case | - |
| Aug 6, 2025 | Notification Of Service | - |
| Aug 6, 2025 | Digital Tracking La Poste Service Receipt | - |
| Aug 5, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Notice To Accompany Service Of Order For Measures | - |
| Aug 1, 2025 | Letter For Service | - |
| Aug 1, 2025 | Formal Checks Notification Of Positive Outcome | - |
| Aug 1, 2025 | Exhibit No. 701 Application French Translation | - |
| Aug 1, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Aug 1, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Aug 1, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Aug 1, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Aug 1, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Aug 1, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Aug 1, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Aug 1, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Aug 1, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Aug 1, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Aug 1, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Aug 1, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Aug 1, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Aug 1, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Aug 1, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Aug 1, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Aug 1, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Aug 1, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Aug 1, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Aug 1, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Aug 1, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Aug 1, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Aug 1, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Aug 1, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Aug 1, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Aug 1, 2025 | Exhibit No. 401 Goodman Poster | - |
| Aug 1, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Aug 1, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Aug 1, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Aug 1, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Aug 1, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Aug 1, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Aug 1, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Aug 1, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 208 French Spc Register | - |
| Aug 1, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Aug 1, 2025 | Exhibit No. 206 French Patent Register | - |
| Aug 1, 2025 | Exhibit No. 205 EP536Patent | - |
| Aug 1, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Aug 1, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Aug 1, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Aug 1, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Aug 1, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Aug 1, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Aug 1, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Aug 1, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Aug 1, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Aug 1, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Aug 1, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Aug 1, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Aug 1, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Aug 1, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Aug 1, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Aug 1, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Aug 1, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Aug 1, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Aug 1, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Aug 1, 2025 | Exhibit No. 106 Larocca | - |
| Aug 1, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Aug 1, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Aug 1, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Aug 1, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Aug 1, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Aug 1, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Aug 1, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Aug 1, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Aug 1, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Aug 1, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Aug 1, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Aug 1, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Aug 1, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Aug 1, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Aug 1, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Aug 1, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Aug 1, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Aug 1, 2025 | Application For Provisional Measures | - |
| Aug 1, 2025 | Application For Measures Receipt | - |
| Aug 1, 2025 | Application For Measures Acknowledgement | - |
| Jul 31, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Jul 31, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Jul 31, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Jul 31, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Jul 31, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Jul 31, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Jul 31, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Jul 31, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Jul 31, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Jul 31, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Jul 31, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Jul 31, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Jul 31, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Jul 31, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Jul 31, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Jul 31, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Jul 31, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Jul 31, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Jul 31, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Jul 31, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Jul 31, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Jul 31, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Jul 31, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Jul 31, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Jul 31, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Jul 31, 2025 | Exhibit No. 401 Goodman Poster | - |
| Jul 31, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Jul 31, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Jul 31, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Jul 31, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Jul 31, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Jul 31, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Jul 31, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Jul 31, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 208 French Spc Register | - |
| Jul 31, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Jul 31, 2025 | Exhibit No. 206 French Patent Register | - |
| Jul 31, 2025 | Exhibit No. 205 EP536Patent | - |
| Jul 31, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Jul 31, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Jul 31, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Jul 31, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Jul 31, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Jul 31, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Jul 31, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Jul 31, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Jul 31, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Jul 31, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Jul 31, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Jul 31, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Jul 31, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Jul 31, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Jul 31, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Jul 31, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Jul 31, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Jul 31, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Jul 31, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Jul 31, 2025 | Exhibit No. 106 Larocca | - |
| Jul 31, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Jul 31, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Jul 31, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Jul 31, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Jul 31, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Jul 31, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Jul 31, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Jul 31, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Jul 31, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Jul 31, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Jul 31, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Jul 31, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Jul 31, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Jul 31, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Jul 31, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Jul 31, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Jul 31, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Jul 31, 2025 | Application For Provisional Measures | - |
| Oct 10, 2025 | Action.Communication | - |
| Oct 9, 2025 | Receipt | - |
| Oct 9, 2025 | Proof Of Payment | - |
| Oct 9, 2025 | Other Document | - |
| Oct 9, 2025 | Fee | - |
| Oct 9, 2025 | Cover Sheet | - |
| Oct 9, 2025 | Application | - |
| Oct 7, 2025 | Order | - |
| Oct 7, 2025 | Action.Issueorder | - |
| Oct 6, 2025 | Action.Communication | - |
| Oct 5, 2025 | Receipt | - |
| Oct 5, 2025 | Cover Sheet | - |
| Oct 5, 2025 | Application | - |
| Oct 2, 2025 | Receipt | - |
| Oct 2, 2025 | Order | - |
| Oct 2, 2025 | Cover Sheet | - |
| Oct 2, 2025 | Application | - |
| Oct 2, 2025 | Action.Issueorder | - |
| Oct 1, 2025 | Statement Of Reply | - |
| Oct 1, 2025 | Receipt | - |
| Oct 1, 2025 | Exhibit | - |
| Oct 1, 2025 | Cover Sheet | - |
| Oct 1, 2025 | Application | - |
| Sep 26, 2025 | Action.Communication | - |
| Sep 25, 2025 | Receipt | - |
| Sep 25, 2025 | Other Document | - |
| Sep 25, 2025 | Exhibit | - |
| Sep 25, 2025 | Cover Sheet | - |
| Sep 25, 2025 | Action.Communication | - |
| Sep 24, 2025 | Order | - |
| Sep 24, 2025 | Action.Issueorder | - |
| Sep 18, 2025 | Request V.Def Pdf A Signed | - |
| Sep 18, 2025 | Receipt | - |
| Sep 18, 2025 | Pc154 Iqvia Agreement Gb | - |
| Sep 18, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 17, 2025 | Receipt | - |
| Sep 17, 2025 | Procedural Order | |
| Sep 17, 2025 | Outcome Of The Order | - |
| Sep 17, 2025 | Headnote And Keywords | - |
| Sep 16, 2025 | Request For Procedural Order | - |
| Sep 16, 2025 | Receipt | - |
| Sep 16, 2025 | Objection | - |
| Sep 15, 2025 | Pj087 Regulation N 469 Gb | - |
| Sep 15, 2025 | Pj086 Court Of Appeal 10X Genomics Harvard V Nanostring Upc Coa 3352023 Gb | - |
| Sep 15, 2025 | Pj085 Dmf Nl Court Of The Hague 1Ere Instance Nl | - |
| Sep 15, 2025 | Pj084 Dmf Be Cour Dappel De Bruxelles Appel Nl | - |
| Sep 15, 2025 | Pj083 Fingolimod De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj082 Phosphodiesterase Nl Appeal Court Of The Hague Appel Nl | - |
| Sep 15, 2025 | Pj081 Dmf De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj080 Munich Local Division 21 May Upccfi432023 De | - |
| Sep 15, 2025 | Pj079 Ca Paris 9 July N2407962 Fr | - |
| Sep 15, 2025 | Pj078 Case Law Of The Boards Of Appeal Id108 Gb | - |
| Sep 15, 2025 | Pj077 Bonnes Pratiques De Distribution Ansm Bulletin Officiel N20149Bis Fr | - |
| Sep 15, 2025 | Pj076 Upc Court Of Appeal 25 September Upccoa1822024 Gb | - |
| Sep 15, 2025 | Pj075 Guidelines For Examination In The European Patent Office Gvii4Gb | - |
| Sep 15, 2025 | Pj074 Decision De La Chambre De Recours De Loeb DU 4 October T 111003 Gb | - |
| Sep 15, 2025 | Pj073 Epo Boa 10 July Eisai V Stada Lenvatinib T 193423 Gb | - |
| Sep 15, 2025 | Pj072 Hamburg Local Division 3 June Upccfi1512024 Gb | - |
| Sep 15, 2025 | Pj071 Dusseldorf Local Division 30 April Upccfi4632023 Gb | - |
| Sep 15, 2025 | Pj070 Dusseldorf Local Division 9 April Upccfi4522023 De | - |
| Sep 15, 2025 | Pj069 Dusseldorf Local Division VALEO V Magna Upc Cfi 3682024 Gb | - |
| Sep 15, 2025 | Pj068 Court Of Appeal Biolitec V Light Guide Optics Sia Lightguide 24 February Upccoa5402024 Gb | - |
| Sep 15, 2025 | Pj067 Ld Munich 15 November Upc Cfi 152023 Gb | - |
| Sep 15, 2025 | Pj065 Cjeu 28 July Synthon C Mertz Memantine C19509 Gb | - |
| Sep 15, 2025 | Pj064 Cjeu 28 July Generics Uk C Synaptech Galantamine C42709 Gb | - |
| Sep 15, 2025 | Pj063 Cass Com 10 February N1320150 Fr | - |
| Sep 15, 2025 | Pj062 Directive 200448CE Gb | - |
| Sep 15, 2025 | Pj061 Neurim Mylan High Court Of Justice 3 June Ewhc 1362 Gb | - |
| Sep 15, 2025 | Pj060 Decision De La Chambre De Recours De Loeb 13 September T023916 Gb | - |
| Sep 15, 2025 | Pj059 Decision De La Chambre De Recours De Loeb 4 October T250612 Gb | - |
| Sep 15, 2025 | Pj058 Tj Paris Refere 17 June Rg 2153849 Cabazitaxel Sanofi C Ever Pharma Fr | - |
| Sep 15, 2025 | Pj057 Tj Paris 12 May Rg 2153136 Cabazitaxel Sanofi C Teva Fr | - |
| Sep 15, 2025 | Pj056 Santen C 673 18 Gb | - |
| Sep 15, 2025 | Pj055 Tgi Paris 22 September 1407707 Fr | - |
| Sep 15, 2025 | Pj054 Cour Dappel De Paris 14 February 1991 Newtec International C Sfeima Pibd N504 Iiii432 Fr | - |
| Sep 15, 2025 | Pj053 Cour De Cassation 20 November Pourvoi N 1118440 Fr | - |
| Sep 15, 2025 | Pj052 Tgi Paris 6 June Rg N1606916 Fr | - |
| Sep 15, 2025 | Pj051 Tgi Rennes 2 September Rg N9803029 Fr | - |
| Sep 15, 2025 | Pj050 Decision De La Chambre De Recours 3306 De Loeb 30 May T 16596 Fr | - |
| Sep 15, 2025 | Pj049 Decision De La Chambre De Recours 3502 De Loeb 29 October T 33515 Fr | - |
| Sep 15, 2025 | Pj048 Decision De La Chambre De Recours De Loeb 10 November 1988 T038187 Gb | - |
| Sep 15, 2025 | Pj047 Tj Paris 22 June Rg N2002792 Fr | - |
| Sep 15, 2025 | Pj046 Decision De La Chambre De Recours De Loeb 20 September T197909 Gb | - |
| Sep 15, 2025 | Pj045 Decision De La Chambre De Recours De Loeb 1Er April T 140906 Gb | - |
| Sep 15, 2025 | Pj044 Decision De La Chambre De Recours De Loeb DU 28 January T 023715 Gb | - |
| Sep 15, 2025 | Pj043 Basf C25899 Gb | - |
| Sep 15, 2025 | Pj042 Gsk C21013 14 Nov Gb | - |
| Sep 15, 2025 | Pj041 Ca Paris 14 February Rg 1903820 Sandoz C Msd Fr | - |
| Sep 15, 2025 | Pj040 Abraxis C 443 17 21 March Gb | - |
| Sep 15, 2025 | Pj039 Case Law Of The Boards Of Appeal Of The Epo I D74 Try And See Solution Gb | - |
| Sep 15, 2025 | Pj038 Tj Paris 20 January Rg N 1901997 Fr | - |
| Sep 15, 2025 | Pj037 Tj Paris 6 September Rg N2106416 Fr | - |
| Sep 15, 2025 | Pj036 Tj Paris 7 June Rg 2153474 Sanofi C Accord Cabazitaxel Fr | - |
| Sep 15, 2025 | Pj035 Ca Paris 29 October Etypharm C Merck Rg N1803876 Fr | - |
| Sep 15, 2025 | Pj034 Cour Dappel De Paris 18 December Rg N 1710112 Fr | - |
| Sep 15, 2025 | Pj033 Decision De La Chambre De Recours De Loeb 25 July T 025915 Gb | - |
| Sep 15, 2025 | Pj032 Decision De La Chambre De Recours De Loeb 29 May T 009198 Gb | - |
| Sep 15, 2025 | Pj031 Decision De La Chambre De Recours De Loeb 5 October T 33397 Gb | - |
| Sep 15, 2025 | Pj030 Decision De La Chambre De Recours De Loeb 6 October T 91801 Gb | - |
| Sep 15, 2025 | Pj029 Decision De La Chambre De Recours De Loeb 14 February 1989 T 24988 Gb | - |
| Sep 15, 2025 | Pj028 Case Law Of The Boards Of Appeal Of The Epo Id71 Reasonable Expectation Of Success Gb | - |
| Sep 15, 2025 | Pj027 Jurisprudences Francaises Essais De Routine Fr | - |
| Sep 15, 2025 | Pj026 Tgi Paris 7 May Hexal C Boehringer Rg 0812537 Fr | - |
| Sep 15, 2025 | Pj025 Jub Division Centrale De Munich 16 July Sanofi C Amgen Upccfi 12023 Gb | - |
| Sep 15, 2025 | Pj024 Jub Cour Dappel 26 February Nanostring C 10X Genomics Upccoa3352023 Gb | - |
| Sep 15, 2025 | Pj023 Decision De La Chambre De Recours 332 De L Oeb 26 February T 92600 Gb | - |
| Sep 15, 2025 | Pj022 Decision De La Chambre De Recours 332 De Loeb 2 June T 30899 Gb | - |
| Sep 15, 2025 | Pj021 Decision De La Chambre De Recours 352 De Loeb 22 October 1993 T 25392 Gb | - |
| Sep 15, 2025 | Pj020 Decision De La Chambre De Recours 332 De Loeb 13 July T 393 01 Gb | - |
| Sep 15, 2025 | Pj019 Ca Paris 19 January Rg 18 21115 Fr | - |
| Sep 15, 2025 | Pj018 Tj Paris 20 July Rg N 21 10327 Fr | - |
| Sep 15, 2025 | Pj017 Ca Paris 14 November Rg N 1502576 Fr | - |
| Sep 15, 2025 | Pj016 Tj Paris 28 March Rg 2208612 Fr | - |
| Sep 15, 2025 | Pj014 Upc Court Of Appeal 13 August Upccoa4462025 Gb | - |
| Sep 15, 2025 | Pj013 Tj Paris 18 June Rg N 23 02356 Fr | - |
| Sep 15, 2025 | Pj012 Munich Local Division 27 August Upccfi2012024 Gb | - |
| Sep 15, 2025 | Pj011 Tj Paris 27 July Rg N 22 54367 Fr | - |
| Sep 15, 2025 | Pj010 Guidelines For Examination Of The Epo Giv1 Gb | - |
| Sep 15, 2025 | Pj009 Ca Paris 25 May Rg 21 18398 Fr | - |
| Sep 15, 2025 | Pj008 Tj Paris 29 September Rg 21 55930 Fr | - |
| Sep 15, 2025 | Pj007 Tj Paris Ordonnance De Refere 6 October Rg 22 55799 Biogen C Viatris Dmf Fr | - |
| Sep 15, 2025 | Pj006 Cjeu 16 July Genmab V Hungarian Ip Office Spc C 181 24 Gb | - |
| Sep 15, 2025 | Pj005 Accord Cadre Leem Ceps 5 March Fr | - |
| Sep 15, 2025 | Pj004 Regulation No 1768 92 Gb | - |
| Sep 15, 2025 | Pj003 Tj Paris Ordonnance Viatris C Novartis 04 August Fingolimod Rg N 2254655 Fr | - |
| Sep 15, 2025 | Pj002 Ca Paris 14 February Rg 1906114 Fr | - |
| Sep 15, 2025 | Pj001 Decision Du Conseil Constitutionnel N 463 Dc DU 12 December Fr | - |
| Sep 15, 2025 | Pc152 Submissions In High Resolution Gb | - |
| Sep 15, 2025 | Pc151 Declaration Dawid Sierzant DU 15 September Et Annexes Gb | - |
| Sep 15, 2025 | Pc150 4 Aminopyridine C5H6N2 Cid 1727 Pubchem Gb | - |
| Sep 15, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 15, 2025 | Pc148 The Fixing Of The Price And Reimboursement Rate Sante Gouv Fr | - |
| Sep 15, 2025 | Pc146 Letter From Viatris To Mez DATED 2 July Gb | - |
| Sep 15, 2025 | Pc145 Letter From Viatris To Merz Of 10 July Fr | - |
| Sep 15, 2025 | Pc143 Chapter 33 Pymadin Paskov Et Al 1986 Gb | - |
| Sep 15, 2025 | Pc142 Kostadinova And Danchev Gb | - |
| Sep 15, 2025 | Pc141 Sartori Et Al 1994 Gb | - |
| Sep 15, 2025 | Pc140 Olg Munchen Acorda Therapeutics V Ratiopharm 6 October 6 U 3044 22 De | - |
| Sep 15, 2025 | Pc139 Upsto Trademark Status Document Retrieval Pymadin Sopharma Gb | - |
| Sep 15, 2025 | Pc138 Website Of The Faculty Of Medicine In Sofia Bg | - |
| Sep 15, 2025 | Pc137 They Are Looking For A Superpill For Alzheimers Technologies News Standard Bg | - |
| Sep 15, 2025 | Pc136 Russian State Archive Of Scientific And Technical Documentation Ru | - |
| Sep 15, 2025 | Pc135 Communication Between The Ceps And Viatris Fr | - |
| Sep 15, 2025 | Pc134 Patient Leaflet Pymadin Bg | - |
| Sep 15, 2025 | Pc133 Smpc Pymadin Bg | - |
| Sep 15, 2025 | Pc132 Free State Gazette Edition 33 Of 2Iv Unofficial Section Ru | - |
| Sep 15, 2025 | Pc131 Disaster Protection Plan Burgas Region Republic Of Bulgaria Bg | - |
| Sep 15, 2025 | Pc130 4 Aminopiridin Spinal Cord Injury Forum Ru Compressed | - |
| Sep 15, 2025 | Pc129 Iqvia About Us Gb | - |
| Sep 15, 2025 | Pc128 Adverse Exhibit No 503 Toumi Et Al External Reference Pricing Simulation Gb | - |
| Sep 15, 2025 | Pc122 Application For Provisional Measures Gb | - |
| Sep 15, 2025 | Pc121 Acorda V Alkem Trial Transcript Volume B Gb | - |
| Sep 15, 2025 | Pc120 Acorda V Alkem Trial Transcript Volume A Gb | - |
| Sep 15, 2025 | Pc119 Hamilton Et Al 1998 Olanzapine Versus Placebo And Haloperidol Quality Of Life And Efficacy Results On The North Am | - |
| Sep 15, 2025 | Pc118 Overall 1994 Journal Of Clinical Psychology VOL 50 Pages 95 102 Gb | - |
| Sep 15, 2025 | Pc117 Alhainen Et Al 1991 Discrimination Of Tetrahydroaminoacridine Responders By A Single Dose Pharmaco Eeg In Patients | - |
| Sep 15, 2025 | Pc116 Sas Library 1997 Repeated Measures Anova Using Sas Proc Glm Gb | - |
| Sep 15, 2025 | Pc115 Sheeber Et Al 1996 Data Analytic Techniques For Treatment Outcome Studies With Pretest Posttest Measurements An Ex | - |
| Sep 15, 2025 | Pc114 Cook Et Al 1983 Design And Analysis Methods For Longitudinal Research Ann Rev Public Health Gb | - |
| Sep 15, 2025 | Pc113 Vickers Hor Many Repeated Measures In Repeates Measures Designs Statistical Issues For Comparative Trials Bmc | - |
| Sep 15, 2025 | Pc112 Uryniak Et Al Responder Analyses A Phrma Position Paper Statistics In Biopharmaceutical Research VOL 3 N3 Gb | - |
| Sep 15, 2025 | Pc111 Schulz Et Al The Efficacy Of Quetiapine VS Haloperidol And Placebo A Meta Analytic Study Of Efficacy Schizopp | - |
| Sep 15, 2025 | Pc110 Temple 1994 Commun Stat Theory Meth VOL 23 Pages 449 521 Gb | - |
| Sep 15, 2025 | Pc109 Lewis Statistics In Medicine VOL 21 Pages 2931 2938 Gb | - |
| Sep 15, 2025 | Pc108 Weiner 1998 Can J Neurol Sci VOL 25 Pages 93101 Gb | - |
| Sep 15, 2025 | Pc107 Petkau 1998 Seminars In Neurology VOL 18 3 Gb | - |
| Sep 15, 2025 | Pc106 Leber Et DAVIS 1998 Threats To The Validity Of Clinical Trials Employing Enrichment Strategies For Sample Selectio | - |
| Sep 15, 2025 | Pc105 DTX 584 Gb | - |
| Sep 15, 2025 | Pc104 4 Aminopyridine Induces Functional Improvement In Multiple Sclerosis Patients A Neurophysiological Study Gb | - |
| Sep 15, 2025 | Pc103 Stefoski Et Al 1991 4 Aminopyridine In Multiple Sclerosis Prolonged Administration Neurology 1991 Gb | - |
| Sep 15, 2025 | Pc102 Clinical Studies In 20 Questions Atelier Presse Clinical Trials Leem 19 May Fr | - |
| Sep 15, 2025 | Pc101 Report By Dr Christian Wolf DATED 2 September Gb | - |
| Sep 15, 2025 | Pc100 EP1732548B9 Gb | - |
| Sep 15, 2025 | Pc099 Matusik Therapy Nutrients 14 4249 Gb | - |
| Sep 15, 2025 | Pc098 Le Progres Article Patients Deprived Of A Medication Due To A Change Of Packaging 26 June Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 2 2 Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 1 2 Fr | - |
| Sep 15, 2025 | Pc096 Kehl Responder Identification In Clinical Trials June Gb | - |
| Sep 15, 2025 | Pc095 CPMP Points To Consider Multiplicity Issues Clinical Trials Gb | - |
| Sep 15, 2025 | Pc094 Hayes Et Al Pharmacokinetic Studies Of Single And Multiple Oral Doses Of Fampridine VOL 26 N4 Pp 185 192 Gb | - |
| Sep 15, 2025 | Pc093 Hayes Et Al Pharmacokinetics Of An Immediate Release Oral Formulation Of Fampridine 4 Aminopyridine In Normal | - |
| Sep 15, 2025 | Pc092 July 1986 Comment Determiner La Posologie Optimale D Un Medicament Fr | - |
| Sep 15, 2025 | Pc091 Dose Ranging Study Wikipedia Gb | - |
| Sep 15, 2025 | Pc090 Rnb Ccp 033 Fr | - |
| Sep 15, 2025 | Pc089 Rnb EP536Fr | - |
| Sep 15, 2025 | Pc088 Chmp 1999 Clinical Investigation Of Medicinal Products In The Treatment Of Parkinson S Disease CPMP Note For Guida | - |
| Sep 15, 2025 | Pc087 Ccne Opinion 79 Transposition Into French Law Of The European Directive On Clinical Trials Of Medicinal Products F | - |
| Sep 15, 2025 | Pc086 Declaration Of Helsinki Ethical Principles For Medical Research Involving Human Subjects Gb | - |
| Sep 15, 2025 | Pc085 Nuremberg Code Gb | - |
| Sep 15, 2025 | Pc084 Afsep Press Release Of 28 May Fr | - |
| Sep 15, 2025 | Pc083 Barus Et Al Fr | - |
| Sep 15, 2025 | Pc082 Extrait De La Base De Donnees Publique Des Medicaments Fampridine Viatris 10 Mg Fr | - |
| Sep 15, 2025 | Pc081 Icht Topic 9 Guideline On Statistical Principles For Clinical Trials September 1998 Gb | - |
| Sep 15, 2025 | Pc080 Website Of The Foundation For Research Into Multiple Sclerosis Fr | - |
| Sep 15, 2025 | Pc079 Notice On The Prices Of Fampridine Pharmaceutical Specialities Fr | - |
| Sep 15, 2025 | Pc078 Info Sheet Fampyra 10Mg Sustained Release Tablet Fr | - |
| Sep 15, 2025 | Pc077 Accession Of Bulgaria Gb | - |
| Sep 15, 2025 | Pc076 Kehl Responder Identification In Clinical Trials With Censored Data Gb | - |
| Sep 15, 2025 | Pc075 Federal Court Of Canada 15 May Acorda V Pharmascience And Taro T 1416 18 And T 220 19 Gb | - |
| Sep 15, 2025 | Pc074 Usa Delaware District Court 25 April Acorda V Teva Roxane Mylan 14 882 Gb | - |
| Sep 15, 2025 | Pc073 Usa Delaware District Court 31 March Acorda V Roxane 14 882 Lps Gb | - |
| Sep 15, 2025 | Pc072 Germany Teva Revocation Of Patent EP548De | - |
| Sep 15, 2025 | Pc071 Germany Ratiopharm Revocation Of Patent EP536De | - |
| Sep 15, 2025 | Pc070 Germany Ratiopharm Admissibility Of The EP536Invalidity Claim De | - |
| Sep 15, 2025 | Pc069 Board Of Appeal Of The European Patent Office 4 September T 0799 16 Gb | - |
| Sep 15, 2025 | Pc068 Decision Of The Epo EP536Gb Compressed | - |
| Sep 15, 2025 | Pc067 Emea Points To Consider On The Choice Of Non Interiority Margin Gb | - |
| Sep 15, 2025 | Pc066 Emea 27 July Points To Consider On Switching Betweend Superiority And Non Inferiority Gb | - |
| Sep 15, 2025 | Pc064 Usa Court Of Appeal 10 September Acorda V Roxane Et Al Et 2134 Gb | - |
| Sep 15, 2025 | Pc063 Form 10 K Wikipedia Presentation Gb | - |
| Sep 15, 2025 | Pc062 Cohen Postgraduate Medicine September 1999 Gb | - |
| Sep 15, 2025 | Pc061 L Echelle Edss Expanded Disability Status Scale Fr | - |
| Sep 15, 2025 | Pc060 O Brien Journal Of Hypertension Gb | - |
| Sep 15, 2025 | Pc059 Ellen R Girden Anova Repeated Measures 1992 Gb | - |
| Sep 15, 2025 | Pc058 Federal Court Of Appeal Of Canada 8 August Acorda Therapeutics V Pharmascience Taro Pharmaceuticals A 145 20 | - |
| Sep 15, 2025 | Pc057 Fda Chapter I Food And Drug Administration Department Of Health And Human Services Subchapter D Drugs For Human Us | - |
| Sep 15, 2025 | Pc056 Polman Arch Neur VOL 51 November 1994 Gb | - |
| Sep 15, 2025 | Pc055 Sheiner Clin Pharmacol Ther Volume 46 Number 1 July 1989 Gb | - |
| Sep 15, 2025 | Pc054 Norleans Statistical Methods For Clinical Trials Gb Compressed | - |
| Sep 15, 2025 | Pc053 Excerpt From The Fda Website Drug Evaluation Process Gb | - |
| Sep 15, 2025 | Pc052 Schwid Et Al April Gb | - |
| Sep 15, 2025 | Pc051 Kaufman Al The Significant Change For The Timed 25 Foot Walk In The Multiple Sclerosis Functional Composite M | - |
| Sep 15, 2025 | Pc050 Extract From The National Institutes Of Health Website Fda Drug Review And Approval Gb | - |
| Sep 15, 2025 | Pc049 Ca 2 562 277 Gb | - |
| Sep 15, 2025 | Pc048 US8663685Gb | - |
| Sep 15, 2025 | Pc047 US8440703Gb | - |
| Sep 15, 2025 | Pc046 US8354437Gb | - |
| Sep 15, 2025 | Pc045 Declaration Of Dr Ron Cohen Gb | - |
| Sep 15, 2025 | Pc044 US8007826Gb | - |
| Sep 15, 2025 | Pc043 Goodman Diaporama Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc042 Medical Research Council Mrc Scale For Muscle Strength Gb | - |
| Sep 15, 2025 | Pc041 National Multiple Sclerosis Society Timed 25 Foot Walk T25 Fw Gb | - |
| Sep 15, 2025 | Pc040 Ninds Fatigue Severity Scale Fss Gb | - |
| Sep 15, 2025 | Pc039 Wikipedia Page Edss Gb | - |
| Sep 15, 2025 | Pc038 Goodman Poster Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc037 Supplemental Information Disclosure Statement Gb | - |
| Sep 15, 2025 | Pc036 Actrims Ectrims Final Program Gb Compressed | - |
| Sep 15, 2025 | Pc035 List Of References Ids Gb | - |
| Sep 15, 2025 | Pc034 List Of Documents Requested US11102559Gb | - |
| Sep 15, 2025 | Pc033 Acorda Therapeutics Form S1 Gb | - |
| Sep 15, 2025 | Pc032 Form S 1 Presentation Gb | - |
| Sep 15, 2025 | Pc031 Sec Overview Gb | - |
| Sep 15, 2025 | Pc030 Goodman Abstract Poster Gb | - |
| Sep 15, 2025 | Pc029 Shargel 1999 Applied Biopharmaceutics And Pharmacokinetics Chapter 7 Extraits Pages 169 178 179 Gb Compressed | - |
| Sep 15, 2025 | Pc028 VAN Diemen Et Al 1992 August Gb | - |
| Sep 15, 2025 | Pc027 EP0484186B1 Gb | - |
| Sep 15, 2025 | Pc026 Schwid Et Al 1997 The American Academy Of Neurology Volume 48 Pages 817 821 Gb | - |
| Sep 15, 2025 | Pc025 Bever 1994 The American Neurological Association 1994 Volume 23 Page 118 S121 Gb | - |
| Sep 15, 2025 | Pc024 Bever Et Al 1994 June Neurology 44 1054 1059 Gb | - |
| Sep 15, 2025 | Pc023 Davis Et Al 1990 The American Neurological Association 1990 Pages 186 192 Gb | - |
| Sep 15, 2025 | Pc022 Sherratt Et Al 1980 Nature Volume 283 5745 Pages 570 572 Gb | - |
| Sep 15, 2025 | Pc021 List Of Documents Cited In The Oppositions Gb | - |
| Sep 15, 2025 | Pc020 Merz Acquires Fampyra Gb | - |
| Sep 15, 2025 | Pc019 European Medicines Agency Guidelines Ich Topic E4 November 1994 Gb | - |
| Sep 15, 2025 | Pc018 EP536Oral Proceedings Gb | - |
| Sep 15, 2025 | Pc017 Verhagen Et Al Australian Journal Of Physiotherapy VOL 50 Gb | - |
| Sep 15, 2025 | Pc016 Piece Composite Synthese Wikipiedia Sur L Ecart Type Et La Valeur P Fr | - |
| Sep 15, 2025 | Pc015 Marien Et Beaud Guide Pratique Pour L Utilisation De La Statistique En Recherche Fr | - |
| Sep 15, 2025 | Pc014 Journal De La Societe Statistique De Paris 1956 Fr | - |
| Sep 15, 2025 | Pc013 Ting N Introduction And New Drug Development Process In Ting N Editor Dose Finding In Drug Development Springer Ne | - |
| Sep 15, 2025 | Pc012 Pirmohamed Et Al Bmj Volume 316 25 April 1998 Gb | - |
| Sep 15, 2025 | Pc011 Edwards And Aronson The Lancet VOL 356 October 7 Gb | - |
| Sep 15, 2025 | Pc010 Ich Topic E 8 General Considerations For Clinical Trials 17 July 1997 Gb | - |
| Sep 15, 2025 | Pc009 Griffin Et Al The Textbook Of Pharmaceutical Medicine 1993 Pages 221 222 Gb Compressed | - |
| Sep 15, 2025 | Pc008 Bopi 20 November N 1547 Pp 235 237 Et 258 Fr | - |
| Sep 15, 2025 | Pc007 Decision Et Requete De Delivrance Du Ccp N 13 C0033 Fr | - |
| Sep 15, 2025 | Pc006 Demande De Ccp Sur La Base Du Brevet EP2377536Fr | - |
| Sep 15, 2025 | Pc005 EP2377536B2 Gb | - |
| Sep 15, 2025 | Pc004 Fampyra Smpc Gb | - |
| Sep 15, 2025 | Pc003 Commission Implementing Decision Of 27 September C20246926 Gb | - |
| Sep 15, 2025 | Pc002 Rcp Fampridine Viatris Lp 10Mg Fr | - |
| Sep 15, 2025 | Pc001 Extrait Kbis Viatris Sante Fr | - |
| Sep 15, 2025 | Objection Viatris Sante App 339802025 Compressed Signed | - |
| Sep 11, 2025 | Summon Oral Hearing | - |
| Sep 11, 2025 | Order Summon The Oral Hearing | |
| Aug 18, 2025 | Procedural Order Timetable And Summon Oh | |
| Aug 18, 2025 | Hearing Dates | - |
| Aug 14, 2025 | Panel Appointment | - |
| Aug 7, 2025 | Acknowledgement Of Access To Case | - |
| Aug 6, 2025 | Notification Of Service | - |
| Aug 6, 2025 | Digital Tracking La Poste Service Receipt | - |
| Aug 5, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Notice To Accompany Service Of Order For Measures | - |
| Aug 1, 2025 | Letter For Service | - |
| Aug 1, 2025 | Formal Checks Notification Of Positive Outcome | - |
| Aug 1, 2025 | Exhibit No. 701 Application French Translation | - |
| Aug 1, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Aug 1, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Aug 1, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Aug 1, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Aug 1, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Aug 1, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Aug 1, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Aug 1, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Aug 1, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Aug 1, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Aug 1, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Aug 1, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Aug 1, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Aug 1, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Aug 1, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Aug 1, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Aug 1, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Aug 1, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Aug 1, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Aug 1, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Aug 1, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Aug 1, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Aug 1, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Aug 1, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Aug 1, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Aug 1, 2025 | Exhibit No. 401 Goodman Poster | - |
| Aug 1, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Aug 1, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Aug 1, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Aug 1, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Aug 1, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Aug 1, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Aug 1, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Aug 1, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 208 French Spc Register | - |
| Aug 1, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Aug 1, 2025 | Exhibit No. 206 French Patent Register | - |
| Aug 1, 2025 | Exhibit No. 205 EP536Patent | - |
| Aug 1, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Aug 1, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Aug 1, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Aug 1, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Aug 1, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Aug 1, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Aug 1, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Aug 1, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Aug 1, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Aug 1, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Aug 1, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Aug 1, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Aug 1, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Aug 1, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Aug 1, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Aug 1, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Aug 1, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Aug 1, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Aug 1, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Aug 1, 2025 | Exhibit No. 106 Larocca | - |
| Aug 1, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Aug 1, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Aug 1, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Aug 1, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Aug 1, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Aug 1, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Aug 1, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Aug 1, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Aug 1, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Aug 1, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Aug 1, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Aug 1, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Aug 1, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Aug 1, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Aug 1, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Aug 1, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Aug 1, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Aug 1, 2025 | Application For Provisional Measures | - |
| Aug 1, 2025 | Application For Measures Receipt | - |
| Aug 1, 2025 | Application For Measures Acknowledgement | - |
| Jul 31, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Jul 31, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Jul 31, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Jul 31, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Jul 31, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Jul 31, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Jul 31, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Jul 31, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Jul 31, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Jul 31, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Jul 31, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Jul 31, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Jul 31, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Jul 31, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Jul 31, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Jul 31, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Jul 31, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Jul 31, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Jul 31, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Jul 31, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Jul 31, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Jul 31, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Jul 31, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Jul 31, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Jul 31, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Jul 31, 2025 | Exhibit No. 401 Goodman Poster | - |
| Jul 31, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Jul 31, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Jul 31, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Jul 31, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Jul 31, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Jul 31, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Jul 31, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Jul 31, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 208 French Spc Register | - |
| Jul 31, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Jul 31, 2025 | Exhibit No. 206 French Patent Register | - |
| Jul 31, 2025 | Exhibit No. 205 EP536Patent | - |
| Jul 31, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Jul 31, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Jul 31, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Jul 31, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Jul 31, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Jul 31, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Jul 31, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Jul 31, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Jul 31, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Jul 31, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Jul 31, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Jul 31, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Jul 31, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Jul 31, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Jul 31, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Jul 31, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Jul 31, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Jul 31, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Jul 31, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Jul 31, 2025 | Exhibit No. 106 Larocca | - |
| Jul 31, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Jul 31, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Jul 31, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Jul 31, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Jul 31, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Jul 31, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Jul 31, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Jul 31, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Jul 31, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Jul 31, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Jul 31, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Jul 31, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Jul 31, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Jul 31, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Jul 31, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Jul 31, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Jul 31, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Jul 31, 2025 | Application For Provisional Measures | - |
| Oct 10, 2025 | Action.Communication | - |
| Oct 9, 2025 | Receipt | - |
| Oct 9, 2025 | Proof Of Payment | - |
| Oct 9, 2025 | Other Document | - |
| Oct 9, 2025 | Fee | - |
| Oct 9, 2025 | Cover Sheet | - |
| Oct 9, 2025 | Application | - |
| Oct 7, 2025 | Order | - |
| Oct 7, 2025 | Action.Issueorder | - |
| Oct 6, 2025 | Action.Communication | - |
| Oct 5, 2025 | Receipt | - |
| Oct 5, 2025 | Cover Sheet | - |
| Oct 5, 2025 | Application | - |
| Oct 2, 2025 | Receipt | - |
| Oct 2, 2025 | Order | - |
| Oct 2, 2025 | Cover Sheet | - |
| Oct 2, 2025 | Application | - |
| Oct 2, 2025 | Action.Issueorder | - |
| Oct 1, 2025 | Statement Of Reply | - |
| Oct 1, 2025 | Receipt | - |
| Oct 1, 2025 | Exhibit | - |
| Oct 1, 2025 | Cover Sheet | - |
| Oct 1, 2025 | Application | - |
| Sep 26, 2025 | Action.Communication | - |
| Sep 25, 2025 | Receipt | - |
| Sep 25, 2025 | Other Document | - |
| Sep 25, 2025 | Exhibit | - |
| Sep 25, 2025 | Cover Sheet | - |
| Sep 25, 2025 | Action.Communication | - |
| Sep 24, 2025 | Order | - |
| Sep 24, 2025 | Action.Issueorder | - |
| Sep 18, 2025 | Request V.Def Pdf A Signed | - |
| Sep 18, 2025 | Receipt | - |
| Sep 18, 2025 | Pc154 Iqvia Agreement Gb | - |
| Sep 18, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 17, 2025 | Receipt | - |
| Sep 17, 2025 | Procedural Order | |
| Sep 17, 2025 | Outcome Of The Order | - |
| Sep 17, 2025 | Headnote And Keywords | - |
| Sep 16, 2025 | Request For Procedural Order | - |
| Sep 16, 2025 | Receipt | - |
| Sep 16, 2025 | Objection | - |
| Sep 15, 2025 | Pj087 Regulation N 469 Gb | - |
| Sep 15, 2025 | Pj086 Court Of Appeal 10X Genomics Harvard V Nanostring Upc Coa 3352023 Gb | - |
| Sep 15, 2025 | Pj085 Dmf Nl Court Of The Hague 1Ere Instance Nl | - |
| Sep 15, 2025 | Pj084 Dmf Be Cour Dappel De Bruxelles Appel Nl | - |
| Sep 15, 2025 | Pj083 Fingolimod De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj082 Phosphodiesterase Nl Appeal Court Of The Hague Appel Nl | - |
| Sep 15, 2025 | Pj081 Dmf De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj080 Munich Local Division 21 May Upccfi432023 De | - |
| Sep 15, 2025 | Pj079 Ca Paris 9 July N2407962 Fr | - |
| Sep 15, 2025 | Pj078 Case Law Of The Boards Of Appeal Id108 Gb | - |
| Sep 15, 2025 | Pj077 Bonnes Pratiques De Distribution Ansm Bulletin Officiel N20149Bis Fr | - |
| Sep 15, 2025 | Pj076 Upc Court Of Appeal 25 September Upccoa1822024 Gb | - |
| Sep 15, 2025 | Pj075 Guidelines For Examination In The European Patent Office Gvii4Gb | - |
| Sep 15, 2025 | Pj074 Decision De La Chambre De Recours De Loeb DU 4 October T 111003 Gb | - |
| Sep 15, 2025 | Pj073 Epo Boa 10 July Eisai V Stada Lenvatinib T 193423 Gb | - |
| Sep 15, 2025 | Pj072 Hamburg Local Division 3 June Upccfi1512024 Gb | - |
| Sep 15, 2025 | Pj071 Dusseldorf Local Division 30 April Upccfi4632023 Gb | - |
| Sep 15, 2025 | Pj070 Dusseldorf Local Division 9 April Upccfi4522023 De | - |
| Sep 15, 2025 | Pj069 Dusseldorf Local Division VALEO V Magna Upc Cfi 3682024 Gb | - |
| Sep 15, 2025 | Pj068 Court Of Appeal Biolitec V Light Guide Optics Sia Lightguide 24 February Upccoa5402024 Gb | - |
| Sep 15, 2025 | Pj067 Ld Munich 15 November Upc Cfi 152023 Gb | - |
| Sep 15, 2025 | Pj065 Cjeu 28 July Synthon C Mertz Memantine C19509 Gb | - |
| Sep 15, 2025 | Pj064 Cjeu 28 July Generics Uk C Synaptech Galantamine C42709 Gb | - |
| Sep 15, 2025 | Pj063 Cass Com 10 February N1320150 Fr | - |
| Sep 15, 2025 | Pj062 Directive 200448CE Gb | - |
| Sep 15, 2025 | Pj061 Neurim Mylan High Court Of Justice 3 June Ewhc 1362 Gb | - |
| Sep 15, 2025 | Pj060 Decision De La Chambre De Recours De Loeb 13 September T023916 Gb | - |
| Sep 15, 2025 | Pj059 Decision De La Chambre De Recours De Loeb 4 October T250612 Gb | - |
| Sep 15, 2025 | Pj058 Tj Paris Refere 17 June Rg 2153849 Cabazitaxel Sanofi C Ever Pharma Fr | - |
| Sep 15, 2025 | Pj057 Tj Paris 12 May Rg 2153136 Cabazitaxel Sanofi C Teva Fr | - |
| Sep 15, 2025 | Pj056 Santen C 673 18 Gb | - |
| Sep 15, 2025 | Pj055 Tgi Paris 22 September 1407707 Fr | - |
| Sep 15, 2025 | Pj054 Cour Dappel De Paris 14 February 1991 Newtec International C Sfeima Pibd N504 Iiii432 Fr | - |
| Sep 15, 2025 | Pj053 Cour De Cassation 20 November Pourvoi N 1118440 Fr | - |
| Sep 15, 2025 | Pj052 Tgi Paris 6 June Rg N1606916 Fr | - |
| Sep 15, 2025 | Pj051 Tgi Rennes 2 September Rg N9803029 Fr | - |
| Sep 15, 2025 | Pj050 Decision De La Chambre De Recours 3306 De Loeb 30 May T 16596 Fr | - |
| Sep 15, 2025 | Pj049 Decision De La Chambre De Recours 3502 De Loeb 29 October T 33515 Fr | - |
| Sep 15, 2025 | Pj048 Decision De La Chambre De Recours De Loeb 10 November 1988 T038187 Gb | - |
| Sep 15, 2025 | Pj047 Tj Paris 22 June Rg N2002792 Fr | - |
| Sep 15, 2025 | Pj046 Decision De La Chambre De Recours De Loeb 20 September T197909 Gb | - |
| Sep 15, 2025 | Pj045 Decision De La Chambre De Recours De Loeb 1Er April T 140906 Gb | - |
| Sep 15, 2025 | Pj044 Decision De La Chambre De Recours De Loeb DU 28 January T 023715 Gb | - |
| Sep 15, 2025 | Pj043 Basf C25899 Gb | - |
| Sep 15, 2025 | Pj042 Gsk C21013 14 Nov Gb | - |
| Sep 15, 2025 | Pj041 Ca Paris 14 February Rg 1903820 Sandoz C Msd Fr | - |
| Sep 15, 2025 | Pj040 Abraxis C 443 17 21 March Gb | - |
| Sep 15, 2025 | Pj039 Case Law Of The Boards Of Appeal Of The Epo I D74 Try And See Solution Gb | - |
| Sep 15, 2025 | Pj038 Tj Paris 20 January Rg N 1901997 Fr | - |
| Sep 15, 2025 | Pj037 Tj Paris 6 September Rg N2106416 Fr | - |
| Sep 15, 2025 | Pj036 Tj Paris 7 June Rg 2153474 Sanofi C Accord Cabazitaxel Fr | - |
| Sep 15, 2025 | Pj035 Ca Paris 29 October Etypharm C Merck Rg N1803876 Fr | - |
| Sep 15, 2025 | Pj034 Cour Dappel De Paris 18 December Rg N 1710112 Fr | - |
| Sep 15, 2025 | Pj033 Decision De La Chambre De Recours De Loeb 25 July T 025915 Gb | - |
| Sep 15, 2025 | Pj032 Decision De La Chambre De Recours De Loeb 29 May T 009198 Gb | - |
| Sep 15, 2025 | Pj031 Decision De La Chambre De Recours De Loeb 5 October T 33397 Gb | - |
| Sep 15, 2025 | Pj030 Decision De La Chambre De Recours De Loeb 6 October T 91801 Gb | - |
| Sep 15, 2025 | Pj029 Decision De La Chambre De Recours De Loeb 14 February 1989 T 24988 Gb | - |
| Sep 15, 2025 | Pj028 Case Law Of The Boards Of Appeal Of The Epo Id71 Reasonable Expectation Of Success Gb | - |
| Sep 15, 2025 | Pj027 Jurisprudences Francaises Essais De Routine Fr | - |
| Sep 15, 2025 | Pj026 Tgi Paris 7 May Hexal C Boehringer Rg 0812537 Fr | - |
| Sep 15, 2025 | Pj025 Jub Division Centrale De Munich 16 July Sanofi C Amgen Upccfi 12023 Gb | - |
| Sep 15, 2025 | Pj024 Jub Cour Dappel 26 February Nanostring C 10X Genomics Upccoa3352023 Gb | - |
| Sep 15, 2025 | Pj023 Decision De La Chambre De Recours 332 De L Oeb 26 February T 92600 Gb | - |
| Sep 15, 2025 | Pj022 Decision De La Chambre De Recours 332 De Loeb 2 June T 30899 Gb | - |
| Sep 15, 2025 | Pj021 Decision De La Chambre De Recours 352 De Loeb 22 October 1993 T 25392 Gb | - |
| Sep 15, 2025 | Pj020 Decision De La Chambre De Recours 332 De Loeb 13 July T 393 01 Gb | - |
| Sep 15, 2025 | Pj019 Ca Paris 19 January Rg 18 21115 Fr | - |
| Sep 15, 2025 | Pj018 Tj Paris 20 July Rg N 21 10327 Fr | - |
| Sep 15, 2025 | Pj017 Ca Paris 14 November Rg N 1502576 Fr | - |
| Sep 15, 2025 | Pj016 Tj Paris 28 March Rg 2208612 Fr | - |
| Sep 15, 2025 | Pj014 Upc Court Of Appeal 13 August Upccoa4462025 Gb | - |
| Sep 15, 2025 | Pj013 Tj Paris 18 June Rg N 23 02356 Fr | - |
| Sep 15, 2025 | Pj012 Munich Local Division 27 August Upccfi2012024 Gb | - |
| Sep 15, 2025 | Pj011 Tj Paris 27 July Rg N 22 54367 Fr | - |
| Sep 15, 2025 | Pj010 Guidelines For Examination Of The Epo Giv1 Gb | - |
| Sep 15, 2025 | Pj009 Ca Paris 25 May Rg 21 18398 Fr | - |
| Sep 15, 2025 | Pj008 Tj Paris 29 September Rg 21 55930 Fr | - |
| Sep 15, 2025 | Pj007 Tj Paris Ordonnance De Refere 6 October Rg 22 55799 Biogen C Viatris Dmf Fr | - |
| Sep 15, 2025 | Pj006 Cjeu 16 July Genmab V Hungarian Ip Office Spc C 181 24 Gb | - |
| Sep 15, 2025 | Pj005 Accord Cadre Leem Ceps 5 March Fr | - |
| Sep 15, 2025 | Pj004 Regulation No 1768 92 Gb | - |
| Sep 15, 2025 | Pj003 Tj Paris Ordonnance Viatris C Novartis 04 August Fingolimod Rg N 2254655 Fr | - |
| Sep 15, 2025 | Pj002 Ca Paris 14 February Rg 1906114 Fr | - |
| Sep 15, 2025 | Pj001 Decision Du Conseil Constitutionnel N 463 Dc DU 12 December Fr | - |
| Sep 15, 2025 | Pc152 Submissions In High Resolution Gb | - |
| Sep 15, 2025 | Pc151 Declaration Dawid Sierzant DU 15 September Et Annexes Gb | - |
| Sep 15, 2025 | Pc150 4 Aminopyridine C5H6N2 Cid 1727 Pubchem Gb | - |
| Sep 15, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 15, 2025 | Pc148 The Fixing Of The Price And Reimboursement Rate Sante Gouv Fr | - |
| Sep 15, 2025 | Pc146 Letter From Viatris To Mez DATED 2 July Gb | - |
| Sep 15, 2025 | Pc145 Letter From Viatris To Merz Of 10 July Fr | - |
| Sep 15, 2025 | Pc143 Chapter 33 Pymadin Paskov Et Al 1986 Gb | - |
| Sep 15, 2025 | Pc142 Kostadinova And Danchev Gb | - |
| Sep 15, 2025 | Pc141 Sartori Et Al 1994 Gb | - |
| Sep 15, 2025 | Pc140 Olg Munchen Acorda Therapeutics V Ratiopharm 6 October 6 U 3044 22 De | - |
| Sep 15, 2025 | Pc139 Upsto Trademark Status Document Retrieval Pymadin Sopharma Gb | - |
| Sep 15, 2025 | Pc138 Website Of The Faculty Of Medicine In Sofia Bg | - |
| Sep 15, 2025 | Pc137 They Are Looking For A Superpill For Alzheimers Technologies News Standard Bg | - |
| Sep 15, 2025 | Pc136 Russian State Archive Of Scientific And Technical Documentation Ru | - |
| Sep 15, 2025 | Pc135 Communication Between The Ceps And Viatris Fr | - |
| Sep 15, 2025 | Pc134 Patient Leaflet Pymadin Bg | - |
| Sep 15, 2025 | Pc133 Smpc Pymadin Bg | - |
| Sep 15, 2025 | Pc132 Free State Gazette Edition 33 Of 2Iv Unofficial Section Ru | - |
| Sep 15, 2025 | Pc131 Disaster Protection Plan Burgas Region Republic Of Bulgaria Bg | - |
| Sep 15, 2025 | Pc130 4 Aminopiridin Spinal Cord Injury Forum Ru Compressed | - |
| Sep 15, 2025 | Pc129 Iqvia About Us Gb | - |
| Sep 15, 2025 | Pc128 Adverse Exhibit No 503 Toumi Et Al External Reference Pricing Simulation Gb | - |
| Sep 15, 2025 | Pc122 Application For Provisional Measures Gb | - |
| Sep 15, 2025 | Pc121 Acorda V Alkem Trial Transcript Volume B Gb | - |
| Sep 15, 2025 | Pc120 Acorda V Alkem Trial Transcript Volume A Gb | - |
| Sep 15, 2025 | Pc119 Hamilton Et Al 1998 Olanzapine Versus Placebo And Haloperidol Quality Of Life And Efficacy Results On The North Am | - |
| Sep 15, 2025 | Pc118 Overall 1994 Journal Of Clinical Psychology VOL 50 Pages 95 102 Gb | - |
| Sep 15, 2025 | Pc117 Alhainen Et Al 1991 Discrimination Of Tetrahydroaminoacridine Responders By A Single Dose Pharmaco Eeg In Patients | - |
| Sep 15, 2025 | Pc116 Sas Library 1997 Repeated Measures Anova Using Sas Proc Glm Gb | - |
| Sep 15, 2025 | Pc115 Sheeber Et Al 1996 Data Analytic Techniques For Treatment Outcome Studies With Pretest Posttest Measurements An Ex | - |
| Sep 15, 2025 | Pc114 Cook Et Al 1983 Design And Analysis Methods For Longitudinal Research Ann Rev Public Health Gb | - |
| Sep 15, 2025 | Pc113 Vickers Hor Many Repeated Measures In Repeates Measures Designs Statistical Issues For Comparative Trials Bmc | - |
| Sep 15, 2025 | Pc112 Uryniak Et Al Responder Analyses A Phrma Position Paper Statistics In Biopharmaceutical Research VOL 3 N3 Gb | - |
| Sep 15, 2025 | Pc111 Schulz Et Al The Efficacy Of Quetiapine VS Haloperidol And Placebo A Meta Analytic Study Of Efficacy Schizopp | - |
| Sep 15, 2025 | Pc110 Temple 1994 Commun Stat Theory Meth VOL 23 Pages 449 521 Gb | - |
| Sep 15, 2025 | Pc109 Lewis Statistics In Medicine VOL 21 Pages 2931 2938 Gb | - |
| Sep 15, 2025 | Pc108 Weiner 1998 Can J Neurol Sci VOL 25 Pages 93101 Gb | - |
| Sep 15, 2025 | Pc107 Petkau 1998 Seminars In Neurology VOL 18 3 Gb | - |
| Sep 15, 2025 | Pc106 Leber Et DAVIS 1998 Threats To The Validity Of Clinical Trials Employing Enrichment Strategies For Sample Selectio | - |
| Sep 15, 2025 | Pc105 DTX 584 Gb | - |
| Sep 15, 2025 | Pc104 4 Aminopyridine Induces Functional Improvement In Multiple Sclerosis Patients A Neurophysiological Study Gb | - |
| Sep 15, 2025 | Pc103 Stefoski Et Al 1991 4 Aminopyridine In Multiple Sclerosis Prolonged Administration Neurology 1991 Gb | - |
| Sep 15, 2025 | Pc102 Clinical Studies In 20 Questions Atelier Presse Clinical Trials Leem 19 May Fr | - |
| Sep 15, 2025 | Pc101 Report By Dr Christian Wolf DATED 2 September Gb | - |
| Sep 15, 2025 | Pc100 EP1732548B9 Gb | - |
| Sep 15, 2025 | Pc099 Matusik Therapy Nutrients 14 4249 Gb | - |
| Sep 15, 2025 | Pc098 Le Progres Article Patients Deprived Of A Medication Due To A Change Of Packaging 26 June Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 2 2 Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 1 2 Fr | - |
| Sep 15, 2025 | Pc096 Kehl Responder Identification In Clinical Trials June Gb | - |
| Sep 15, 2025 | Pc095 CPMP Points To Consider Multiplicity Issues Clinical Trials Gb | - |
| Sep 15, 2025 | Pc094 Hayes Et Al Pharmacokinetic Studies Of Single And Multiple Oral Doses Of Fampridine VOL 26 N4 Pp 185 192 Gb | - |
| Sep 15, 2025 | Pc093 Hayes Et Al Pharmacokinetics Of An Immediate Release Oral Formulation Of Fampridine 4 Aminopyridine In Normal | - |
| Sep 15, 2025 | Pc092 July 1986 Comment Determiner La Posologie Optimale D Un Medicament Fr | - |
| Sep 15, 2025 | Pc091 Dose Ranging Study Wikipedia Gb | - |
| Sep 15, 2025 | Pc090 Rnb Ccp 033 Fr | - |
| Sep 15, 2025 | Pc089 Rnb EP536Fr | - |
| Sep 15, 2025 | Pc088 Chmp 1999 Clinical Investigation Of Medicinal Products In The Treatment Of Parkinson S Disease CPMP Note For Guida | - |
| Sep 15, 2025 | Pc087 Ccne Opinion 79 Transposition Into French Law Of The European Directive On Clinical Trials Of Medicinal Products F | - |
| Sep 15, 2025 | Pc086 Declaration Of Helsinki Ethical Principles For Medical Research Involving Human Subjects Gb | - |
| Sep 15, 2025 | Pc085 Nuremberg Code Gb | - |
| Sep 15, 2025 | Pc084 Afsep Press Release Of 28 May Fr | - |
| Sep 15, 2025 | Pc083 Barus Et Al Fr | - |
| Sep 15, 2025 | Pc082 Extrait De La Base De Donnees Publique Des Medicaments Fampridine Viatris 10 Mg Fr | - |
| Sep 15, 2025 | Pc081 Icht Topic 9 Guideline On Statistical Principles For Clinical Trials September 1998 Gb | - |
| Sep 15, 2025 | Pc080 Website Of The Foundation For Research Into Multiple Sclerosis Fr | - |
| Sep 15, 2025 | Pc079 Notice On The Prices Of Fampridine Pharmaceutical Specialities Fr | - |
| Sep 15, 2025 | Pc078 Info Sheet Fampyra 10Mg Sustained Release Tablet Fr | - |
| Sep 15, 2025 | Pc077 Accession Of Bulgaria Gb | - |
| Sep 15, 2025 | Pc076 Kehl Responder Identification In Clinical Trials With Censored Data Gb | - |
| Sep 15, 2025 | Pc075 Federal Court Of Canada 15 May Acorda V Pharmascience And Taro T 1416 18 And T 220 19 Gb | - |
| Sep 15, 2025 | Pc074 Usa Delaware District Court 25 April Acorda V Teva Roxane Mylan 14 882 Gb | - |
| Sep 15, 2025 | Pc073 Usa Delaware District Court 31 March Acorda V Roxane 14 882 Lps Gb | - |
| Sep 15, 2025 | Pc072 Germany Teva Revocation Of Patent EP548De | - |
| Sep 15, 2025 | Pc071 Germany Ratiopharm Revocation Of Patent EP536De | - |
| Sep 15, 2025 | Pc070 Germany Ratiopharm Admissibility Of The EP536Invalidity Claim De | - |
| Sep 15, 2025 | Pc069 Board Of Appeal Of The European Patent Office 4 September T 0799 16 Gb | - |
| Sep 15, 2025 | Pc068 Decision Of The Epo EP536Gb Compressed | - |
| Sep 15, 2025 | Pc067 Emea Points To Consider On The Choice Of Non Interiority Margin Gb | - |
| Sep 15, 2025 | Pc066 Emea 27 July Points To Consider On Switching Betweend Superiority And Non Inferiority Gb | - |
| Sep 15, 2025 | Pc064 Usa Court Of Appeal 10 September Acorda V Roxane Et Al Et 2134 Gb | - |
| Sep 15, 2025 | Pc063 Form 10 K Wikipedia Presentation Gb | - |
| Sep 15, 2025 | Pc062 Cohen Postgraduate Medicine September 1999 Gb | - |
| Sep 15, 2025 | Pc061 L Echelle Edss Expanded Disability Status Scale Fr | - |
| Sep 15, 2025 | Pc060 O Brien Journal Of Hypertension Gb | - |
| Sep 15, 2025 | Pc059 Ellen R Girden Anova Repeated Measures 1992 Gb | - |
| Sep 15, 2025 | Pc058 Federal Court Of Appeal Of Canada 8 August Acorda Therapeutics V Pharmascience Taro Pharmaceuticals A 145 20 | - |
| Sep 15, 2025 | Pc057 Fda Chapter I Food And Drug Administration Department Of Health And Human Services Subchapter D Drugs For Human Us | - |
| Sep 15, 2025 | Pc056 Polman Arch Neur VOL 51 November 1994 Gb | - |
| Sep 15, 2025 | Pc055 Sheiner Clin Pharmacol Ther Volume 46 Number 1 July 1989 Gb | - |
| Sep 15, 2025 | Pc054 Norleans Statistical Methods For Clinical Trials Gb Compressed | - |
| Sep 15, 2025 | Pc053 Excerpt From The Fda Website Drug Evaluation Process Gb | - |
| Sep 15, 2025 | Pc052 Schwid Et Al April Gb | - |
| Sep 15, 2025 | Pc051 Kaufman Al The Significant Change For The Timed 25 Foot Walk In The Multiple Sclerosis Functional Composite M | - |
| Sep 15, 2025 | Pc050 Extract From The National Institutes Of Health Website Fda Drug Review And Approval Gb | - |
| Sep 15, 2025 | Pc049 Ca 2 562 277 Gb | - |
| Sep 15, 2025 | Pc048 US8663685Gb | - |
| Sep 15, 2025 | Pc047 US8440703Gb | - |
| Sep 15, 2025 | Pc046 US8354437Gb | - |
| Sep 15, 2025 | Pc045 Declaration Of Dr Ron Cohen Gb | - |
| Sep 15, 2025 | Pc044 US8007826Gb | - |
| Sep 15, 2025 | Pc043 Goodman Diaporama Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc042 Medical Research Council Mrc Scale For Muscle Strength Gb | - |
| Sep 15, 2025 | Pc041 National Multiple Sclerosis Society Timed 25 Foot Walk T25 Fw Gb | - |
| Sep 15, 2025 | Pc040 Ninds Fatigue Severity Scale Fss Gb | - |
| Sep 15, 2025 | Pc039 Wikipedia Page Edss Gb | - |
| Sep 15, 2025 | Pc038 Goodman Poster Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc037 Supplemental Information Disclosure Statement Gb | - |
| Sep 15, 2025 | Pc036 Actrims Ectrims Final Program Gb Compressed | - |
| Sep 15, 2025 | Pc035 List Of References Ids Gb | - |
| Sep 15, 2025 | Pc034 List Of Documents Requested US11102559Gb | - |
| Sep 15, 2025 | Pc033 Acorda Therapeutics Form S1 Gb | - |
| Sep 15, 2025 | Pc032 Form S 1 Presentation Gb | - |
| Sep 15, 2025 | Pc031 Sec Overview Gb | - |
| Sep 15, 2025 | Pc030 Goodman Abstract Poster Gb | - |
| Sep 15, 2025 | Pc029 Shargel 1999 Applied Biopharmaceutics And Pharmacokinetics Chapter 7 Extraits Pages 169 178 179 Gb Compressed | - |
| Sep 15, 2025 | Pc028 VAN Diemen Et Al 1992 August Gb | - |
| Sep 15, 2025 | Pc027 EP0484186B1 Gb | - |
| Sep 15, 2025 | Pc026 Schwid Et Al 1997 The American Academy Of Neurology Volume 48 Pages 817 821 Gb | - |
| Sep 15, 2025 | Pc025 Bever 1994 The American Neurological Association 1994 Volume 23 Page 118 S121 Gb | - |
| Sep 15, 2025 | Pc024 Bever Et Al 1994 June Neurology 44 1054 1059 Gb | - |
| Sep 15, 2025 | Pc023 Davis Et Al 1990 The American Neurological Association 1990 Pages 186 192 Gb | - |
| Sep 15, 2025 | Pc022 Sherratt Et Al 1980 Nature Volume 283 5745 Pages 570 572 Gb | - |
| Sep 15, 2025 | Pc021 List Of Documents Cited In The Oppositions Gb | - |
| Sep 15, 2025 | Pc020 Merz Acquires Fampyra Gb | - |
| Sep 15, 2025 | Pc019 European Medicines Agency Guidelines Ich Topic E4 November 1994 Gb | - |
| Sep 15, 2025 | Pc018 EP536Oral Proceedings Gb | - |
| Sep 15, 2025 | Pc017 Verhagen Et Al Australian Journal Of Physiotherapy VOL 50 Gb | - |
| Sep 15, 2025 | Pc016 Piece Composite Synthese Wikipiedia Sur L Ecart Type Et La Valeur P Fr | - |
| Sep 15, 2025 | Pc015 Marien Et Beaud Guide Pratique Pour L Utilisation De La Statistique En Recherche Fr | - |
| Sep 15, 2025 | Pc014 Journal De La Societe Statistique De Paris 1956 Fr | - |
| Sep 15, 2025 | Pc013 Ting N Introduction And New Drug Development Process In Ting N Editor Dose Finding In Drug Development Springer Ne | - |
| Sep 15, 2025 | Pc012 Pirmohamed Et Al Bmj Volume 316 25 April 1998 Gb | - |
| Sep 15, 2025 | Pc011 Edwards And Aronson The Lancet VOL 356 October 7 Gb | - |
| Sep 15, 2025 | Pc010 Ich Topic E 8 General Considerations For Clinical Trials 17 July 1997 Gb | - |
| Sep 15, 2025 | Pc009 Griffin Et Al The Textbook Of Pharmaceutical Medicine 1993 Pages 221 222 Gb Compressed | - |
| Sep 15, 2025 | Pc008 Bopi 20 November N 1547 Pp 235 237 Et 258 Fr | - |
| Sep 15, 2025 | Pc007 Decision Et Requete De Delivrance Du Ccp N 13 C0033 Fr | - |
| Sep 15, 2025 | Pc006 Demande De Ccp Sur La Base Du Brevet EP2377536Fr | - |
| Sep 15, 2025 | Pc005 EP2377536B2 Gb | - |
| Sep 15, 2025 | Pc004 Fampyra Smpc Gb | - |
| Sep 15, 2025 | Pc003 Commission Implementing Decision Of 27 September C20246926 Gb | - |
| Sep 15, 2025 | Pc002 Rcp Fampridine Viatris Lp 10Mg Fr | - |
| Sep 15, 2025 | Pc001 Extrait Kbis Viatris Sante Fr | - |
| Sep 15, 2025 | Objection Viatris Sante App 339802025 Compressed Signed | - |
| Sep 11, 2025 | Summon Oral Hearing | - |
| Sep 11, 2025 | Order Summon The Oral Hearing | |
| Aug 18, 2025 | Procedural Order Timetable And Summon Oh | |
| Aug 18, 2025 | Hearing Dates | - |
| Aug 14, 2025 | Panel Appointment | - |
| Aug 7, 2025 | Acknowledgement Of Access To Case | - |
| Aug 6, 2025 | Notification Of Service | - |
| Aug 6, 2025 | Digital Tracking La Poste Service Receipt | - |
| Aug 5, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Notice To Accompany Service Of Order For Measures | - |
| Aug 1, 2025 | Letter For Service | - |
| Aug 1, 2025 | Formal Checks Notification Of Positive Outcome | - |
| Aug 1, 2025 | Exhibit No. 701 Application French Translation | - |
| Aug 1, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Aug 1, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Aug 1, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Aug 1, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Aug 1, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Aug 1, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Aug 1, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Aug 1, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Aug 1, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Aug 1, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Aug 1, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Aug 1, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Aug 1, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Aug 1, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Aug 1, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Aug 1, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Aug 1, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Aug 1, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Aug 1, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Aug 1, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Aug 1, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Aug 1, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Aug 1, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Aug 1, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Aug 1, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Aug 1, 2025 | Exhibit No. 401 Goodman Poster | - |
| Aug 1, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Aug 1, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Aug 1, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Aug 1, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Aug 1, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Aug 1, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Aug 1, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Aug 1, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 208 French Spc Register | - |
| Aug 1, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Aug 1, 2025 | Exhibit No. 206 French Patent Register | - |
| Aug 1, 2025 | Exhibit No. 205 EP536Patent | - |
| Aug 1, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Aug 1, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Aug 1, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Aug 1, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Aug 1, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Aug 1, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Aug 1, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Aug 1, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Aug 1, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Aug 1, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Aug 1, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Aug 1, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Aug 1, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Aug 1, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Aug 1, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Aug 1, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Aug 1, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Aug 1, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Aug 1, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Aug 1, 2025 | Exhibit No. 106 Larocca | - |
| Aug 1, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Aug 1, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Aug 1, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Aug 1, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Aug 1, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Aug 1, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Aug 1, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Aug 1, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Aug 1, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Aug 1, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Aug 1, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Aug 1, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Aug 1, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Aug 1, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Aug 1, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Aug 1, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Aug 1, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Aug 1, 2025 | Application For Provisional Measures | - |
| Aug 1, 2025 | Application For Measures Receipt | - |
| Aug 1, 2025 | Application For Measures Acknowledgement | - |
| Jul 31, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Jul 31, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Jul 31, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Jul 31, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Jul 31, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Jul 31, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Jul 31, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Jul 31, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Jul 31, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Jul 31, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Jul 31, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Jul 31, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Jul 31, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Jul 31, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Jul 31, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Jul 31, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Jul 31, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Jul 31, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Jul 31, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Jul 31, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Jul 31, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Jul 31, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Jul 31, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Jul 31, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Jul 31, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Jul 31, 2025 | Exhibit No. 401 Goodman Poster | - |
| Jul 31, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Jul 31, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Jul 31, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Jul 31, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Jul 31, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Jul 31, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Jul 31, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Jul 31, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 208 French Spc Register | - |
| Jul 31, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Jul 31, 2025 | Exhibit No. 206 French Patent Register | - |
| Jul 31, 2025 | Exhibit No. 205 EP536Patent | - |
| Jul 31, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Jul 31, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Jul 31, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Jul 31, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Jul 31, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Jul 31, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Jul 31, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Jul 31, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Jul 31, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Jul 31, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Jul 31, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Jul 31, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Jul 31, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Jul 31, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Jul 31, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Jul 31, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Jul 31, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Jul 31, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Jul 31, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Jul 31, 2025 | Exhibit No. 106 Larocca | - |
| Jul 31, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Jul 31, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Jul 31, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Jul 31, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Jul 31, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Jul 31, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Jul 31, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Jul 31, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Jul 31, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Jul 31, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Jul 31, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Jul 31, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Jul 31, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Jul 31, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Jul 31, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Jul 31, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Jul 31, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Jul 31, 2025 | Application For Provisional Measures | - |
| Oct 10, 2025 | Action.Communication | - |
| Oct 9, 2025 | Receipt | - |
| Oct 9, 2025 | Proof Of Payment | - |
| Oct 9, 2025 | Other Document | - |
| Oct 9, 2025 | Fee | - |
| Oct 9, 2025 | Cover Sheet | - |
| Oct 9, 2025 | Application | - |
| Oct 7, 2025 | Order | - |
| Oct 7, 2025 | Action.Issueorder | - |
| Oct 6, 2025 | Action.Communication | - |
| Oct 5, 2025 | Receipt | - |
| Oct 5, 2025 | Cover Sheet | - |
| Oct 5, 2025 | Application | - |
| Oct 2, 2025 | Receipt | - |
| Oct 2, 2025 | Order | - |
| Oct 2, 2025 | Cover Sheet | - |
| Oct 2, 2025 | Application | - |
| Oct 2, 2025 | Action.Issueorder | - |
| Oct 1, 2025 | Statement Of Reply | - |
| Oct 1, 2025 | Receipt | - |
| Oct 1, 2025 | Exhibit | - |
| Oct 1, 2025 | Cover Sheet | - |
| Oct 1, 2025 | Application | - |
| Sep 26, 2025 | Action.Communication | - |
| Sep 25, 2025 | Receipt | - |
| Sep 25, 2025 | Other Document | - |
| Sep 25, 2025 | Exhibit | - |
| Sep 25, 2025 | Cover Sheet | - |
| Sep 25, 2025 | Action.Communication | - |
| Sep 24, 2025 | Order | - |
| Sep 24, 2025 | Action.Issueorder | - |
| Sep 18, 2025 | Request V.Def Pdf A Signed | - |
| Sep 18, 2025 | Receipt | - |
| Sep 18, 2025 | Pc154 Iqvia Agreement Gb | - |
| Sep 18, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 17, 2025 | Receipt | - |
| Sep 17, 2025 | Procedural Order | |
| Sep 17, 2025 | Outcome Of The Order | - |
| Sep 17, 2025 | Headnote And Keywords | - |
| Sep 16, 2025 | Request For Procedural Order | - |
| Sep 16, 2025 | Receipt | - |
| Sep 16, 2025 | Objection | - |
| Sep 15, 2025 | Pj087 Regulation N 469 Gb | - |
| Sep 15, 2025 | Pj086 Court Of Appeal 10X Genomics Harvard V Nanostring Upc Coa 3352023 Gb | - |
| Sep 15, 2025 | Pj085 Dmf Nl Court Of The Hague 1Ere Instance Nl | - |
| Sep 15, 2025 | Pj084 Dmf Be Cour Dappel De Bruxelles Appel Nl | - |
| Sep 15, 2025 | Pj083 Fingolimod De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj082 Phosphodiesterase Nl Appeal Court Of The Hague Appel Nl | - |
| Sep 15, 2025 | Pj081 Dmf De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj080 Munich Local Division 21 May Upccfi432023 De | - |
| Sep 15, 2025 | Pj079 Ca Paris 9 July N2407962 Fr | - |
| Sep 15, 2025 | Pj078 Case Law Of The Boards Of Appeal Id108 Gb | - |
| Sep 15, 2025 | Pj077 Bonnes Pratiques De Distribution Ansm Bulletin Officiel N20149Bis Fr | - |
| Sep 15, 2025 | Pj076 Upc Court Of Appeal 25 September Upccoa1822024 Gb | - |
| Sep 15, 2025 | Pj075 Guidelines For Examination In The European Patent Office Gvii4Gb | - |
| Sep 15, 2025 | Pj074 Decision De La Chambre De Recours De Loeb DU 4 October T 111003 Gb | - |
| Sep 15, 2025 | Pj073 Epo Boa 10 July Eisai V Stada Lenvatinib T 193423 Gb | - |
| Sep 15, 2025 | Pj072 Hamburg Local Division 3 June Upccfi1512024 Gb | - |
| Sep 15, 2025 | Pj071 Dusseldorf Local Division 30 April Upccfi4632023 Gb | - |
| Sep 15, 2025 | Pj070 Dusseldorf Local Division 9 April Upccfi4522023 De | - |
| Sep 15, 2025 | Pj069 Dusseldorf Local Division VALEO V Magna Upc Cfi 3682024 Gb | - |
| Sep 15, 2025 | Pj068 Court Of Appeal Biolitec V Light Guide Optics Sia Lightguide 24 February Upccoa5402024 Gb | - |
| Sep 15, 2025 | Pj067 Ld Munich 15 November Upc Cfi 152023 Gb | - |
| Sep 15, 2025 | Pj065 Cjeu 28 July Synthon C Mertz Memantine C19509 Gb | - |
| Sep 15, 2025 | Pj064 Cjeu 28 July Generics Uk C Synaptech Galantamine C42709 Gb | - |
| Sep 15, 2025 | Pj063 Cass Com 10 February N1320150 Fr | - |
| Sep 15, 2025 | Pj062 Directive 200448CE Gb | - |
| Sep 15, 2025 | Pj061 Neurim Mylan High Court Of Justice 3 June Ewhc 1362 Gb | - |
| Sep 15, 2025 | Pj060 Decision De La Chambre De Recours De Loeb 13 September T023916 Gb | - |
| Sep 15, 2025 | Pj059 Decision De La Chambre De Recours De Loeb 4 October T250612 Gb | - |
| Sep 15, 2025 | Pj058 Tj Paris Refere 17 June Rg 2153849 Cabazitaxel Sanofi C Ever Pharma Fr | - |
| Sep 15, 2025 | Pj057 Tj Paris 12 May Rg 2153136 Cabazitaxel Sanofi C Teva Fr | - |
| Sep 15, 2025 | Pj056 Santen C 673 18 Gb | - |
| Sep 15, 2025 | Pj055 Tgi Paris 22 September 1407707 Fr | - |
| Sep 15, 2025 | Pj054 Cour Dappel De Paris 14 February 1991 Newtec International C Sfeima Pibd N504 Iiii432 Fr | - |
| Sep 15, 2025 | Pj053 Cour De Cassation 20 November Pourvoi N 1118440 Fr | - |
| Sep 15, 2025 | Pj052 Tgi Paris 6 June Rg N1606916 Fr | - |
| Sep 15, 2025 | Pj051 Tgi Rennes 2 September Rg N9803029 Fr | - |
| Sep 15, 2025 | Pj050 Decision De La Chambre De Recours 3306 De Loeb 30 May T 16596 Fr | - |
| Sep 15, 2025 | Pj049 Decision De La Chambre De Recours 3502 De Loeb 29 October T 33515 Fr | - |
| Sep 15, 2025 | Pj048 Decision De La Chambre De Recours De Loeb 10 November 1988 T038187 Gb | - |
| Sep 15, 2025 | Pj047 Tj Paris 22 June Rg N2002792 Fr | - |
| Sep 15, 2025 | Pj046 Decision De La Chambre De Recours De Loeb 20 September T197909 Gb | - |
| Sep 15, 2025 | Pj045 Decision De La Chambre De Recours De Loeb 1Er April T 140906 Gb | - |
| Sep 15, 2025 | Pj044 Decision De La Chambre De Recours De Loeb DU 28 January T 023715 Gb | - |
| Sep 15, 2025 | Pj043 Basf C25899 Gb | - |
| Sep 15, 2025 | Pj042 Gsk C21013 14 Nov Gb | - |
| Sep 15, 2025 | Pj041 Ca Paris 14 February Rg 1903820 Sandoz C Msd Fr | - |
| Sep 15, 2025 | Pj040 Abraxis C 443 17 21 March Gb | - |
| Sep 15, 2025 | Pj039 Case Law Of The Boards Of Appeal Of The Epo I D74 Try And See Solution Gb | - |
| Sep 15, 2025 | Pj038 Tj Paris 20 January Rg N 1901997 Fr | - |
| Sep 15, 2025 | Pj037 Tj Paris 6 September Rg N2106416 Fr | - |
| Sep 15, 2025 | Pj036 Tj Paris 7 June Rg 2153474 Sanofi C Accord Cabazitaxel Fr | - |
| Sep 15, 2025 | Pj035 Ca Paris 29 October Etypharm C Merck Rg N1803876 Fr | - |
| Sep 15, 2025 | Pj034 Cour Dappel De Paris 18 December Rg N 1710112 Fr | - |
| Sep 15, 2025 | Pj033 Decision De La Chambre De Recours De Loeb 25 July T 025915 Gb | - |
| Sep 15, 2025 | Pj032 Decision De La Chambre De Recours De Loeb 29 May T 009198 Gb | - |
| Sep 15, 2025 | Pj031 Decision De La Chambre De Recours De Loeb 5 October T 33397 Gb | - |
| Sep 15, 2025 | Pj030 Decision De La Chambre De Recours De Loeb 6 October T 91801 Gb | - |
| Sep 15, 2025 | Pj029 Decision De La Chambre De Recours De Loeb 14 February 1989 T 24988 Gb | - |
| Sep 15, 2025 | Pj028 Case Law Of The Boards Of Appeal Of The Epo Id71 Reasonable Expectation Of Success Gb | - |
| Sep 15, 2025 | Pj027 Jurisprudences Francaises Essais De Routine Fr | - |
| Sep 15, 2025 | Pj026 Tgi Paris 7 May Hexal C Boehringer Rg 0812537 Fr | - |
| Sep 15, 2025 | Pj025 Jub Division Centrale De Munich 16 July Sanofi C Amgen Upccfi 12023 Gb | - |
| Sep 15, 2025 | Pj024 Jub Cour Dappel 26 February Nanostring C 10X Genomics Upccoa3352023 Gb | - |
| Sep 15, 2025 | Pj023 Decision De La Chambre De Recours 332 De L Oeb 26 February T 92600 Gb | - |
| Sep 15, 2025 | Pj022 Decision De La Chambre De Recours 332 De Loeb 2 June T 30899 Gb | - |
| Sep 15, 2025 | Pj021 Decision De La Chambre De Recours 352 De Loeb 22 October 1993 T 25392 Gb | - |
| Sep 15, 2025 | Pj020 Decision De La Chambre De Recours 332 De Loeb 13 July T 393 01 Gb | - |
| Sep 15, 2025 | Pj019 Ca Paris 19 January Rg 18 21115 Fr | - |
| Sep 15, 2025 | Pj018 Tj Paris 20 July Rg N 21 10327 Fr | - |
| Sep 15, 2025 | Pj017 Ca Paris 14 November Rg N 1502576 Fr | - |
| Sep 15, 2025 | Pj016 Tj Paris 28 March Rg 2208612 Fr | - |
| Sep 15, 2025 | Pj014 Upc Court Of Appeal 13 August Upccoa4462025 Gb | - |
| Sep 15, 2025 | Pj013 Tj Paris 18 June Rg N 23 02356 Fr | - |
| Sep 15, 2025 | Pj012 Munich Local Division 27 August Upccfi2012024 Gb | - |
| Sep 15, 2025 | Pj011 Tj Paris 27 July Rg N 22 54367 Fr | - |
| Sep 15, 2025 | Pj010 Guidelines For Examination Of The Epo Giv1 Gb | - |
| Sep 15, 2025 | Pj009 Ca Paris 25 May Rg 21 18398 Fr | - |
| Sep 15, 2025 | Pj008 Tj Paris 29 September Rg 21 55930 Fr | - |
| Sep 15, 2025 | Pj007 Tj Paris Ordonnance De Refere 6 October Rg 22 55799 Biogen C Viatris Dmf Fr | - |
| Sep 15, 2025 | Pj006 Cjeu 16 July Genmab V Hungarian Ip Office Spc C 181 24 Gb | - |
| Sep 15, 2025 | Pj005 Accord Cadre Leem Ceps 5 March Fr | - |
| Sep 15, 2025 | Pj004 Regulation No 1768 92 Gb | - |
| Sep 15, 2025 | Pj003 Tj Paris Ordonnance Viatris C Novartis 04 August Fingolimod Rg N 2254655 Fr | - |
| Sep 15, 2025 | Pj002 Ca Paris 14 February Rg 1906114 Fr | - |
| Sep 15, 2025 | Pj001 Decision Du Conseil Constitutionnel N 463 Dc DU 12 December Fr | - |
| Sep 15, 2025 | Pc152 Submissions In High Resolution Gb | - |
| Sep 15, 2025 | Pc151 Declaration Dawid Sierzant DU 15 September Et Annexes Gb | - |
| Sep 15, 2025 | Pc150 4 Aminopyridine C5H6N2 Cid 1727 Pubchem Gb | - |
| Sep 15, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 15, 2025 | Pc148 The Fixing Of The Price And Reimboursement Rate Sante Gouv Fr | - |
| Sep 15, 2025 | Pc146 Letter From Viatris To Mez DATED 2 July Gb | - |
| Sep 15, 2025 | Pc145 Letter From Viatris To Merz Of 10 July Fr | - |
| Sep 15, 2025 | Pc143 Chapter 33 Pymadin Paskov Et Al 1986 Gb | - |
| Sep 15, 2025 | Pc142 Kostadinova And Danchev Gb | - |
| Sep 15, 2025 | Pc141 Sartori Et Al 1994 Gb | - |
| Sep 15, 2025 | Pc140 Olg Munchen Acorda Therapeutics V Ratiopharm 6 October 6 U 3044 22 De | - |
| Sep 15, 2025 | Pc139 Upsto Trademark Status Document Retrieval Pymadin Sopharma Gb | - |
| Sep 15, 2025 | Pc138 Website Of The Faculty Of Medicine In Sofia Bg | - |
| Sep 15, 2025 | Pc137 They Are Looking For A Superpill For Alzheimers Technologies News Standard Bg | - |
| Sep 15, 2025 | Pc136 Russian State Archive Of Scientific And Technical Documentation Ru | - |
| Sep 15, 2025 | Pc135 Communication Between The Ceps And Viatris Fr | - |
| Sep 15, 2025 | Pc134 Patient Leaflet Pymadin Bg | - |
| Sep 15, 2025 | Pc133 Smpc Pymadin Bg | - |
| Sep 15, 2025 | Pc132 Free State Gazette Edition 33 Of 2Iv Unofficial Section Ru | - |
| Sep 15, 2025 | Pc131 Disaster Protection Plan Burgas Region Republic Of Bulgaria Bg | - |
| Sep 15, 2025 | Pc130 4 Aminopiridin Spinal Cord Injury Forum Ru Compressed | - |
| Sep 15, 2025 | Pc129 Iqvia About Us Gb | - |
| Sep 15, 2025 | Pc128 Adverse Exhibit No 503 Toumi Et Al External Reference Pricing Simulation Gb | - |
| Sep 15, 2025 | Pc122 Application For Provisional Measures Gb | - |
| Sep 15, 2025 | Pc121 Acorda V Alkem Trial Transcript Volume B Gb | - |
| Sep 15, 2025 | Pc120 Acorda V Alkem Trial Transcript Volume A Gb | - |
| Sep 15, 2025 | Pc119 Hamilton Et Al 1998 Olanzapine Versus Placebo And Haloperidol Quality Of Life And Efficacy Results On The North Am | - |
| Sep 15, 2025 | Pc118 Overall 1994 Journal Of Clinical Psychology VOL 50 Pages 95 102 Gb | - |
| Sep 15, 2025 | Pc117 Alhainen Et Al 1991 Discrimination Of Tetrahydroaminoacridine Responders By A Single Dose Pharmaco Eeg In Patients | - |
| Sep 15, 2025 | Pc116 Sas Library 1997 Repeated Measures Anova Using Sas Proc Glm Gb | - |
| Sep 15, 2025 | Pc115 Sheeber Et Al 1996 Data Analytic Techniques For Treatment Outcome Studies With Pretest Posttest Measurements An Ex | - |
| Sep 15, 2025 | Pc114 Cook Et Al 1983 Design And Analysis Methods For Longitudinal Research Ann Rev Public Health Gb | - |
| Sep 15, 2025 | Pc113 Vickers Hor Many Repeated Measures In Repeates Measures Designs Statistical Issues For Comparative Trials Bmc | - |
| Sep 15, 2025 | Pc112 Uryniak Et Al Responder Analyses A Phrma Position Paper Statistics In Biopharmaceutical Research VOL 3 N3 Gb | - |
| Sep 15, 2025 | Pc111 Schulz Et Al The Efficacy Of Quetiapine VS Haloperidol And Placebo A Meta Analytic Study Of Efficacy Schizopp | - |
| Sep 15, 2025 | Pc110 Temple 1994 Commun Stat Theory Meth VOL 23 Pages 449 521 Gb | - |
| Sep 15, 2025 | Pc109 Lewis Statistics In Medicine VOL 21 Pages 2931 2938 Gb | - |
| Sep 15, 2025 | Pc108 Weiner 1998 Can J Neurol Sci VOL 25 Pages 93101 Gb | - |
| Sep 15, 2025 | Pc107 Petkau 1998 Seminars In Neurology VOL 18 3 Gb | - |
| Sep 15, 2025 | Pc106 Leber Et DAVIS 1998 Threats To The Validity Of Clinical Trials Employing Enrichment Strategies For Sample Selectio | - |
| Sep 15, 2025 | Pc105 DTX 584 Gb | - |
| Sep 15, 2025 | Pc104 4 Aminopyridine Induces Functional Improvement In Multiple Sclerosis Patients A Neurophysiological Study Gb | - |
| Sep 15, 2025 | Pc103 Stefoski Et Al 1991 4 Aminopyridine In Multiple Sclerosis Prolonged Administration Neurology 1991 Gb | - |
| Sep 15, 2025 | Pc102 Clinical Studies In 20 Questions Atelier Presse Clinical Trials Leem 19 May Fr | - |
| Sep 15, 2025 | Pc101 Report By Dr Christian Wolf DATED 2 September Gb | - |
| Sep 15, 2025 | Pc100 EP1732548B9 Gb | - |
| Sep 15, 2025 | Pc099 Matusik Therapy Nutrients 14 4249 Gb | - |
| Sep 15, 2025 | Pc098 Le Progres Article Patients Deprived Of A Medication Due To A Change Of Packaging 26 June Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 2 2 Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 1 2 Fr | - |
| Sep 15, 2025 | Pc096 Kehl Responder Identification In Clinical Trials June Gb | - |
| Sep 15, 2025 | Pc095 CPMP Points To Consider Multiplicity Issues Clinical Trials Gb | - |
| Sep 15, 2025 | Pc094 Hayes Et Al Pharmacokinetic Studies Of Single And Multiple Oral Doses Of Fampridine VOL 26 N4 Pp 185 192 Gb | - |
| Sep 15, 2025 | Pc093 Hayes Et Al Pharmacokinetics Of An Immediate Release Oral Formulation Of Fampridine 4 Aminopyridine In Normal | - |
| Sep 15, 2025 | Pc092 July 1986 Comment Determiner La Posologie Optimale D Un Medicament Fr | - |
| Sep 15, 2025 | Pc091 Dose Ranging Study Wikipedia Gb | - |
| Sep 15, 2025 | Pc090 Rnb Ccp 033 Fr | - |
| Sep 15, 2025 | Pc089 Rnb EP536Fr | - |
| Sep 15, 2025 | Pc088 Chmp 1999 Clinical Investigation Of Medicinal Products In The Treatment Of Parkinson S Disease CPMP Note For Guida | - |
| Sep 15, 2025 | Pc087 Ccne Opinion 79 Transposition Into French Law Of The European Directive On Clinical Trials Of Medicinal Products F | - |
| Sep 15, 2025 | Pc086 Declaration Of Helsinki Ethical Principles For Medical Research Involving Human Subjects Gb | - |
| Sep 15, 2025 | Pc085 Nuremberg Code Gb | - |
| Sep 15, 2025 | Pc084 Afsep Press Release Of 28 May Fr | - |
| Sep 15, 2025 | Pc083 Barus Et Al Fr | - |
| Sep 15, 2025 | Pc082 Extrait De La Base De Donnees Publique Des Medicaments Fampridine Viatris 10 Mg Fr | - |
| Sep 15, 2025 | Pc081 Icht Topic 9 Guideline On Statistical Principles For Clinical Trials September 1998 Gb | - |
| Sep 15, 2025 | Pc080 Website Of The Foundation For Research Into Multiple Sclerosis Fr | - |
| Sep 15, 2025 | Pc079 Notice On The Prices Of Fampridine Pharmaceutical Specialities Fr | - |
| Sep 15, 2025 | Pc078 Info Sheet Fampyra 10Mg Sustained Release Tablet Fr | - |
| Sep 15, 2025 | Pc077 Accession Of Bulgaria Gb | - |
| Sep 15, 2025 | Pc076 Kehl Responder Identification In Clinical Trials With Censored Data Gb | - |
| Sep 15, 2025 | Pc075 Federal Court Of Canada 15 May Acorda V Pharmascience And Taro T 1416 18 And T 220 19 Gb | - |
| Sep 15, 2025 | Pc074 Usa Delaware District Court 25 April Acorda V Teva Roxane Mylan 14 882 Gb | - |
| Sep 15, 2025 | Pc073 Usa Delaware District Court 31 March Acorda V Roxane 14 882 Lps Gb | - |
| Sep 15, 2025 | Pc072 Germany Teva Revocation Of Patent EP548De | - |
| Sep 15, 2025 | Pc071 Germany Ratiopharm Revocation Of Patent EP536De | - |
| Sep 15, 2025 | Pc070 Germany Ratiopharm Admissibility Of The EP536Invalidity Claim De | - |
| Sep 15, 2025 | Pc069 Board Of Appeal Of The European Patent Office 4 September T 0799 16 Gb | - |
| Sep 15, 2025 | Pc068 Decision Of The Epo EP536Gb Compressed | - |
| Sep 15, 2025 | Pc067 Emea Points To Consider On The Choice Of Non Interiority Margin Gb | - |
| Sep 15, 2025 | Pc066 Emea 27 July Points To Consider On Switching Betweend Superiority And Non Inferiority Gb | - |
| Sep 15, 2025 | Pc064 Usa Court Of Appeal 10 September Acorda V Roxane Et Al Et 2134 Gb | - |
| Sep 15, 2025 | Pc063 Form 10 K Wikipedia Presentation Gb | - |
| Sep 15, 2025 | Pc062 Cohen Postgraduate Medicine September 1999 Gb | - |
| Sep 15, 2025 | Pc061 L Echelle Edss Expanded Disability Status Scale Fr | - |
| Sep 15, 2025 | Pc060 O Brien Journal Of Hypertension Gb | - |
| Sep 15, 2025 | Pc059 Ellen R Girden Anova Repeated Measures 1992 Gb | - |
| Sep 15, 2025 | Pc058 Federal Court Of Appeal Of Canada 8 August Acorda Therapeutics V Pharmascience Taro Pharmaceuticals A 145 20 | - |
| Sep 15, 2025 | Pc057 Fda Chapter I Food And Drug Administration Department Of Health And Human Services Subchapter D Drugs For Human Us | - |
| Sep 15, 2025 | Pc056 Polman Arch Neur VOL 51 November 1994 Gb | - |
| Sep 15, 2025 | Pc055 Sheiner Clin Pharmacol Ther Volume 46 Number 1 July 1989 Gb | - |
| Sep 15, 2025 | Pc054 Norleans Statistical Methods For Clinical Trials Gb Compressed | - |
| Sep 15, 2025 | Pc053 Excerpt From The Fda Website Drug Evaluation Process Gb | - |
| Sep 15, 2025 | Pc052 Schwid Et Al April Gb | - |
| Sep 15, 2025 | Pc051 Kaufman Al The Significant Change For The Timed 25 Foot Walk In The Multiple Sclerosis Functional Composite M | - |
| Sep 15, 2025 | Pc050 Extract From The National Institutes Of Health Website Fda Drug Review And Approval Gb | - |
| Sep 15, 2025 | Pc049 Ca 2 562 277 Gb | - |
| Sep 15, 2025 | Pc048 US8663685Gb | - |
| Sep 15, 2025 | Pc047 US8440703Gb | - |
| Sep 15, 2025 | Pc046 US8354437Gb | - |
| Sep 15, 2025 | Pc045 Declaration Of Dr Ron Cohen Gb | - |
| Sep 15, 2025 | Pc044 US8007826Gb | - |
| Sep 15, 2025 | Pc043 Goodman Diaporama Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc042 Medical Research Council Mrc Scale For Muscle Strength Gb | - |
| Sep 15, 2025 | Pc041 National Multiple Sclerosis Society Timed 25 Foot Walk T25 Fw Gb | - |
| Sep 15, 2025 | Pc040 Ninds Fatigue Severity Scale Fss Gb | - |
| Sep 15, 2025 | Pc039 Wikipedia Page Edss Gb | - |
| Sep 15, 2025 | Pc038 Goodman Poster Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc037 Supplemental Information Disclosure Statement Gb | - |
| Sep 15, 2025 | Pc036 Actrims Ectrims Final Program Gb Compressed | - |
| Sep 15, 2025 | Pc035 List Of References Ids Gb | - |
| Sep 15, 2025 | Pc034 List Of Documents Requested US11102559Gb | - |
| Sep 15, 2025 | Pc033 Acorda Therapeutics Form S1 Gb | - |
| Sep 15, 2025 | Pc032 Form S 1 Presentation Gb | - |
| Sep 15, 2025 | Pc031 Sec Overview Gb | - |
| Sep 15, 2025 | Pc030 Goodman Abstract Poster Gb | - |
| Sep 15, 2025 | Pc029 Shargel 1999 Applied Biopharmaceutics And Pharmacokinetics Chapter 7 Extraits Pages 169 178 179 Gb Compressed | - |
| Sep 15, 2025 | Pc028 VAN Diemen Et Al 1992 August Gb | - |
| Sep 15, 2025 | Pc027 EP0484186B1 Gb | - |
| Sep 15, 2025 | Pc026 Schwid Et Al 1997 The American Academy Of Neurology Volume 48 Pages 817 821 Gb | - |
| Sep 15, 2025 | Pc025 Bever 1994 The American Neurological Association 1994 Volume 23 Page 118 S121 Gb | - |
| Sep 15, 2025 | Pc024 Bever Et Al 1994 June Neurology 44 1054 1059 Gb | - |
| Sep 15, 2025 | Pc023 Davis Et Al 1990 The American Neurological Association 1990 Pages 186 192 Gb | - |
| Sep 15, 2025 | Pc022 Sherratt Et Al 1980 Nature Volume 283 5745 Pages 570 572 Gb | - |
| Sep 15, 2025 | Pc021 List Of Documents Cited In The Oppositions Gb | - |
| Sep 15, 2025 | Pc020 Merz Acquires Fampyra Gb | - |
| Sep 15, 2025 | Pc019 European Medicines Agency Guidelines Ich Topic E4 November 1994 Gb | - |
| Sep 15, 2025 | Pc018 EP536Oral Proceedings Gb | - |
| Sep 15, 2025 | Pc017 Verhagen Et Al Australian Journal Of Physiotherapy VOL 50 Gb | - |
| Sep 15, 2025 | Pc016 Piece Composite Synthese Wikipiedia Sur L Ecart Type Et La Valeur P Fr | - |
| Sep 15, 2025 | Pc015 Marien Et Beaud Guide Pratique Pour L Utilisation De La Statistique En Recherche Fr | - |
| Sep 15, 2025 | Pc014 Journal De La Societe Statistique De Paris 1956 Fr | - |
| Sep 15, 2025 | Pc013 Ting N Introduction And New Drug Development Process In Ting N Editor Dose Finding In Drug Development Springer Ne | - |
| Sep 15, 2025 | Pc012 Pirmohamed Et Al Bmj Volume 316 25 April 1998 Gb | - |
| Sep 15, 2025 | Pc011 Edwards And Aronson The Lancet VOL 356 October 7 Gb | - |
| Sep 15, 2025 | Pc010 Ich Topic E 8 General Considerations For Clinical Trials 17 July 1997 Gb | - |
| Sep 15, 2025 | Pc009 Griffin Et Al The Textbook Of Pharmaceutical Medicine 1993 Pages 221 222 Gb Compressed | - |
| Sep 15, 2025 | Pc008 Bopi 20 November N 1547 Pp 235 237 Et 258 Fr | - |
| Sep 15, 2025 | Pc007 Decision Et Requete De Delivrance Du Ccp N 13 C0033 Fr | - |
| Sep 15, 2025 | Pc006 Demande De Ccp Sur La Base Du Brevet EP2377536Fr | - |
| Sep 15, 2025 | Pc005 EP2377536B2 Gb | - |
| Sep 15, 2025 | Pc004 Fampyra Smpc Gb | - |
| Sep 15, 2025 | Pc003 Commission Implementing Decision Of 27 September C20246926 Gb | - |
| Sep 15, 2025 | Pc002 Rcp Fampridine Viatris Lp 10Mg Fr | - |
| Sep 15, 2025 | Pc001 Extrait Kbis Viatris Sante Fr | - |
| Sep 15, 2025 | Objection Viatris Sante App 339802025 Compressed Signed | - |
| Sep 11, 2025 | Summon Oral Hearing | - |
| Sep 11, 2025 | Order Summon The Oral Hearing | |
| Aug 18, 2025 | Procedural Order Timetable And Summon Oh | |
| Aug 18, 2025 | Hearing Dates | - |
| Aug 14, 2025 | Panel Appointment | - |
| Aug 7, 2025 | Acknowledgement Of Access To Case | - |
| Aug 6, 2025 | Notification Of Service | - |
| Aug 6, 2025 | Digital Tracking La Poste Service Receipt | - |
| Aug 5, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Notice To Accompany Service Of Order For Measures | - |
| Aug 1, 2025 | Letter For Service | - |
| Aug 1, 2025 | Formal Checks Notification Of Positive Outcome | - |
| Aug 1, 2025 | Exhibit No. 701 Application French Translation | - |
| Aug 1, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Aug 1, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Aug 1, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Aug 1, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Aug 1, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Aug 1, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Aug 1, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Aug 1, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Aug 1, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Aug 1, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Aug 1, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Aug 1, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Aug 1, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Aug 1, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Aug 1, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Aug 1, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Aug 1, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Aug 1, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Aug 1, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Aug 1, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Aug 1, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Aug 1, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Aug 1, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Aug 1, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Aug 1, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Aug 1, 2025 | Exhibit No. 401 Goodman Poster | - |
| Aug 1, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Aug 1, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Aug 1, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Aug 1, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Aug 1, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Aug 1, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Aug 1, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Aug 1, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 208 French Spc Register | - |
| Aug 1, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Aug 1, 2025 | Exhibit No. 206 French Patent Register | - |
| Aug 1, 2025 | Exhibit No. 205 EP536Patent | - |
| Aug 1, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Aug 1, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Aug 1, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Aug 1, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Aug 1, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Aug 1, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Aug 1, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Aug 1, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Aug 1, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Aug 1, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Aug 1, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Aug 1, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Aug 1, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Aug 1, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Aug 1, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Aug 1, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Aug 1, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Aug 1, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Aug 1, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Aug 1, 2025 | Exhibit No. 106 Larocca | - |
| Aug 1, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Aug 1, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Aug 1, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Aug 1, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Aug 1, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Aug 1, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Aug 1, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Aug 1, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Aug 1, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Aug 1, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Aug 1, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Aug 1, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Aug 1, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Aug 1, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Aug 1, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Aug 1, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Aug 1, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Aug 1, 2025 | Application For Provisional Measures | - |
| Aug 1, 2025 | Application For Measures Receipt | - |
| Aug 1, 2025 | Application For Measures Acknowledgement | - |
| Jul 31, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Jul 31, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Jul 31, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Jul 31, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Jul 31, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Jul 31, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Jul 31, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Jul 31, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Jul 31, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Jul 31, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Jul 31, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Jul 31, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Jul 31, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Jul 31, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Jul 31, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Jul 31, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Jul 31, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Jul 31, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Jul 31, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Jul 31, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Jul 31, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Jul 31, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Jul 31, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Jul 31, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Jul 31, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Jul 31, 2025 | Exhibit No. 401 Goodman Poster | - |
| Jul 31, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Jul 31, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Jul 31, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Jul 31, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Jul 31, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Jul 31, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Jul 31, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Jul 31, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 208 French Spc Register | - |
| Jul 31, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Jul 31, 2025 | Exhibit No. 206 French Patent Register | - |
| Jul 31, 2025 | Exhibit No. 205 EP536Patent | - |
| Jul 31, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Jul 31, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Jul 31, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Jul 31, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Jul 31, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Jul 31, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Jul 31, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Jul 31, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Jul 31, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Jul 31, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Jul 31, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Jul 31, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Jul 31, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Jul 31, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Jul 31, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Jul 31, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Jul 31, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Jul 31, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Jul 31, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Jul 31, 2025 | Exhibit No. 106 Larocca | - |
| Jul 31, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Jul 31, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Jul 31, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Jul 31, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Jul 31, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Jul 31, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Jul 31, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Jul 31, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Jul 31, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Jul 31, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Jul 31, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Jul 31, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Jul 31, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Jul 31, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Jul 31, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Jul 31, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Jul 31, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Jul 31, 2025 | Application For Provisional Measures | - |
| Oct 10, 2025 | Action.Communication | - |
| Oct 9, 2025 | Receipt | - |
| Oct 9, 2025 | Proof Of Payment | - |
| Oct 9, 2025 | Other Document | - |
| Oct 9, 2025 | Fee | - |
| Oct 9, 2025 | Cover Sheet | - |
| Oct 9, 2025 | Application | - |
| Oct 7, 2025 | Order | - |
| Oct 7, 2025 | Action.Issueorder | - |
| Oct 6, 2025 | Action.Communication | - |
| Oct 5, 2025 | Receipt | - |
| Oct 5, 2025 | Cover Sheet | - |
| Oct 5, 2025 | Application | - |
| Oct 2, 2025 | Receipt | - |
| Oct 2, 2025 | Order | - |
| Oct 2, 2025 | Cover Sheet | - |
| Oct 2, 2025 | Application | - |
| Oct 2, 2025 | Action.Issueorder | - |
| Oct 1, 2025 | Statement Of Reply | - |
| Oct 1, 2025 | Receipt | - |
| Oct 1, 2025 | Exhibit | - |
| Oct 1, 2025 | Cover Sheet | - |
| Oct 1, 2025 | Application | - |
| Sep 26, 2025 | Action.Communication | - |
| Sep 25, 2025 | Receipt | - |
| Sep 25, 2025 | Other Document | - |
| Sep 25, 2025 | Exhibit | - |
| Sep 25, 2025 | Cover Sheet | - |
| Sep 25, 2025 | Action.Communication | - |
| Sep 24, 2025 | Order | - |
| Sep 24, 2025 | Action.Issueorder | - |
| Sep 18, 2025 | Request V.Def Pdf A Signed | - |
| Sep 18, 2025 | Receipt | - |
| Sep 18, 2025 | Pc154 Iqvia Agreement Gb | - |
| Sep 18, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 17, 2025 | Receipt | - |
| Sep 17, 2025 | Procedural Order | |
| Sep 17, 2025 | Outcome Of The Order | - |
| Sep 17, 2025 | Headnote And Keywords | - |
| Sep 16, 2025 | Request For Procedural Order | - |
| Sep 16, 2025 | Receipt | - |
| Sep 16, 2025 | Objection | - |
| Sep 15, 2025 | Pj087 Regulation N 469 Gb | - |
| Sep 15, 2025 | Pj086 Court Of Appeal 10X Genomics Harvard V Nanostring Upc Coa 3352023 Gb | - |
| Sep 15, 2025 | Pj085 Dmf Nl Court Of The Hague 1Ere Instance Nl | - |
| Sep 15, 2025 | Pj084 Dmf Be Cour Dappel De Bruxelles Appel Nl | - |
| Sep 15, 2025 | Pj083 Fingolimod De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj082 Phosphodiesterase Nl Appeal Court Of The Hague Appel Nl | - |
| Sep 15, 2025 | Pj081 Dmf De Olg Dusseldorf Appel De | - |
| Sep 15, 2025 | Pj080 Munich Local Division 21 May Upccfi432023 De | - |
| Sep 15, 2025 | Pj079 Ca Paris 9 July N2407962 Fr | - |
| Sep 15, 2025 | Pj078 Case Law Of The Boards Of Appeal Id108 Gb | - |
| Sep 15, 2025 | Pj077 Bonnes Pratiques De Distribution Ansm Bulletin Officiel N20149Bis Fr | - |
| Sep 15, 2025 | Pj076 Upc Court Of Appeal 25 September Upccoa1822024 Gb | - |
| Sep 15, 2025 | Pj075 Guidelines For Examination In The European Patent Office Gvii4Gb | - |
| Sep 15, 2025 | Pj074 Decision De La Chambre De Recours De Loeb DU 4 October T 111003 Gb | - |
| Sep 15, 2025 | Pj073 Epo Boa 10 July Eisai V Stada Lenvatinib T 193423 Gb | - |
| Sep 15, 2025 | Pj072 Hamburg Local Division 3 June Upccfi1512024 Gb | - |
| Sep 15, 2025 | Pj071 Dusseldorf Local Division 30 April Upccfi4632023 Gb | - |
| Sep 15, 2025 | Pj070 Dusseldorf Local Division 9 April Upccfi4522023 De | - |
| Sep 15, 2025 | Pj069 Dusseldorf Local Division VALEO V Magna Upc Cfi 3682024 Gb | - |
| Sep 15, 2025 | Pj068 Court Of Appeal Biolitec V Light Guide Optics Sia Lightguide 24 February Upccoa5402024 Gb | - |
| Sep 15, 2025 | Pj067 Ld Munich 15 November Upc Cfi 152023 Gb | - |
| Sep 15, 2025 | Pj065 Cjeu 28 July Synthon C Mertz Memantine C19509 Gb | - |
| Sep 15, 2025 | Pj064 Cjeu 28 July Generics Uk C Synaptech Galantamine C42709 Gb | - |
| Sep 15, 2025 | Pj063 Cass Com 10 February N1320150 Fr | - |
| Sep 15, 2025 | Pj062 Directive 200448CE Gb | - |
| Sep 15, 2025 | Pj061 Neurim Mylan High Court Of Justice 3 June Ewhc 1362 Gb | - |
| Sep 15, 2025 | Pj060 Decision De La Chambre De Recours De Loeb 13 September T023916 Gb | - |
| Sep 15, 2025 | Pj059 Decision De La Chambre De Recours De Loeb 4 October T250612 Gb | - |
| Sep 15, 2025 | Pj058 Tj Paris Refere 17 June Rg 2153849 Cabazitaxel Sanofi C Ever Pharma Fr | - |
| Sep 15, 2025 | Pj057 Tj Paris 12 May Rg 2153136 Cabazitaxel Sanofi C Teva Fr | - |
| Sep 15, 2025 | Pj056 Santen C 673 18 Gb | - |
| Sep 15, 2025 | Pj055 Tgi Paris 22 September 1407707 Fr | - |
| Sep 15, 2025 | Pj054 Cour Dappel De Paris 14 February 1991 Newtec International C Sfeima Pibd N504 Iiii432 Fr | - |
| Sep 15, 2025 | Pj053 Cour De Cassation 20 November Pourvoi N 1118440 Fr | - |
| Sep 15, 2025 | Pj052 Tgi Paris 6 June Rg N1606916 Fr | - |
| Sep 15, 2025 | Pj051 Tgi Rennes 2 September Rg N9803029 Fr | - |
| Sep 15, 2025 | Pj050 Decision De La Chambre De Recours 3306 De Loeb 30 May T 16596 Fr | - |
| Sep 15, 2025 | Pj049 Decision De La Chambre De Recours 3502 De Loeb 29 October T 33515 Fr | - |
| Sep 15, 2025 | Pj048 Decision De La Chambre De Recours De Loeb 10 November 1988 T038187 Gb | - |
| Sep 15, 2025 | Pj047 Tj Paris 22 June Rg N2002792 Fr | - |
| Sep 15, 2025 | Pj046 Decision De La Chambre De Recours De Loeb 20 September T197909 Gb | - |
| Sep 15, 2025 | Pj045 Decision De La Chambre De Recours De Loeb 1Er April T 140906 Gb | - |
| Sep 15, 2025 | Pj044 Decision De La Chambre De Recours De Loeb DU 28 January T 023715 Gb | - |
| Sep 15, 2025 | Pj043 Basf C25899 Gb | - |
| Sep 15, 2025 | Pj042 Gsk C21013 14 Nov Gb | - |
| Sep 15, 2025 | Pj041 Ca Paris 14 February Rg 1903820 Sandoz C Msd Fr | - |
| Sep 15, 2025 | Pj040 Abraxis C 443 17 21 March Gb | - |
| Sep 15, 2025 | Pj039 Case Law Of The Boards Of Appeal Of The Epo I D74 Try And See Solution Gb | - |
| Sep 15, 2025 | Pj038 Tj Paris 20 January Rg N 1901997 Fr | - |
| Sep 15, 2025 | Pj037 Tj Paris 6 September Rg N2106416 Fr | - |
| Sep 15, 2025 | Pj036 Tj Paris 7 June Rg 2153474 Sanofi C Accord Cabazitaxel Fr | - |
| Sep 15, 2025 | Pj035 Ca Paris 29 October Etypharm C Merck Rg N1803876 Fr | - |
| Sep 15, 2025 | Pj034 Cour Dappel De Paris 18 December Rg N 1710112 Fr | - |
| Sep 15, 2025 | Pj033 Decision De La Chambre De Recours De Loeb 25 July T 025915 Gb | - |
| Sep 15, 2025 | Pj032 Decision De La Chambre De Recours De Loeb 29 May T 009198 Gb | - |
| Sep 15, 2025 | Pj031 Decision De La Chambre De Recours De Loeb 5 October T 33397 Gb | - |
| Sep 15, 2025 | Pj030 Decision De La Chambre De Recours De Loeb 6 October T 91801 Gb | - |
| Sep 15, 2025 | Pj029 Decision De La Chambre De Recours De Loeb 14 February 1989 T 24988 Gb | - |
| Sep 15, 2025 | Pj028 Case Law Of The Boards Of Appeal Of The Epo Id71 Reasonable Expectation Of Success Gb | - |
| Sep 15, 2025 | Pj027 Jurisprudences Francaises Essais De Routine Fr | - |
| Sep 15, 2025 | Pj026 Tgi Paris 7 May Hexal C Boehringer Rg 0812537 Fr | - |
| Sep 15, 2025 | Pj025 Jub Division Centrale De Munich 16 July Sanofi C Amgen Upccfi 12023 Gb | - |
| Sep 15, 2025 | Pj024 Jub Cour Dappel 26 February Nanostring C 10X Genomics Upccoa3352023 Gb | - |
| Sep 15, 2025 | Pj023 Decision De La Chambre De Recours 332 De L Oeb 26 February T 92600 Gb | - |
| Sep 15, 2025 | Pj022 Decision De La Chambre De Recours 332 De Loeb 2 June T 30899 Gb | - |
| Sep 15, 2025 | Pj021 Decision De La Chambre De Recours 352 De Loeb 22 October 1993 T 25392 Gb | - |
| Sep 15, 2025 | Pj020 Decision De La Chambre De Recours 332 De Loeb 13 July T 393 01 Gb | - |
| Sep 15, 2025 | Pj019 Ca Paris 19 January Rg 18 21115 Fr | - |
| Sep 15, 2025 | Pj018 Tj Paris 20 July Rg N 21 10327 Fr | - |
| Sep 15, 2025 | Pj017 Ca Paris 14 November Rg N 1502576 Fr | - |
| Sep 15, 2025 | Pj016 Tj Paris 28 March Rg 2208612 Fr | - |
| Sep 15, 2025 | Pj014 Upc Court Of Appeal 13 August Upccoa4462025 Gb | - |
| Sep 15, 2025 | Pj013 Tj Paris 18 June Rg N 23 02356 Fr | - |
| Sep 15, 2025 | Pj012 Munich Local Division 27 August Upccfi2012024 Gb | - |
| Sep 15, 2025 | Pj011 Tj Paris 27 July Rg N 22 54367 Fr | - |
| Sep 15, 2025 | Pj010 Guidelines For Examination Of The Epo Giv1 Gb | - |
| Sep 15, 2025 | Pj009 Ca Paris 25 May Rg 21 18398 Fr | - |
| Sep 15, 2025 | Pj008 Tj Paris 29 September Rg 21 55930 Fr | - |
| Sep 15, 2025 | Pj007 Tj Paris Ordonnance De Refere 6 October Rg 22 55799 Biogen C Viatris Dmf Fr | - |
| Sep 15, 2025 | Pj006 Cjeu 16 July Genmab V Hungarian Ip Office Spc C 181 24 Gb | - |
| Sep 15, 2025 | Pj005 Accord Cadre Leem Ceps 5 March Fr | - |
| Sep 15, 2025 | Pj004 Regulation No 1768 92 Gb | - |
| Sep 15, 2025 | Pj003 Tj Paris Ordonnance Viatris C Novartis 04 August Fingolimod Rg N 2254655 Fr | - |
| Sep 15, 2025 | Pj002 Ca Paris 14 February Rg 1906114 Fr | - |
| Sep 15, 2025 | Pj001 Decision Du Conseil Constitutionnel N 463 Dc DU 12 December Fr | - |
| Sep 15, 2025 | Pc152 Submissions In High Resolution Gb | - |
| Sep 15, 2025 | Pc151 Declaration Dawid Sierzant DU 15 September Et Annexes Gb | - |
| Sep 15, 2025 | Pc150 4 Aminopyridine C5H6N2 Cid 1727 Pubchem Gb | - |
| Sep 15, 2025 | Pc149 Iqvia Data Unredacted Version Gb | - |
| Sep 15, 2025 | Pc148 The Fixing Of The Price And Reimboursement Rate Sante Gouv Fr | - |
| Sep 15, 2025 | Pc146 Letter From Viatris To Mez DATED 2 July Gb | - |
| Sep 15, 2025 | Pc145 Letter From Viatris To Merz Of 10 July Fr | - |
| Sep 15, 2025 | Pc143 Chapter 33 Pymadin Paskov Et Al 1986 Gb | - |
| Sep 15, 2025 | Pc142 Kostadinova And Danchev Gb | - |
| Sep 15, 2025 | Pc141 Sartori Et Al 1994 Gb | - |
| Sep 15, 2025 | Pc140 Olg Munchen Acorda Therapeutics V Ratiopharm 6 October 6 U 3044 22 De | - |
| Sep 15, 2025 | Pc139 Upsto Trademark Status Document Retrieval Pymadin Sopharma Gb | - |
| Sep 15, 2025 | Pc138 Website Of The Faculty Of Medicine In Sofia Bg | - |
| Sep 15, 2025 | Pc137 They Are Looking For A Superpill For Alzheimers Technologies News Standard Bg | - |
| Sep 15, 2025 | Pc136 Russian State Archive Of Scientific And Technical Documentation Ru | - |
| Sep 15, 2025 | Pc135 Communication Between The Ceps And Viatris Fr | - |
| Sep 15, 2025 | Pc134 Patient Leaflet Pymadin Bg | - |
| Sep 15, 2025 | Pc133 Smpc Pymadin Bg | - |
| Sep 15, 2025 | Pc132 Free State Gazette Edition 33 Of 2Iv Unofficial Section Ru | - |
| Sep 15, 2025 | Pc131 Disaster Protection Plan Burgas Region Republic Of Bulgaria Bg | - |
| Sep 15, 2025 | Pc130 4 Aminopiridin Spinal Cord Injury Forum Ru Compressed | - |
| Sep 15, 2025 | Pc129 Iqvia About Us Gb | - |
| Sep 15, 2025 | Pc128 Adverse Exhibit No 503 Toumi Et Al External Reference Pricing Simulation Gb | - |
| Sep 15, 2025 | Pc122 Application For Provisional Measures Gb | - |
| Sep 15, 2025 | Pc121 Acorda V Alkem Trial Transcript Volume B Gb | - |
| Sep 15, 2025 | Pc120 Acorda V Alkem Trial Transcript Volume A Gb | - |
| Sep 15, 2025 | Pc119 Hamilton Et Al 1998 Olanzapine Versus Placebo And Haloperidol Quality Of Life And Efficacy Results On The North Am | - |
| Sep 15, 2025 | Pc118 Overall 1994 Journal Of Clinical Psychology VOL 50 Pages 95 102 Gb | - |
| Sep 15, 2025 | Pc117 Alhainen Et Al 1991 Discrimination Of Tetrahydroaminoacridine Responders By A Single Dose Pharmaco Eeg In Patients | - |
| Sep 15, 2025 | Pc116 Sas Library 1997 Repeated Measures Anova Using Sas Proc Glm Gb | - |
| Sep 15, 2025 | Pc115 Sheeber Et Al 1996 Data Analytic Techniques For Treatment Outcome Studies With Pretest Posttest Measurements An Ex | - |
| Sep 15, 2025 | Pc114 Cook Et Al 1983 Design And Analysis Methods For Longitudinal Research Ann Rev Public Health Gb | - |
| Sep 15, 2025 | Pc113 Vickers Hor Many Repeated Measures In Repeates Measures Designs Statistical Issues For Comparative Trials Bmc | - |
| Sep 15, 2025 | Pc112 Uryniak Et Al Responder Analyses A Phrma Position Paper Statistics In Biopharmaceutical Research VOL 3 N3 Gb | - |
| Sep 15, 2025 | Pc111 Schulz Et Al The Efficacy Of Quetiapine VS Haloperidol And Placebo A Meta Analytic Study Of Efficacy Schizopp | - |
| Sep 15, 2025 | Pc110 Temple 1994 Commun Stat Theory Meth VOL 23 Pages 449 521 Gb | - |
| Sep 15, 2025 | Pc109 Lewis Statistics In Medicine VOL 21 Pages 2931 2938 Gb | - |
| Sep 15, 2025 | Pc108 Weiner 1998 Can J Neurol Sci VOL 25 Pages 93101 Gb | - |
| Sep 15, 2025 | Pc107 Petkau 1998 Seminars In Neurology VOL 18 3 Gb | - |
| Sep 15, 2025 | Pc106 Leber Et DAVIS 1998 Threats To The Validity Of Clinical Trials Employing Enrichment Strategies For Sample Selectio | - |
| Sep 15, 2025 | Pc105 DTX 584 Gb | - |
| Sep 15, 2025 | Pc104 4 Aminopyridine Induces Functional Improvement In Multiple Sclerosis Patients A Neurophysiological Study Gb | - |
| Sep 15, 2025 | Pc103 Stefoski Et Al 1991 4 Aminopyridine In Multiple Sclerosis Prolonged Administration Neurology 1991 Gb | - |
| Sep 15, 2025 | Pc102 Clinical Studies In 20 Questions Atelier Presse Clinical Trials Leem 19 May Fr | - |
| Sep 15, 2025 | Pc101 Report By Dr Christian Wolf DATED 2 September Gb | - |
| Sep 15, 2025 | Pc100 EP1732548B9 Gb | - |
| Sep 15, 2025 | Pc099 Matusik Therapy Nutrients 14 4249 Gb | - |
| Sep 15, 2025 | Pc098 Le Progres Article Patients Deprived Of A Medication Due To A Change Of Packaging 26 June Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 2 2 Fr | - |
| Sep 15, 2025 | Pc097 Screenshots Of Patients Testimonies Online 1 2 Fr | - |
| Sep 15, 2025 | Pc096 Kehl Responder Identification In Clinical Trials June Gb | - |
| Sep 15, 2025 | Pc095 CPMP Points To Consider Multiplicity Issues Clinical Trials Gb | - |
| Sep 15, 2025 | Pc094 Hayes Et Al Pharmacokinetic Studies Of Single And Multiple Oral Doses Of Fampridine VOL 26 N4 Pp 185 192 Gb | - |
| Sep 15, 2025 | Pc093 Hayes Et Al Pharmacokinetics Of An Immediate Release Oral Formulation Of Fampridine 4 Aminopyridine In Normal | - |
| Sep 15, 2025 | Pc092 July 1986 Comment Determiner La Posologie Optimale D Un Medicament Fr | - |
| Sep 15, 2025 | Pc091 Dose Ranging Study Wikipedia Gb | - |
| Sep 15, 2025 | Pc090 Rnb Ccp 033 Fr | - |
| Sep 15, 2025 | Pc089 Rnb EP536Fr | - |
| Sep 15, 2025 | Pc088 Chmp 1999 Clinical Investigation Of Medicinal Products In The Treatment Of Parkinson S Disease CPMP Note For Guida | - |
| Sep 15, 2025 | Pc087 Ccne Opinion 79 Transposition Into French Law Of The European Directive On Clinical Trials Of Medicinal Products F | - |
| Sep 15, 2025 | Pc086 Declaration Of Helsinki Ethical Principles For Medical Research Involving Human Subjects Gb | - |
| Sep 15, 2025 | Pc085 Nuremberg Code Gb | - |
| Sep 15, 2025 | Pc084 Afsep Press Release Of 28 May Fr | - |
| Sep 15, 2025 | Pc083 Barus Et Al Fr | - |
| Sep 15, 2025 | Pc082 Extrait De La Base De Donnees Publique Des Medicaments Fampridine Viatris 10 Mg Fr | - |
| Sep 15, 2025 | Pc081 Icht Topic 9 Guideline On Statistical Principles For Clinical Trials September 1998 Gb | - |
| Sep 15, 2025 | Pc080 Website Of The Foundation For Research Into Multiple Sclerosis Fr | - |
| Sep 15, 2025 | Pc079 Notice On The Prices Of Fampridine Pharmaceutical Specialities Fr | - |
| Sep 15, 2025 | Pc078 Info Sheet Fampyra 10Mg Sustained Release Tablet Fr | - |
| Sep 15, 2025 | Pc077 Accession Of Bulgaria Gb | - |
| Sep 15, 2025 | Pc076 Kehl Responder Identification In Clinical Trials With Censored Data Gb | - |
| Sep 15, 2025 | Pc075 Federal Court Of Canada 15 May Acorda V Pharmascience And Taro T 1416 18 And T 220 19 Gb | - |
| Sep 15, 2025 | Pc074 Usa Delaware District Court 25 April Acorda V Teva Roxane Mylan 14 882 Gb | - |
| Sep 15, 2025 | Pc073 Usa Delaware District Court 31 March Acorda V Roxane 14 882 Lps Gb | - |
| Sep 15, 2025 | Pc072 Germany Teva Revocation Of Patent EP548De | - |
| Sep 15, 2025 | Pc071 Germany Ratiopharm Revocation Of Patent EP536De | - |
| Sep 15, 2025 | Pc070 Germany Ratiopharm Admissibility Of The EP536Invalidity Claim De | - |
| Sep 15, 2025 | Pc069 Board Of Appeal Of The European Patent Office 4 September T 0799 16 Gb | - |
| Sep 15, 2025 | Pc068 Decision Of The Epo EP536Gb Compressed | - |
| Sep 15, 2025 | Pc067 Emea Points To Consider On The Choice Of Non Interiority Margin Gb | - |
| Sep 15, 2025 | Pc066 Emea 27 July Points To Consider On Switching Betweend Superiority And Non Inferiority Gb | - |
| Sep 15, 2025 | Pc064 Usa Court Of Appeal 10 September Acorda V Roxane Et Al Et 2134 Gb | - |
| Sep 15, 2025 | Pc063 Form 10 K Wikipedia Presentation Gb | - |
| Sep 15, 2025 | Pc062 Cohen Postgraduate Medicine September 1999 Gb | - |
| Sep 15, 2025 | Pc061 L Echelle Edss Expanded Disability Status Scale Fr | - |
| Sep 15, 2025 | Pc060 O Brien Journal Of Hypertension Gb | - |
| Sep 15, 2025 | Pc059 Ellen R Girden Anova Repeated Measures 1992 Gb | - |
| Sep 15, 2025 | Pc058 Federal Court Of Appeal Of Canada 8 August Acorda Therapeutics V Pharmascience Taro Pharmaceuticals A 145 20 | - |
| Sep 15, 2025 | Pc057 Fda Chapter I Food And Drug Administration Department Of Health And Human Services Subchapter D Drugs For Human Us | - |
| Sep 15, 2025 | Pc056 Polman Arch Neur VOL 51 November 1994 Gb | - |
| Sep 15, 2025 | Pc055 Sheiner Clin Pharmacol Ther Volume 46 Number 1 July 1989 Gb | - |
| Sep 15, 2025 | Pc054 Norleans Statistical Methods For Clinical Trials Gb Compressed | - |
| Sep 15, 2025 | Pc053 Excerpt From The Fda Website Drug Evaluation Process Gb | - |
| Sep 15, 2025 | Pc052 Schwid Et Al April Gb | - |
| Sep 15, 2025 | Pc051 Kaufman Al The Significant Change For The Timed 25 Foot Walk In The Multiple Sclerosis Functional Composite M | - |
| Sep 15, 2025 | Pc050 Extract From The National Institutes Of Health Website Fda Drug Review And Approval Gb | - |
| Sep 15, 2025 | Pc049 Ca 2 562 277 Gb | - |
| Sep 15, 2025 | Pc048 US8663685Gb | - |
| Sep 15, 2025 | Pc047 US8440703Gb | - |
| Sep 15, 2025 | Pc046 US8354437Gb | - |
| Sep 15, 2025 | Pc045 Declaration Of Dr Ron Cohen Gb | - |
| Sep 15, 2025 | Pc044 US8007826Gb | - |
| Sep 15, 2025 | Pc043 Goodman Diaporama Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc042 Medical Research Council Mrc Scale For Muscle Strength Gb | - |
| Sep 15, 2025 | Pc041 National Multiple Sclerosis Society Timed 25 Foot Walk T25 Fw Gb | - |
| Sep 15, 2025 | Pc040 Ninds Fatigue Severity Scale Fss Gb | - |
| Sep 15, 2025 | Pc039 Wikipedia Page Edss Gb | - |
| Sep 15, 2025 | Pc038 Goodman Poster Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb | - |
| Sep 15, 2025 | Pc037 Supplemental Information Disclosure Statement Gb | - |
| Sep 15, 2025 | Pc036 Actrims Ectrims Final Program Gb Compressed | - |
| Sep 15, 2025 | Pc035 List Of References Ids Gb | - |
| Sep 15, 2025 | Pc034 List Of Documents Requested US11102559Gb | - |
| Sep 15, 2025 | Pc033 Acorda Therapeutics Form S1 Gb | - |
| Sep 15, 2025 | Pc032 Form S 1 Presentation Gb | - |
| Sep 15, 2025 | Pc031 Sec Overview Gb | - |
| Sep 15, 2025 | Pc030 Goodman Abstract Poster Gb | - |
| Sep 15, 2025 | Pc029 Shargel 1999 Applied Biopharmaceutics And Pharmacokinetics Chapter 7 Extraits Pages 169 178 179 Gb Compressed | - |
| Sep 15, 2025 | Pc028 VAN Diemen Et Al 1992 August Gb | - |
| Sep 15, 2025 | Pc027 EP0484186B1 Gb | - |
| Sep 15, 2025 | Pc026 Schwid Et Al 1997 The American Academy Of Neurology Volume 48 Pages 817 821 Gb | - |
| Sep 15, 2025 | Pc025 Bever 1994 The American Neurological Association 1994 Volume 23 Page 118 S121 Gb | - |
| Sep 15, 2025 | Pc024 Bever Et Al 1994 June Neurology 44 1054 1059 Gb | - |
| Sep 15, 2025 | Pc023 Davis Et Al 1990 The American Neurological Association 1990 Pages 186 192 Gb | - |
| Sep 15, 2025 | Pc022 Sherratt Et Al 1980 Nature Volume 283 5745 Pages 570 572 Gb | - |
| Sep 15, 2025 | Pc021 List Of Documents Cited In The Oppositions Gb | - |
| Sep 15, 2025 | Pc020 Merz Acquires Fampyra Gb | - |
| Sep 15, 2025 | Pc019 European Medicines Agency Guidelines Ich Topic E4 November 1994 Gb | - |
| Sep 15, 2025 | Pc018 EP536Oral Proceedings Gb | - |
| Sep 15, 2025 | Pc017 Verhagen Et Al Australian Journal Of Physiotherapy VOL 50 Gb | - |
| Sep 15, 2025 | Pc016 Piece Composite Synthese Wikipiedia Sur L Ecart Type Et La Valeur P Fr | - |
| Sep 15, 2025 | Pc015 Marien Et Beaud Guide Pratique Pour L Utilisation De La Statistique En Recherche Fr | - |
| Sep 15, 2025 | Pc014 Journal De La Societe Statistique De Paris 1956 Fr | - |
| Sep 15, 2025 | Pc013 Ting N Introduction And New Drug Development Process In Ting N Editor Dose Finding In Drug Development Springer Ne | - |
| Sep 15, 2025 | Pc012 Pirmohamed Et Al Bmj Volume 316 25 April 1998 Gb | - |
| Sep 15, 2025 | Pc011 Edwards And Aronson The Lancet VOL 356 October 7 Gb | - |
| Sep 15, 2025 | Pc010 Ich Topic E 8 General Considerations For Clinical Trials 17 July 1997 Gb | - |
| Sep 15, 2025 | Pc009 Griffin Et Al The Textbook Of Pharmaceutical Medicine 1993 Pages 221 222 Gb Compressed | - |
| Sep 15, 2025 | Pc008 Bopi 20 November N 1547 Pp 235 237 Et 258 Fr | - |
| Sep 15, 2025 | Pc007 Decision Et Requete De Delivrance Du Ccp N 13 C0033 Fr | - |
| Sep 15, 2025 | Pc006 Demande De Ccp Sur La Base Du Brevet EP2377536Fr | - |
| Sep 15, 2025 | Pc005 EP2377536B2 Gb | - |
| Sep 15, 2025 | Pc004 Fampyra Smpc Gb | - |
| Sep 15, 2025 | Pc003 Commission Implementing Decision Of 27 September C20246926 Gb | - |
| Sep 15, 2025 | Pc002 Rcp Fampridine Viatris Lp 10Mg Fr | - |
| Sep 15, 2025 | Pc001 Extrait Kbis Viatris Sante Fr | - |
| Sep 15, 2025 | Objection Viatris Sante App 339802025 Compressed Signed | - |
| Sep 11, 2025 | Summon Oral Hearing | - |
| Sep 11, 2025 | Order Summon The Oral Hearing | |
| Aug 18, 2025 | Procedural Order Timetable And Summon Oh | |
| Aug 18, 2025 | Hearing Dates | - |
| Aug 14, 2025 | Panel Appointment | - |
| Aug 7, 2025 | Acknowledgement Of Access To Case | - |
| Aug 6, 2025 | Notification Of Service | - |
| Aug 6, 2025 | Digital Tracking La Poste Service Receipt | - |
| Aug 5, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Panel Appointment | - |
| Aug 1, 2025 | Notice To Accompany Service Of Order For Measures | - |
| Aug 1, 2025 | Letter For Service | - |
| Aug 1, 2025 | Formal Checks Notification Of Positive Outcome | - |
| Aug 1, 2025 | Exhibit No. 701 Application French Translation | - |
| Aug 1, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Aug 1, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Aug 1, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Aug 1, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Aug 1, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Aug 1, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Aug 1, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Aug 1, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Aug 1, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Aug 1, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Aug 1, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Aug 1, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Aug 1, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Aug 1, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Aug 1, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Aug 1, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Aug 1, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Aug 1, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Aug 1, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Aug 1, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Aug 1, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Aug 1, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Aug 1, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Aug 1, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Aug 1, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Aug 1, 2025 | Exhibit No. 401 Goodman Poster | - |
| Aug 1, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Aug 1, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Aug 1, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Aug 1, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Aug 1, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Aug 1, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Aug 1, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Aug 1, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Aug 1, 2025 | Exhibit No. 208 French Spc Register | - |
| Aug 1, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Aug 1, 2025 | Exhibit No. 206 French Patent Register | - |
| Aug 1, 2025 | Exhibit No. 205 EP536Patent | - |
| Aug 1, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Aug 1, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Aug 1, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Aug 1, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Aug 1, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Aug 1, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Aug 1, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Aug 1, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Aug 1, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Aug 1, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Aug 1, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Aug 1, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Aug 1, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Aug 1, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Aug 1, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Aug 1, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Aug 1, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Aug 1, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Aug 1, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Aug 1, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Aug 1, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Aug 1, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Aug 1, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Aug 1, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Aug 1, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Aug 1, 2025 | Exhibit No. 106 Larocca | - |
| Aug 1, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Aug 1, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Aug 1, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Aug 1, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Aug 1, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Aug 1, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Aug 1, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Aug 1, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Aug 1, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Aug 1, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Aug 1, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Aug 1, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Aug 1, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Aug 1, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Aug 1, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Aug 1, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Aug 1, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Aug 1, 2025 | Application For Provisional Measures | - |
| Aug 1, 2025 | Application For Measures Receipt | - |
| Aug 1, 2025 | Application For Measures Acknowledgement | - |
| Jul 31, 2025 | Exhibit No. 700 Proof Of Payment | - |
| Jul 31, 2025 | Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03 | - |
| Jul 31, 2025 | Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02 | - |
| Jul 31, 2025 | Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09 | - |
| Jul 31, 2025 | Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03 | - |
| Jul 31, 2025 | Exhibit No. 604 Coa Biolitec V Light Guide 24.02 | - |
| Jul 31, 2025 | Exhibit No. 601 Coa Mammut V Orthovox 25.09 | - |
| Jul 31, 2025 | Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10 | - |
| Jul 31, 2025 | Exhibit No. 512 Performance Based Remuneration | - |
| Jul 31, 2025 | Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07 | - |
| Jul 31, 2025 | Exhibit No. 510 Order Pharmacists Health Insurance 31.03 | - |
| Jul 31, 2025 | Exhibit No. 509 Substituting Generic Product On Ameli | - |
| Jul 31, 2025 | Exhibit No. 508 Ceilings For Discounts Decree | - |
| Jul 31, 2025 | Exhibit No. 507 Article L. 138 9 | - |
| Jul 31, 2025 | Exhibit No. 506 Cfiec T 201.04 R 22.12 | - |
| Jul 31, 2025 | Exhibit No. 505 Cfiec T 114.06 R 20.07 | - |
| Jul 31, 2025 | Exhibit No. 504 Leem Economic Extracts | - |
| Jul 31, 2025 | Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation | - |
| Jul 31, 2025 | Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation | - |
| Jul 31, 2025 | Exhibit No. 501 Health Products Agreement | - |
| Jul 31, 2025 | Exhibit No. 500 Notice Amendment Generic Distribution 6.01 | - |
| Jul 31, 2025 | Exhibit No. 405 Ema Guideline Mr Dosage Forms | - |
| Jul 31, 2025 | Exhibit No. 404 Acorda Sec S 1 Form | - |
| Jul 31, 2025 | Exhibit No. 403 Goodman Abstract | - |
| Jul 31, 2025 | Exhibit No. 402 Goodman Slideshow | - |
| Jul 31, 2025 | Exhibit No. 401 Goodman Poster | - |
| Jul 31, 2025 | Exhibit No. 400 Who Inn List 35 | - |
| Jul 31, 2025 | Exhibit No. 302 Epo T 0421.14 Decision | - |
| Jul 31, 2025 | Exhibit No. 301 Federal Patent Court Decision | - |
| Jul 31, 2025 | Exhibit No. 300 Epo T 0799.16 Decision | - |
| Jul 31, 2025 | Exhibit No. 213 French Patent Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 212 Acorda And Merz Llc Short Form Assignment | - |
| Jul 31, 2025 | Exhibit No. 211 French Spc Grant Publication | - |
| Jul 31, 2025 | Exhibit No. 210 French Spc Grant Decision | - |
| Jul 31, 2025 | Exhibit No. 209 French Spc Annuity Extract | - |
| Jul 31, 2025 | Exhibit No. 208 French Spc Register | - |
| Jul 31, 2025 | Exhibit No. 207 Upc Opt Out Extract | - |
| Jul 31, 2025 | Exhibit No. 206 French Patent Register | - |
| Jul 31, 2025 | Exhibit No. 205 EP536Patent | - |
| Jul 31, 2025 | Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence | - |
| Jul 31, 2025 | Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence | - |
| Jul 31, 2025 | Exhibit No. 202 Official Intellectual Property Bulletin 25 | - |
| Jul 31, 2025 | Exhibit No. 201 French Spc Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 200 French Patent Registration Entries | - |
| Jul 31, 2025 | Exhibit No. 132 Fampyra French Co Payment Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 131 Fampyra French Price Notice 04.06 | - |
| Jul 31, 2025 | Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 129 Fampyra French Reimbursement Order 02.06 | - |
| Jul 31, 2025 | Exhibit No. 128 Reply Letter 10.07 | - |
| Jul 31, 2025 | Exhibit No. 127 Notice Letter 4.07 | - |
| Jul 31, 2025 | Exhibit No. 126 Reply Letter 2.07 | - |
| Jul 31, 2025 | Exhibit No. 125 Notice Letter 18.06 | - |
| Jul 31, 2025 | Exhibit No. 124 Monthly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 123 Weekly Gers Fampridine Sales | - |
| Jul 31, 2025 | Exhibit No. 122 French Fampridine Ma | - |
| Jul 31, 2025 | Exhibit No. 121 French Co Payment Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 120 French Price Notice 22.11 | - |
| Jul 31, 2025 | Exhibit No. 119 French Public Institution Approval Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 118 French Reimbursement Order 19.11 | - |
| Jul 31, 2025 | Exhibit No. 117 French Generics List Decision 19.09 | - |
| Jul 31, 2025 | Exhibit No. 116 Fampridine Viatris French Directory | - |
| Jul 31, 2025 | Exhibit No. 115 Fampridine Viatris Pil | - |
| Jul 31, 2025 | Exhibit No. 114 Fampridine Viatris Smpc | - |
| Jul 31, 2025 | Exhibit No. 113 Ema Assessment Report | - |
| Jul 31, 2025 | Exhibit No. 112 Fampyra Eu Definitive Approval | - |
| Jul 31, 2025 | Exhibit No. 111 Eu Marketing Decisions | - |
| Jul 31, 2025 | Exhibit No. 110 Fampyra Eu Conditional Approval | - |
| Jul 31, 2025 | Exhibit No. 109 Fampyra Epar Summary | - |
| Jul 31, 2025 | Exhibit No. 108 Fampyra Smpc | - |
| Jul 31, 2025 | Exhibit No. 107 Fampyra French Directory | - |
| Jul 31, 2025 | Exhibit No. 106 Larocca | - |
| Jul 31, 2025 | Exhibit No. 105 Kasser Et Al. | - |
| Jul 31, 2025 | Exhibit No. 104 Lublin Reingold 1996 | - |
| Jul 31, 2025 | Exhibit No. 103 Lucchinetti Et Al. | - |
| Jul 31, 2025 | Exhibit No. 100 Merz Fampyra Launch News | - |
| Jul 31, 2025 | Exhibit No. 013 Acorda Webpage | - |
| Jul 31, 2025 | Exhibit No. 012 Viatris France Webpage | - |
| Jul 31, 2025 | Exhibit No. 011 Viatris Generics Webpage | - |
| Jul 31, 2025 | Exhibit No. 010 Viatris Products Webpage | - |
| Jul 31, 2025 | Exhibit No. 009 Fr Commercial Register Viatris Sante | - |
| Jul 31, 2025 | Exhibit No. 008 Fr Commercial Register Merz Pharma France | - |
| Jul 31, 2025 | Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh | - |
| Jul 31, 2025 | Exhibit No. 006 Merz Acorda Asset News | - |
| Jul 31, 2025 | Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc | - |
| Jul 31, 2025 | Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan | - |
| Jul 31, 2025 | Exhibit No. 003 Merz Therapeutics Website | - |
| Jul 31, 2025 | Exhibit No. 002 Merz Businesses Webpage | - |
| Jul 31, 2025 | Exhibit No. 001 Merz History Webpage | - |
| Jul 31, 2025 | Application For Provisional Measures | - |